Per Ljungman

About me
Publications
Public outreach and news

About me

Per Ljungman is emeritus professor of hematology and former director of and senior physician at the Dept. of Hematology and the Dept. of Cellular Therapy and Allogeneic Stem Cell Transplantation. He is the member of the Ethical Advisory board of the KI, honorary member of the European Society for Blood and Marrow Transplantation and the Swedish Society for Hematology. He is currently the scientific co-chair of the Transplant Associated Virus Forum under the auspices of University of California Berkeley and an advisor to the Adult Immunization Board organized by University of Antwerp and University Degli Studi Firenze.

Research

Viral infections and vaccination of patients after allogeneic stem cell transplantation

Articles

Journal article: CURRENT RESEARCH IN TRANSLATIONAL MEDICINE. 2024;72(3):103461

Pitfalls in definitions on respiratory viruses and particularities of Adenovirus infection in hematopoietic cell transplantation patients: Recommendations from the EBMT practice harmonization and guidelines committee

Pinana JL; Cesaro S; Mikulska M; Verweij PE; Bergeron A; Neofytos D; Styczynski J; Sanchez-Ortega I; Greco R; Onida F; Yakoub-Agha I; Averbuch D; de la Camara R; Ljungman P
Article: BONE MARROW TRANSPLANTATION. 2024;59(6):832-837

Harmonizing definitions for hematopoietic recovery, graft rejection, graft failure, poor graft function, and donor chimerism in allogeneic hematopoietic cell transplantation: a report on behalf of the EBMT, ASTCT, CIBMTR, and APBMT

Sureda A; Carpenter PA; Bacigalupo A; Bhatt VR; de la Fuente J; Ho A; Kean L; Lee JW; Sanchez-Ortega I; Savani BN; Schetelig J; Stadtmauer EA; Takahashi Y; Atsuta Y; Koreth J; Kroeger N; Ljungman P; Okamoto S; Popat U; Soiffer R; Stefanski HE; Kharfan-Dabaja MA
Article: JOURNAL OF CLINICAL ONCOLOGY. 2024;42(14):1699-1721

Vaccination of Adults With Cancer: ASCO Guideline

Kamboj M; Bohlke K; Baptiste DM; Dunleavy K; Fueger A; Jones L; Kelkar AH; Law LY; Lefebvre KB; Ljungman P; Miller ED; Meyer LA; Moore HN; Soares HP; Taplitz RA; Woldetsadik ES; Kohn EC
Article: INFECTION. 2024;:1-12

Outcome of Human Parainfluenza Virus infection in allogeneic stem cell transplantation recipients: possible impact of ribavirin therapy

Perez A; Montoro J; Chorao P; Gomez D; Guerreiro M; Gimenez E; Villalba M; Sanz J; Hernani R; Hernandez-Boluda JC; Lorenzo I; Navarro D; Solano C; Ljungman P; Pinana JL
Article: JOURNAL OF CLINICAL ONCOLOGY. 2024;42(12):1378-1390

Patient-Specific Measurable Residual Disease Markers Predict Outcome in Patients With Myelodysplastic Syndrome and Related Diseases After Hematopoietic Stem-Cell Transplantation

Tobiasson M; Pandzic T; Illman J; Nilsson L; Westrom S; Ejerblad E; Olesen G; Bjorklund A; Olsnes Kittang A; Werlenius O; Lorentz F; Rasmussen B; Cammenga J; Weber D; Lindholm C; Wiggh J; Dimitriou M; Moen AE; Lundstrom LY; von Bahr L; Baltzer-Sollander K; Jadersten M; Kytola S; Walldin G; Ljungman P; Groenbaek K; Mielke S; Jacobsen SEW; Ebeling F; Cavelier L; Smidstrup Friis L; Dybedal I; Hellstrom-Lindberg E
Article: BLOOD. 2024;143(11):953-966

Identification and surveillance of rare relapse-initiating stem cells during complete remission after transplantation

Dimitriou M; Mortera-Blanco T; Tobiasson M; Mazzi S; Lehander M; Hoegstrand K; Karimi M; Walldin G; Jansson M; Vonlanthen S; Ljungman P; Langemeijer S; Yoshizato T; Hellstroem-Lindberg E; Woll PS; Jacobsen SEW
Article: CELL HOST & MICROBE. 2024;32(2):156-161.e3

Memory T cells effectively recognize the SARS-CoV-2 hypermutated BA.2.86 variant

Muller TR; Gao Y; Wu J; Ribeiro O; Chen P; Bergman P; Blennow O; Hansson L; Mielke S; Nowak P; Vesterbacka J; Akber M; Soderdahl G; Smith CIE; Lore K; Chen MS; Ljungman P; Ingelman-Sundberg HM; Ljunggren H-G; Osterborg A; Sette A; Grifoni A; Aleman S; Buggert M
Article: JOURNAL OF INFECTIOUS DISEASES. 2024;57(SUPPL 1):83-94

Upper and/or lower respiratory tract infection caused by human metapneumovirus after allogeneic stem cell transplantation

Pinana JL; Tridelo G; Xhaard A; Wendel L; Montoro J; Vazquez L; Heras I; Ljungman P; Mikulska M; Salmen-Niemi U; Perez-Martinez A; Kroeger N; Cornelissen J; Sala E; Martino R; Lawson S; Byrne J; Maertens J; Kerre T; Martin M; Pascual MJ; Yeshurun M; Finke J; Groll AH; Shaw P; Blijlevens N; Arcese W; Ganser A; Suarez M; Alzahrani M; Choi G; Forcade E; Mussetti A; Wachowiak J; Zuckerman T; Bader P; Clausen J; Fegueux N; Holter W; Mayer J; Schroyens W; Metafun E; Knelange N; Averbuch D; De la Camara R
Article: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2024;95(2):125-133

Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort study

Silfverberg T; Zjukovskaja C; Ljungman P; Nahimi A; Ahlstrand E; Dreimane A; Einarsdottir S; Fagius J; Iacobaeus E; Hagglund H; Lange N; Lenhoff S; Lycke J; Mellergard J; Piehl F; Svenningsson A; Tolf A; Cherif H; Carlson K; Burman J
Article: BONE MARROW TRANSPLANTATION. 2024;59(1):52-58

Outcomes for patients with EBV-positive PTLD post-allogeneic HCT after failure of rituximab-containing therapy

Socie G; Barba P; Barlev A; Sanz J; Garcia-Cadenas I; Chevallier P; Fagioli F; Guzman-Becerra N; Kumar D; Ljungman P; Pigneux A; Sadetsky N; San Segundo LY; Shadman M; Storek J; Thirumalai D; Xing B; Mohty M
Article: BONE MARROW TRANSPLANTATION. 2024;59(1):59-65

Prevalence, management, and new treatment modalities of EBV-DNA-emia and EBV-PTLD after allo-HCT: survey of Infectious Diseases Working Party EBMT

Styczynski J; Tridello G; Wendel L; Knelange N; Cesaro S; Gil L; Ljungman P; Mikulska M; Averbuch D; de la Camara R
Article: BMJ OPEN. 2023;13(12):e078023

ProFertil study protocol for the investigation of gonadotropin-releasing hormone agonists (GnRHa) during chemotherapy aiming at fertility protection of young women and teenagers with cancer in Sweden-a phase III randomised double-blinded placebo-controlled study

Rodriguez-Wallberg KA; Nilsson HP; Bergh J; Malmros J; Ljungman P; Foukakis T; Stragliotto CL; Friman EI; Linderholm B; Valachis A; Andersson A; Harrysson S; Vennstrom L; Frisk P; Moerse H; Eloranta S
Article: BONE MARROW TRANSPLANTATION. 2023;58(12):1348-1356

Fresh or frozen grafts for allogeneic stem cell transplantation: conceptual considerations and a survey on the practice during the COVID-19 pandemic from the EBMT Infectious Diseases Working Party (IDWP) and Cellular Therapy & Immunobiology Working Party (CTIWP)

Worel N; Ljungman P; Verheggen ICM; Hoogenboom JD; Knelange NS; Eikema D-J; Sanchez-Ortega I; Riillo C; Centorrino I; Averbuch D; Chabannon C; de la Camara R; Kuball J; Ruggeri A
Article: CLINICAL INFECTIOUS DISEASES. 2023;77(8):1102-1110

A Phase 3, Randomized, Double-Blind, Comparator-Controlled Study to Evaluate Safety, Tolerability, and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vaccine, in Allogeneic Hematopoietic Cell Transplant Recipients (PNEU-STEM)

Wilck M; Cornely OA; Cordonnier C; Diego Velez J; Ljungman P; Maertens J; Selleslag D; Mullane KM; Nabhan S; Chen Q; Dagan R; Richmond P; Daus C; Geddie K; Tamms G; Sterling T; Patel SM; Shekar T; Musey L; Buchwald UK
Article: OPEN FORUM INFECTIOUS DISEASES. 2023;10(8):ofad386

Impact of Baseline and Week 2 and Week 4 Posttransplant CMV Cell-Mediated Immunity on Risk of CMV Infections and Mortality in Recipients of Allogeneic Hematopoietic Cell Transplant

Ariza-Heredia EJ; Winston DJ; Rowley SD; Mullane K; Chandrasekar P; Hari P; Avery RK; Peggs KS; Kumar D; Nath R; Ljungman P; Mossad SB; El Haddad L; Shah DP; Jiang Y; Khawaja F; Dadwal S; Blanchard T; Chemaly RF
Article: BONE MARROW TRANSPLANTATION. 2023;58(8):881-892

Decrease of lethal infectious complications in the context of causes of death (COD) after hematopoietic cell transplantation: COD-2 and COD-1 study of the Infectious Diseases Working Party EBMT

Styczynski J; Tridello G; Koster L; Knelange N; Wendel L; van Biezen A; van der Werf S; Mikulska M; Gil L; Cordonnier C; Ljungman P; Averbuch D; Cesaro S; Baldomero H; Chabannon C; Corbacioglu S; Dolstra H; Glass B; Greco R; Kroeger N; de Latour RP; Mohty M; Neven B; Peric Z; Snowden JA; Sureda A; Yakoub-Agha I; de la Camara R
Article: EBIOMEDICINE. 2023;94:104700

Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a one-year follow-up of the prospective clinical trial COVAXID

Chen P; Bergman P; Blennow O; Hansson L; Mielke S; Nowak P; Soderdahl G; oesterborg A; Smith CIE; Vesterbacka J; Wullimann D; Cuapio A; Akber M; Bogdanovic G; Muschiol S; aberg M; Lore K; Chen MS; Buggert M; Ljungman P; Aleman S; Ljunggren H-G
Article: SCIENCE TRANSLATIONAL MEDICINE. 2023;15(704):eadg9452

Additive effects of booster mRNA vaccination and SARS-CoV-2 Omicron infection on T cell immunity across immunocompromised states

Muller TRR; Sekine T; Trubach D; Niessl J; Chen P; Bergman P; Blennow O; Hansson L; Mielke S; Nowak P; Vesterbacka J; Akber M; Olofsson A; Hernandez SPA; Gao Y; Cai C; Soderdahl G; Smith CIE; Osterborg A; Lore K; Sallberg Chen M; Ljungman P; Ljunggren H-G; Karlsson ACC; Saini SK; Aleman S; Buggert M
Article: JOURNAL OF AUTOIMMUNITY. 2023;136:103024

Outcome of SARS-CoV2 infection in hematopoietic stem cell transplant recipients for autoimmune diseases

Greco R; Snowden JA; Knelange NS; Tridello G; Cacciatore C; Xhaard A; Ciceri F; Collin M; Ferra C; De Becker A; Badoglio M; Averbuch D; Alexander T; Ljungman P; De la Camara R
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2023;29(4):275.e1-275.e5

Long-Term Immunity Against Tetanus and Diphtheria after Vaccination of Allogeneic Stem Cell Transplantation Recipients

Einarsdottir S; Sverrisdottir I; Vaht K; Bergstrom T; Brune M; Andersson P-O; Wenneras C; Ljungman P
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2023;110(3):313-321

Bone marrow expression of CD68/CD163 macrophages, IL-17 and FOXP3 cells in aplastic anemia and their relation to prognosis

Vaht K; Brenner J; Ednersson SB; Ljungman P; Brune M; Andersson P-O
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2023;29(3):151-163

Harmonizing Definitions for Diagnostic Criteria and Prognostic Assessment of Transplantation-Associated Thrombotic Microangiopathy: A Report on Behalf of the European Society for Blood and Marrow Transplantation, American Society for Transplantation and Cellular Therapy, Asia-Pacific Blood and Marrow Transplantation Group, and Center for International Blood and Marrow Transplant Research

Schoettler ML; Carreras E; Cho B; Dandoy CE; Ho VT; Jodele S; Moissev I; Sanchez-Ortega I; Srivastava A; Atsuta Y; Carpenter P; Koreth J; Kroger N; Ljungman P; Page K; Popat U; Shaw BE; Sureda A; Soiffer R; Vasu S
Article: BONE MARROW TRANSPLANTATION. 2023;58(2):203-208

New trends in the management of cytomegalovirus infection after allogeneic hematopoietic cell transplantation: a survey of the Infectiois Diseases Working Pary of EBMT

Cesaro S; Ljungman P; Tridello G; Mikulska M; Wendel L; Styczynski J; Averbuch D; de la Camara R
Article: FRONTIERS IN IMMUNOLOGY. 2023;14:1125824

Improved outcomes over time and higher mortality in CMV seropositive allogeneic stem cell transplantation patients with COVID-19; An infectious disease working party study from the European Society for Blood and Marrow Transplantation registry

Ljungman P; Tridello G; Pinana JL; Ciceri F; Sengeloev H; Kulagin A; Mielke S; Yegin ZA; Collin M; Einardottir S; Lepretre SD; Maertens J; Campos A; Metafuni E; Pichler H; Folber F; Solano C; Nicholson E; Yuksel MK; Carlson K; Aguado B; Besley C; Byrne J; Heras I; Dignan F; Kroger N; Robin C; Khan A; Lenhoff S; Grassi A; Dobsinska V; Miranda N; Jimenez M-J; Yonal-Hindilerden I; Wilson K; Averbuch D; Cesaro S; Xhaard A; Knelange N; Styczynski J; Mikulska M; de la Camara R
Article: CLINICAL INFECTIOUS DISEASES. 2022;75(7):1210-1216

Consensus Definitions of BK Polyomavirus Nephropathy in Renal Transplant Recipients for Clinical Trials

Imlay H; Baum P; Brennan DC; Hanson KE; Hodges MR; Hodowanec AC; Komatsu TE; Ljungman P; Miller V; Natori Y; Nickeleit V; O'Rear J; Pikis A; Randhawa PS; Sawinski D; Singh HK; Westman G; Limaye AP
Article: IMMUNITY. 2022;55(9):1732-1746.e5

Immunodeficiency syndromes differentially impact the functional profile of SARS-CoV-2-specific T cells elicited by mRNA vaccination

Gao Y; Cai C; Wullimann D; Niessl J; Rivera-Ballesteros O; Chen P; Lange J; Cuapio A; Blennow O; Hansson L; Mielke S; Nowak P; Vesterbacka J; Akber M; Perez-Potti A; Sekine T; Muller TR; Boulouis C; Kammann T; Parrot T; Muvva JR; Sobkowiak M; Healy K; Bogdanovic G; Muschiol S; Soderdahl G; Osterborg A; Hellgren F; Grifoni A; Weiskopf D; Sette A; Lore K; Chen MS; Ljungman P; Sandberg JK; Smith CIE; Bergman P; Ljunggren H-G; Aleman S; Buggert M
Article: VIRUSES-BASEL. 2022;14(7):1350

The Importance of Secretor-Status in Norovirus Infection Following Allogeneic Hematopoietic Stem Cell Transplantation

Swartling L; Sparrelid E; Ljungman P; Boriskina K; Valentini D; Svensson L; Nordgren J
Article: JOURNAL OF CLINICAL MEDICINE. 2022;11(12):3541

Complications of Autologous Stem Cell Transplantation in Multiple Myeloma: Results from the CALM Study

Waszczuk-Gajda A; Penack O; Sbianchi G; Koster L; Blaise D; Remenyi P; Russell N; Ljungman P; Trneny M; Mayer J; Iacobelli S; Kobbe G; Scheid C; Apperley J; Touzeau C; Lenhoff S; Jantunen E; Anagnostopoulos A; Paris L; Browne P; Thieblemont C; Schaap N; Sierra J; Yakoub-Agha I; Garderet L; Styczynski J; Schoemans H; Moiseev I; Duarte RF; Peric Z; Montoto S; van Biezen A; Mikulska M; Aljurf M; Ruutu T; Kroeger N; Morris C; Koenecke C; Schoenland S; Basak GW
Article: BLOOD ADVANCES. 2022;6(9):2723-2730

Deficiency of SARS-CoV-2 T-cell responses after vaccination in long-term allo-HSCT survivors translates into abated humoral immunity

Einarsdottir S; Martner A; Waldenstrom J; Nicklasson M; Ringlander J; Arabpour M; Tornell A; Wiktorin HG; Nilsson S; Bittar R; Nilsson M; Lisak M; Veje M; Friman V; Al-Dury S; Bergstrom T; Ljungman P; Brune M; Hellstrand K; Lagging M
Article: BONE MARROW TRANSPLANTATION. 2022;57(5):817-823

Allogeneic hematopoietic stem cell transplantation for adult HLH: a retrospective study by the chronic malignancies and inborn errors working parties of EBMT

Machowicz R; Suarez F; Wiktor-Jedrzejczak W; Eikema D-J; de Wreede LC; Blok H-J; Isaksson C; Einsele H; Poire X; van Dorp S; Nikolousis E; Johansson J-E; Kobbe G; Zecca M; Arnold R; Gerbitz A; Finke J; Diez-Martin JL; Bonifazi F; McQuaker G; Lenhoff S; Rohrlich P-S; Theobald M; Ljungman P; Collin M; Albert MH; Ehninger G; Carlson K; Halaburda K; Lehmberg K; Schoenland S; Yakoub-Agha I; Gennery AR; Lankester AC; Kroeger N
Article: BONE MARROW TRANSPLANTATION. 2022;57(5):795-802

Cancer incidence in healthy Swedish peripheral blood stem cell donors

Pahnke S; Nygell UA; Johansson J-E; Kisch A; Ljungman P; Sandstedt A; Hagglund H; Larfors G
Article: BONE MARROW TRANSPLANTATION. 2022;57(4):598-606

Failure to reach hematopoietic allogenic stem cell transplantation in patients with myelodysplastic syndromes planned for transplantation: a population-based study

Lindholm C; Olofsson E; Creignou M; Nilsson L; Garelius HG; Cammenga J; Ljungman P; Ejerblad E; Tobiasson M
Article: AMERICAN JOURNAL OF HEMATOLOGY. 2022;97(4):421-430

Adverse outcomes in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: Follow-up of patients diagnosed 2002-2017 in a complete coverage and nationwide agnostic register study

Dahlen T; Edgren G; Ljungman P; Flygt H; Richter J; Olsson-Stromberg U; Wadenvik H; Dreimane A; Myhr-Eriksson K; Zhao J; Sjalander A; Hoglund M; Stenke L
Article: CELL REPORTS MEDICINE. 2022;3(2):100508

Autologous NK cells as consolidation therapy following stem cell transplantation in multiple myeloma

Nahi H; Chrobok M; Meinke S; Gran C; Marquardt N; Afram G; Sutlu T; Gilljam M; Stellan B; Wagner AK; Blomberg P; Holmqvist P-H; Walther-Jallow L; Mellstrom K; Liwing J; Gustafsson C; Mansson R; Klimkowska M; Gahrton G; Lund J; Ljungman P; Ljunggren H-G; Alici E
Article: MED. 2022;3(2):137-153.e3

Salivary IgG to SARS-CoV-2 indicates seroconversion and correlates to serum neutralization in mRNA-vaccinated immunocompromised individuals

Healy K; Pin E; Chen P; Soderdahl G; Nowak P; Mielke S; Hansson L; Bergman P; Smith CIE; Ljungman P; Valentini D; Blennow O; Osterborg A; Gabarrini G; Al-Manei K; Alkharaan H; Sobkowiak MJ; Yousef J; Mravinacova S; Cuapio A; Xu X; Akber M; Lore K; Hellstrom C; Muschiol S; Bogdanovic G; Buggert M; Ljunggren H-G; Hober S; Nilsson P; Aleman S; Chen MS
Article: MOLECULAR MEDICINE. 2022;28(1):20

NK cell frequencies, function and correlates to vaccine outcome in BNT162b2 mRNA anti-SARS-CoV-2 vaccinated healthy and immunocompromised individuals

Cuapio A; Boulouis C; Filipovic I; Wullimann D; Kammann T; Parrot T; Chen P; Akber M; Gao Y; Hammer Q; Strunz B; Potti AP; Ballesteros OR; Lange J; Muvva JR; Bergman P; Blennow O; Hansson L; Mielke S; Nowak P; Soderdahl G; Osterborg A; Smith CIE; Bogdanovic G; Muschiol S; Hellgren F; Lore K; Sobkowiak MJ; Gabarrini G; Healy K; Chen MS; Alici E; Bjorkstrom NK; Buggert M; Ljungman P; Sandberg JK; Aleman S; Ljunggren H-G
Article: BONE MARROW TRANSPLANTATION. 2022;57(2):215-223

Long-term results and GvHD after prophylactic and preemptive donor lymphocyte infusion after allogeneic stem cell transplantation for acute leukemia

Schmid C; Labopin M; Schaap N; Veelken H; Brecht A; Stadler M; Finke J; Baron F; Collin M; Bug G; Ljungman P; Blaise D; Tischer J; Bloor A; Kulagin A; Giebel S; Gorin N-C; Esteve J; Ciceri F; Savani B; Nagler A; Mohty M
Article: FRONTIERS IN IMMUNOLOGY. 2022;13:1027593

Different recovery patterns of CMV-specific and WT1-specific T cells in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: Impact of CMV infection and leukemia relapse

Luo X-H; Poiret T; Liu Z; Meng Q; Nagchowdhury A; Ljungman P
Article: FRONTIERS IN IMMUNOLOGY. 2022;13:1079995

Persistence of salivary antibody responses after COVID-19 vaccination is associated with oral microbiome variation in both healthy and people living with HIV

Ghorbani M; Al-Manei K; Naud S; Healy K; Gabarrini G; Sobkowiak MJ; Chen P; Ray S; Akber M; Muschiol S; Bogdanovic G; Bergman P; Ljungman P; Buggert M; Ljunggren H-G; Pin E; Nowak P; Aleman S; Saellberg Chen M
Article: JOURNAL OF INFECTION. 2022;84(1):71-79

Efficacy, safety and feasibility of treatment of chronic HCV infection with directly acting agents in hematopoietic stem cell transplant recipients - Study of infectious diseases working party of EBMT

Mikulska M; Knelange N; Nicolini LA; Tridello G; Santarone S; Di Bartolomeo P; de la Camara R; Cuellar C; Velardi A; Perruccio K; Ljungman P; Zaucha J; Piekarska A; Basak G; Karakulska-Prystupiuk E; Angelucci E; Ciceri F; Lupo-Stanghellini MT; Fouillard L; Garcia-Cadenas I; Menconi M; Blau IW; Nassi L; Cesaro S; Styczynski J
Article: HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM. 2021;2021(1):587-591

Infectious complications and vaccines

Ljungman P
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2021;27(12):991.e1-991.e9

Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelomonocytic Leukemia: Clinical and Molecular Genetic Prognostic Factors in a Nordic Population

Wedge E; Hansen JW; Dybedal I; Creignou M; Ejerblad E; Lorenz F; Werlenius O; Ungerstedt J; Holm MS; Nilsson L; Kittang AO; Antunovic P; Rohon P; Andersen MK; Papaemmanuil E; Bernard E; Jadersten M; Hellstrom-Lindberg E; Gronbaek K; Ljungman P; Friis LS
Article: JOURNAL OF CANCER SURVIVORSHIP. 2021;15(6):933-941

Important factors associated with sick leave after allogeneic haematopoietic stem cell transplantation-a 1-year prospective study

Eriksson L; Wennman-Larsen A; Bergkvist K; Ljungman P; Winterling J
Article: EBIOMEDICINE. 2021;74:103705

Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial

Bergman P; Blennow O; Hansson L; Mielke S; Nowak P; Chen P; Soderdahl G; Osterborg A; Smith CIE; Wullimann D; Vesterbacka J; Lindgren G; Blixt L; Friman G; Wahren-Borgstrom E; Nordlander A; Gomez AC; Akber M; Valentini D; Norlin A-C; Thalme A; Bogdanovic G; Muschiol S; Nilsson P; Hober S; Lore K; Chen MS; Buggert M; Ljunggren H-G; Ljungman P; Aleman S
Article: BONE MARROW TRANSPLANTATION. 2021;56(10):2367-2381

Second allogeneic transplants for multiple myeloma: a report from the EBMT Chronic Malignancies Working Party

Hayden PJ; Eikema D-J; de Wreede LC; Koster L; Kroger N; Einsele H; Minnema M; Dominietto A; Potter M; Passweg J; Bermudez A; Nguyen-quoc S; Platzbecker U; Tischer J; Ciceri F; Veelken JH; Ljungman P; Schaap N; Forcade E; Carella AM; Gandemer V; Arcese W; Bloor A; Olivieri A; Vincent L; Beksac M; Schonland S; Yakoub-Agha I
Article: LEUKEMIA. 2021;35(10):2885-2894

COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey

Ljungman P; de la Camara R; Mikulska M; Tridello G; Aguado B; Al Zahrani M; Apperley J; Berceanu A; Bofarull RM; Calbacho M; Ciceri F; Lopez-Corral L; Crippa C; Fox ML; Grassi A; Jimenez M-J; Demir SK; Kwon M; Llamas CV; Lorenzo JLL; Mielke S; Orchard K; Porras RP; Vallisa D; Xhaard A; Knelange NS; Cedillo A; Kroger N; Pinana JL; Styczynski J
Article: BONE MARROW TRANSPLANTATION. 2021;56(10):2518-2532

Special issues related to the diagnosis and management of acquired aplastic anemia in countries with restricted resources, a report on behalf of the Eastern Mediterranean blood and marrow transplantation (EMBMT) group and severe aplastic anemia working party of the European Society for blood and marrow transplantation (SAAWP of EBMT)

Iftikhar R; Ahmad P; de Latour R; Dufour C; Risitano A; Chaudhri N; Bazarbachi A; De la Fuente J; Hoechsmann B; Ahmed SO; Gergis U; Elhaddad A; Halkes C; Albeirouti B; Alotaibi S; Kulasekararaj A; Alzahrani H; Ben Othman T; Cesaro S; Alahmari A; Rihani R; Alshemmari S; Hamidieh AA; Bekadja M-A; Passweg J; Al-Khabori M; Rasheed W; Bacigalupo A; Chaudhry Q-U; Ljungman P; Marsh J; El Fakih R; Aljurf M
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2021;194(1):145-157

Incidence and impact of community respiratory viral infections in post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis and haploidentical stem cell transplantation

Mulroney CM; Bilal Abid M; Bashey A; Chemaly RF; Ciurea SO; Chen M; Dandoy CE; Diaz Perez MA; Friend BD; Fuchs E; Ganguly S; Goldsmith SR; Kanakry CG; Kim S; Komanduri KV; Krem MM; Lazarus HM; Ljungman P; Maziarz R; Nishihori T; Patel SS; Perales M-A; Romee R; Singh AK; Reid Wingard J; Yared J; Riches M; Taplitz R
Article: BONE MARROW TRANSPLANTATION. 2021;56(7):1493-1508

Hematopoietic stem cell transplantation for autoimmune diseases in the time of COVID-19: EBMT guidelines and recommendations

Greco R; Alexander T; Burman J; Del Papa N; de Vries-Bouwstra J; Farge D; Henes J; Kazmi M; Kirgizov K; Muraro PA; Ricart E; Rovira M; Saccardi R; Sharrack B; Snarski E; Withers B; Jessop H; Boglione C; Kramer E; Badoglio M; Labopin M; Orchard K; Corbacioglu S; Ljungman P; Mikulska M; De la Camara R; Snowden JA
Article: BONE MARROW TRANSPLANTATION. 2021;56(7):1563-1572

Impact of early candidemia on the long-term outcome of allogeneic hematopoietic stem cell transplant in non-leukemic patients: an outcome analysis on behalf of IDWP-EBMT

Cesaro S; Tridello G; Knelange NS; Blijlevens N; Martin M; Snowden JA; Malladi R; Ljungman P; Deconinck E; Gedde-Dahl T; Byrne J; Xhaard A; Chevallier P; Maertens J; Zuckerman T; Lioure B; Petersen E; Cornelissen JJ; Arcese W; Blaise D; Milpied N; Cahn JY; Aljurf M; de Wreede L; Mauro M; de la Camara R; Averbuch D; Mikulska M; Styczynski J
Article: BLOOD. 2021;137(23):3291-3305

Posttransplant cyclophosphamide is associated with increased cytomegalovirus infection: a CIBMTR analysis

Goldsmith SR; Abid MB; Auletta JJ; Bashey A; Beitinjaneh A; Castillo P; Chemaly RF; Chen M; Ciurea S; Dandoy CE; Diaz MA; Fuchs E; Ganguly S; Kanakry CG; Kanakry JA; Kim S; Komanduri KV; Krem MM; Lazarus HM; Liu H; Ljungman P; Masiarz R; Mulroney C; Nathan S; Nishihori T; Page KM; Perales M-A; Taplitz R; Romee R; Riches M
Article: BONE MARROW TRANSPLANTATION. 2021;56(5):1171-1179

Use of letermovir in off-label indications: Infectious Diseases Working Party of European Society of Blood and Marrow Transplantation retrospective study

Styczynski J; Tridello G; Xhaard A; Medinger M; Mielke S; Taskinen M; Blijlevens N; Rodriguez MAB; Solano C; Nikolousis E; Biffi A; Groll AH; Junghanss C; Tsirigotis P; Lioure B; Sramek J; Holler E; Galaverna F; Fagioli F; Knelange N; Wendel L; Gil L; de la Camara R; Mikulska M; Ljungman P
Article: BMJ OPEN. 2021;11(3):e044483

A randomised, open-label trial to assess the optimal treatment strategy in early diffuse cutaneous systemic sclerosis: the UPSIDE study protocol

Spierings J; van Rhenen A; Welsing PMW; Marijnissen ACA; De Langhe E; Del Papa N; Dierickx D; Gheorghe KR; Henes J; Hesselstrand R; Kerre T; Ljungman P; van de Loosdrecht AA; Marijt EWAF; Mayer M; Schmalzing M; Schroers R; Smith V; Voll RE; Vonk MC; Voskuyl AE; de Vries-Bouwstra JK; Walker UA; Wuttge DM; van Laar JM
Article: ECLINICALMEDICINE. 2021;33:100787

A randomised, placebo-controlled phase 3 study to evaluate the efficacy and safety of ASP0113, a DNA-based CMV vaccine, in seropositive allogeneic haematopoietic cell transplant recipients

Ljungman P; Bermudez A; Logan AC; Kharfan-Dabaja MA; Chevallier P; Martino R; Wulf G; Selleslag D; Kakihana K; Langston A; Lee D-G; Solano C; Okamoto S; Smith LR; Boeckh M; Wingard JR; Cywin B; Fredericks C; Lademacher C; Wang X; Young J; Maertens J
Article: ANNALS OF HEMATOLOGY. 2021;100(3):779-787

Abatacept as salvage therapy in chronic graft-versus-host disease-a retrospective analysis

Wertheimer T; Dohse M; Afram G; Weber D; Heidenreich M; Holler B; Kattner A-S; Neubauer A; Mielke S; Ljungman P; Holler E; Herr W; Edinger M; Martinez AP; Fante M; Wolff D
Article: VACCINE. 2021;39(7):1035-1038

Vaccination against tick-borne encephalitis (TBE) after autologous and allogeneic stem cell transplantation

Einarsdottir S; Nicklasson M; Veje M; Bergstrom T; Studahl M; Lisak M; Olsson M; Johansson B; Andreasson B; Piauger B; Roth A; Friman V; Ljungman P; Brune M
Article: BLOOD ADVANCES. 2021;5(1):262-273

Allogeneic hematopoietic stem cell transplantation in leukocyte adhesion deficiency type I and III

Bakhtiar S; Salzmann-Manrique E; Blok H-J; Eikema D-J; Hazelaar S; Ayas M; Toren A; Goldstein G; Moshous D; Locatelli F; Merli P; Michel G; Ozturk G; Schulz A; Heilmann C; Ifversen M; Wynn RF; Aleinikova O; Bertrand Y; Tbakhi A; Veys P; Karakukcu M; Kupesiz A; Ghavamzadeh A; Handgretinger R; Unal E; Perez-Martinez A; Gokce M; Porta F; Aksu T; Karasu G; Badell I; Ljungman P; Skorobogatova E; Yesilipek A; Zuckerman T; Bredius RRG; Stepensky P; Shadur B; Slatter M; Gennery AR; Albert MH; Bader P; Lankester A
Article: BONE MARROW TRANSPLANTATION. 2021;56(1):210-217

Upfront stem cell transplantation for newly diagnosed multiple myeloma with del(17p) and t(4;14): a study from the CMWP-EBMT

Gagelmann N; Eikema D-J; de Wreede LC; Rambaldi A; Iacobelli S; Koster L; Caillot D; Blaise D; Rememyi P; Bulabois C-E; Passweg J; Leleu X; Zver S; Kobbe G; Ljungman P; Chevallier P; Ringhoffer M; Martin M; Salmenniemi U; Poire X; Lenhoff S; Pioltelli P; Mordini N; Delforge M; Garderet L; Schoenland S; Yakoub-Agha I; Kroeger N
Article: CLINICAL INFECTIOUS DISEASES. 2020;71(11):2777-2786

A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial of Presatovir for the Treatment of Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hematopoietic-Cell Transplant Recipients

Chemaly RF; Dadwal SS; Bergeron A; Ljungman P; Kim Y-J; Cheng G-S; Pipavath SN; Limaye AP; Blanchard E; Winston DJ; Stiff PJ; Zuckerman T; Lachance S; Rahav G; Small CB; Mullane KM; Patron RL; Lee D-G; Hirsch HH; Waghmare A; McKevitt M; Jordan R; Guo Y; German P; Porter DP; Gossage DL; Watkins TR; Marty FM; Chien JW; Boeckh M
Article: CLINICAL INFECTIOUS DISEASES. 2020;71(11):2787-2795

A Phase 2b, Randomized, Double-blind, Placebo-Controlled Multicenter Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of Presatovir in Hematopoietic Cell Transplant Recipients with Respiratory Syncytial Virus Infection of the Lower Respiratory Tract

Marty FM; Chemaly RF; Mullane KM; Lee D-G; Hirsch HH; Small CB; Bergeron A; Shoham S; Ljungman P; Waghmare A; Blanchard E; Kim Y-J; McKevitt M; Porter DP; Jordan R; Guo Y; German P; Boeckh M; Watkins TR; Chien JW; Dadwal SS
Article: CLINICAL INFECTIOUS DISEASES. 2020;71(9):2365-2374

Cytomegalovirus (CMV) Cell-Mediated Immunity and CMV Infection After Allogeneic Hematopoietic Cell Transplantation: The REACT Study

Chemaly RF; El Haddad L; Winston DJ; Rowley SD; Mulane KM; Chandrasekar P; Avery RK; Hari P; Peggs KS; Kumar D; Nath R; Ljungman P; Mossad SB; Dadwal SS; Blanchard T; Shah DP; Jiang Y; Ariza-Heredia E
Article: JOURNAL OF INFECTION. 2020;81(6):882-894

Intercontinental study on pre-engraftment and post-engraftment Gram-negative rods bacteremia in hematopoietic stem cell transplantation patients: Risk factors and association with mortality

Averbuch D; Tridello G; Hoek J; Mikulska M; Pabst T; Yanez San Segundo L; Akan H; Ozcelik T; Donnini I; Klyasova G; de Sousa AB; Zuckerman T; Tecchio C; de la Camara R; Aki SZ; Ljungman P; Gulbas Z; Nicolas-Virelizier E; Calore E; Perruccio K; Ram R; Annaloro C; Martino R; Avni B; Shaw PJ; Jungova A; Codeluppi K; O'Brien T; Waszczuk-Gajda A; Batlle M; Pouli A; Lueck C; Gil L; Iacobelli S; Styczynski J; Engelhard D; Cesaro S
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2020;26(12):2181-2189

Real-World Issues and Potential Solutions in Hematopoietic Cell Transplantation during the COVID-19 Pandemic: Perspectives from the Worldwide Network for Blood and Marrow Transplantation and Center for International Blood and Marrow Transplant Research Health Services and International Studies Committee

Algwaiz G; Aljurf M; Koh M; Horowitz MM; Ljungman P; Weisdorf D; Saber W; Kodera Y; Szer J; Jawdat D; Wood WA; Brazauskas R; Lehmann L; Pasquini MC; Seber A; Lu PH; Atsuta Y; Riches M; Perales M-A; Worel N; Okamoto S; Srivastava A; Chemaly RF; Cordonnier C; Dandoy CE; Wingard JR; Kharfan-Dabaja MA; Hamadani M; Majhail NS; Waghmare AA; Chao N; Kroger N; Shaw B; Mohty M; Niederwieser D; Greinix H; Hashmi SK
Article: BONE MARROW TRANSPLANTATION. 2020;55(11):2071-2076

The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy

Ljungman P; Mikulska M; de la Camara R; Basak GW; Chabannon C; Corbacioglu S; Duarte R; Dolstra H; Lankester AC; Mohty M; Montoto S; Murray J; de Latour RP; Snowden JA; Yakoub-Agha I; Verhouven B; Kroeger N; Styczynski J
Article: STEM CELLS TRANSLATIONAL MEDICINE. 2020;9(10):1190-1202

Treatment of chronicGvHDwith mesenchymal stromal cells induces durable responses: A phaseIIstudy

Boberg E; von Bahr L; Afram G; Lindstrom C; Ljungman P; Heldring N; Petzelbauer P; Legert KG; Kadri N; Le Blanc K
Article: BLOOD. 2020;136(10):1201-1211

Hematopoietic cell transplantation in chronic granulomatous disease: a study of 712 children and adults

Chiesa R; Wang J; Blok H-J; Hazelaar S; Neven B; Moshous D; Schulz A; Hoenig M; Hauck F; Al Seraihy A; Gozdzik J; Ljungman P; Lindemans CA; Fernandes JF; Kalwak K; Strahm B; Schanz U; Sedlacek P; Sykora K-W; Aksoylar S; Locatelli F; Stepensky P; Wynn R; Lurn SH; Zecca M; Porta F; Taskinen M; Gibson B; Matthes S; Karakukcu M; Hauri-Hohl M; Veys P; Gennery AR; Lucchini G; Felber M; Albert MH; Balashov D; Lankester A; Gungor T; Slatter MA
Article: PEDIATRIC BLOOD & CANCER. 2020;67(9):e28507

A prospective study on the long-term outcome of prepubertal and pubertal boys undergoing testicular biopsy for fertility preservation prior to hematologic stem cell transplantation

Borgstrom B; Fridstrom M; Gustafsson B; Ljungman P; Rodriguez-Wallberg KA
Article: BONE MARROW TRANSPLANTATION. 2020;55(9):1796-1809

Long-term outcome after allogeneic hematopoietic stem cell transplantation for Shwachman-Diamond syndrome: a retrospective analysis and a review of the literature by the Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation (SAAWP-EBMT)

Cesaro S; Pillon M; Sauer M; Smiers F; Faraci M; de Heredia CD; Wynn R; Greil J; Locatelli F; Veys P; Uyttebroeck A; Ljungman P; Chevalier P; Ansari M; Badell I; Guengoer T; Salim R; Tischer J; Tecchio C; Russell N; Chybicka A; Styzynski J; Krivan G; Smith O; Stein J; Afanasyev B; Pochon C; Menconi MC; Bosman P; Mauro M; Tridello G; de Latour RP; Dufour C
Article: ONCOIMMUNOLOGY. 2020;9(1):1792058

Complete and long-lasting clinical responses in immune checkpoint inhibitor-resistant, metastasized melanoma treated with adoptive T cell transfer combined with DC vaccination

Lovgren T; Wolodarski M; Wickstrom S; Edback U; Wallin M; Martell E; Markland K; Blomberg P; Nystrom M; Lundqvist A; Jacobsson H; Ullenhag G; Ljungman P; Hansson J; Masucci G; Tell R; Poschke I; Adamson L; Mattsson J; Kiessling R
Article: BONE MARROW TRANSPLANTATION. 2020;55(7):1255-1263

Hepatitis E virus is an infrequent but potentially serious infection in allogeneic hematopoietic stem cell transplant recipients

Swartling L; Norden R; Samuelsson E; Boriskina K; Valentini D; Westin J; Norder H; Sparrelid E; Ljungman P
Article: AMERICAN JOURNAL OF TRANSPLANTATION. 2020;20(6):1703-1711

Outcomes of patients with detectable CMV DNA at randomization in the phase III trial of letermovir for the prevention of CMV infection in allogeneic hematopoietic cell transplantation

Marty FM; Ljungman PT; Chemaly RF; Wan H; Teal VL; Butterton JR; Yeh WW; Leavitt RY; Badshah CS
Article: CLINICAL INFECTIOUS DISEASES. 2020;70(8):1525-1533

A Mortality Analysis of Letermovir Prophylaxis for Cytomegalovirus (CMV) in CMV-seropositive Recipients of Allogeneic Hematopoietic Cell Transplantation

Ljungman P; Schmitt M; Marty FM; Maertens J; Chemaly RF; Kartsonis NA; Butterton JR; Wan H; Teal VL; Sarratt K; Murata Y; Leavitt RY; Badshah C
Article: JOURNAL OF NEUROLOGY. 2020;267(2):430-439

Central nervous system disorders after hematopoietic stem cell transplantation: a prospective study of the Infectious Diseases Working Party of EBMT

Schmidt-Hieber M; Engelhard D; Ullmann A; Ljungman P; Maertens J; Martino R; Rovira M; Shaw PJ; Robin C; Faraci M; Byrne J; Schaefer-Eckart K; Einsele H; Faber E; Rigacci L; Saccardi R; Balaguer-Rosello A; Isaksson C; Christopeit M; Tridello G; Wang J; Knelange N; Mikulska M; Cesaro S; Styczynski J
Article: VACCINE. 2020;38(5):1084-1088

Humoral immunity to tetanus, diphtheria and polio in adults after treatment for hematological malignancies

Einarsdottir S; Ljungman P; Kaijser B; Nicklasson M; Horal P; Norder H; Bergstrom T; Brune M
Article: BONE MARROW TRANSPLANTATION. 2020;55(1):126-136

Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factors

Styczynski J; Tridello G; Koster L; Iacobelli S; van Biezen A; van der Werf S; Mikulska M; Gil L; Cordonnier C; Ljungman P; Averbuch D; Cesaro S; de la Camara R; Baldomero H; Bader P; Basak G; Bonini C; Duarte R; Dufour C; Kuball J; Lankester A; Montoto S; Nagler A; Snowden JA; Kroeger N; Mohty M; Gratwohl A
Article: FRONTIERS IN IMMUNOLOGY. 2020;11:584520

Haplotype Motif-Based Models for KIR-Genotype Informed Selection of Hematopoietic Cell Donors Fail to Predict Outcome of Patients With Myelodysplastic Syndromes or Secondary Acute Myeloid Leukemia

Schetelig J; Baldauf H; Koster L; Kuxhausen M; Heidenreich F; de Wreede LC; Spellman S; van Gelder M; Bruno B; Onida F; Lange V; Massalski C; Potter V; Ljungman P; Schaap N; Hayden P; Lee SJ; Kroeger N; Hsu K; Schmidt AH; Yakoub-Agha I; Robin M
Article: BONE MARROW TRANSPLANTATION. 2019;54(12):2060-2071

Prognostic impact of EBV serostatus in patients with lymphomas or chronic malignancies undergoing allogeneic HCT

Styczynski J; Tridello G; Gil L; Ljungman P; Mikulska M; Ward KN; Cordonnier C; de la Camara R; Averbuch D; Knelange N; Socie G; Chevallier P; Blaise D; Yakoub-Agha I; Forcade E; Cornelissen J; Maertens J; Petersen E; Nguyen-Quoc S; Veelken H; Schaap N; Passweg J; Michallet M; Fegueux N; Deconinck E; Russell N; Basak G; Bader P; Montoto S; Kroeger N; Cesaro S
Article: CLINICAL TRANSPLANTATION. 2019;33(12):e13742

Bone and hormonal status 10 years post-allogeneic bone marrow transplantation

Gubrianska D; Machaczka M; Hassan M; Hagglund H; Ljungman P; Palmer M
Article: HEMASPHERE. 2019;3(6):e321

Nordic Guidelines for Germline Predisposition to Myeloid Neoplasms in Adults: Recommendations for Genetic Diagnosis, Clinical Management and Follow-up

Baliakas P; Tesi B; Wartiovaara-Kautto U; Stray-Pedersen A; Friis LS; Dybedal I; Hovland R; Jahnukainen K; Raaschou-Jensen K; Ljungman P; Rustad CF; Lautrup CK; Kilpivaara O; Kittang AO; Gronbaek K; Cammenga J; Hellstrom-Lindberg E; Andersen MK
Article: BONE MARROW TRANSPLANTATION. 2019;54(11):1764-1774

Allogeneic stem cell transplantation for chronic myeloid leukemia in the TKI era: population-based data from the Swedish CML registry

Lubking A; Dreimane A; Sandin F; Isaksson C; Markevarn B; Brune M; Ljungman P; Lenhoff S; Stenke L; Hoglund M; Richter J; Olsson-Stromberg U
Article: HAEMATOLOGICA. 2019;104(11):2155-2163

Guidelines from the 2017 European Conference on Infections in Leukaemia for management of HHV-6 infection in patients with hematologic malignancies and after hematopoietic stem cell transplantation

Ward KN; Hill JA; Hubacek P; de la Camara R; Crocchiolo R; Einsele H; Navarro D; Robin C; Cordonnier C; Ljungman P
Article: CLINICAL INFECTIOUS DISEASES. 2019;69(10):1771-1779

Bloodstream Infection Due to Vancomycin-resistant Enterococcus Is Associated With Increased Mortality After Hematopoietic Cell Transplantation for Acute Leukemia and Myelodysplastic Syndrome: A Multicenter, Retrospective Cohort Study

Papanicolaou GA; Ustun C; Young J-AH; Chen M; Kim S; Ahn KW; Komanduri K; Lindemans C; Auletta JJ; Riches ML; Abdel-Azim H; Ahmed IA; Aljurf M; Antin J; Ballen KK; Beitinjaneh A; Brown VI; Cerny J; Champlin R; Chao N; Chhabra S; Dahi PB; Daly A; Dandoy C; Dvorak CC; Forman S; Freytes C; Ganguly S; Hashmi SK; Kharfan-Dabaja MA; Lazarus H; Ljungman P; Malone AK; Murthy G; Nishihori T; Page K; Pingali RSR; Reddy V; Saad A; Savani BN; Seftel M; Szer J; Vij R; Weisdorf D; William BM; Williams K; Wirk B; Yared J; Yu LC
Article: TRANSPLANT INFECTIOUS DISEASE. 2019;21(5):e13145

Survival outcomes of allogeneic hematopoietic cell transplants with EBV-positive or EBV-negative post-transplant lymphoproliferative disorder, A CIBMTR study

Naik S; Riches M; Hari P; Kim S; Chen M; Bachier C; Shaughnessy P; Hill J; Ljungman P; Battiwalla M; Chhabra S; Daly A; Storek J; Ustun C; Diaz MA; Cerny J; Beitinjaneh A; Yared J; Brown V; Page K; Dahi PB; Ganguly S; Seo S; Chao N; Freytes CO; Saad A; Savani BN; Ahn KW; Boeckh M; Heslop HE; Lazarus HM; Auletta JJ; Kamble RT
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2019;25(10):2008-2016

Allogeneic Stem Cell Transplantation for Blast Crisis Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors: A Retrospective Study by the EBMT Chronic Malignancies Working Party

Radujkovic A; Dietrich S; Blok H-J; Nagler A; Ayuk F; Finke J; Tischer J; Mayer J; Koc Y; Sora F; Passweg J; Byrne JL; Jindra P; Veelken JH; Socie G; Maertens J; Schaap N; Stadler M; Itala-Remes M; Tholouli E; Arat M; Rocha V; Ljungman P; Yakoub-Agha I; Kroeger N; Chalandon Y
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2019;25(10):1970-1974

High Graft-versus-Host Disease-Free, Relapse/Rejection-Free Survival and Similar Outcome of Related and Unrelated Allogeneic Stem Cell Transplantation for Aplastic Anemia: A Nationwide Swedish Cohort Study

Vaht K; Goransson M; Carlson K; Isaksson C; Lenhoff S; Sandstedt A; Uggla B; Winiarski J; Ljungman P; Andersson P-O; Brune M
Article: HAEMATOLOGICA. 2019;104(9):1782-1788

Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis

Robin M; de Wreede LC; Wolschke C; Schetelig J; Eikema D-J; Van Lint MT; Knelange NS; Beelen D; Brecht A; Niederwieser D; Vitek A; Bethge W; Arnold R; Finke J; Volin L; Yakoub-Agha I; Nagler A; Poire X; Einsele H; Chevallier P; Holler E; Ljungman P; Robinson S; Radujkovic A; McLornan D; Chalandon Y; Kroeger N
Article: BONE MARROW TRANSPLANTATION. 2019;54(9):1391-1398

EBMT prospective observational study on allogeneic hematopoietic stem cell transplantation in T-prolymphocytic leukemia (T-PLL)

Wiktor-Jedrzejczak W; Drozd-Sokolowska J; Eikema DJ; Hoek J; Potter M; Wulf G; Sellner L; Ljungman P; Chevallier P; Volin L; Koc Y; Martin S; Bunjes D; Rovira M; Itala-Remes M; Foa R; Deconinck E; Gedde-Dahl T; Cornelissen J; Collin M; Brecht A; Patel A; de Groot M; Remenyi P; Nagler A; Finke J; Turlure P; Iacobelli S; van Biezen A; Schetelig J; Kroeger N; Dreger P
Article: LEUKEMIA & LYMPHOMA. 2019;60(10):2404-2414

A prospective non-interventional study on the impact of transfusion burden and related iron toxicity on outcome in myelodysplastic syndromes undergoing allogeneic hematopoietic cell transplantation

Cremers EMP; de Witte T; de Wreede L; Eikema D-J; Koster L; van Biezen A; Finke J; Socie G; Beelen D; Maertens J; Nagler A; Kobbe G; Ziagkos D; Itala-Remes M; Gedde-Dahl T; Sierra J; Niederwieser D; Ljungman P; Beguin Y; Ozkurt ZN; Anagnostopoulos A; Jindra P; Robin M; Kroeger N
Article: ANNALS OF HEMATOLOGY. 2019;98(8):1867-1875

Allogeneic donor split skin grafts for treatment of refractory ulcers in cutaneous chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation-a retrospective analysis on seven patients

Lamby P; Wolff D; Mielke S; Grigoleit GU; Ljungman P; Hilgendorf I; Holler E; Holler B; Weber D; Herr W; Schiltz D; Klein S; Graf S; Bjornhagen-Safwenberg V; Dolderer J; Prantl L
Article: BONE MARROW TRANSPLANTATION. 2019;54(8):1275-1280

A survey on incidence and management of adenovirus infection after allogeneic HSCT

Cesaro S; Berger M; Tridello G; Mikulska M; Ward KN; Ljungman P; Van der Werf S; Averbuch D; Styczynski J
Article: BONE MARROW TRANSPLANTATION. 2019;54(8):1254-1265

Bacterial blood stream infections (BSIs), particularly post-engraftment BSIs, are associated with increased mortality after allogeneic hematopoietic cell transplantation

Ustun C; Young J-AH; Papanicolaou GA; Kim S; Ahn KW; Chen M; Abdel-Azim H; Aljurf M; Beitinjaneh A; Brown V; Cerny J; Chhabra S; Kharfan-Dabaja MA; Dahi PB; Daly A; Dandoy CE; Dvorak CC; Freytes CO; Hashmi S; Lazarus H; Ljungman P; Nishihori T; Page K; Pingali SRK; Saad A; Savani BN; Weisdorf D; Williams K; Wirk B; Auletta JJ; Lindemans CA; Komanduri K; Riches M
Article: ANNALS OF HEMATOLOGY. 2019;98(7):1755-1763

The prognostic impact of the cytomegalovirus serostatus in patients with chronic hematological malignancies after allogeneic hematopoietic stem cell transplantation: a report from the Infectious Diseases Working Party of EBMT

Schmidt-Hieber M; Tridello G; Ljungman P; Mikulska M; Knelange N; Blaise D; Socie G; Volin L; Blijlevens N; Fegueux N; Yakoub-Agha I; Forcade E; Maertens J; Chevallier P; Passweg J; Cornelissen J; Russell N; Craddock C; Bourhis JH; Marchand T; Remenyi P; Cahn JY; Michallet M; Montoto S; Kroeger N; Glass B; Styczynski J
Article: ANNALS OF HEMATOLOGY. 2019;98(6):1341-1350

Use of eltrombopag in aplastic anemia in Europe

Ecsedi M; Lengline E; Knol-Bout C; Bosman P; Eikema D-J; Afanasyev B; Maschan A; Dreger P; Halkes CJM; Drexler B; Cortelezzi A; Drenou B; Patriarca A; Bruno B; Onofrillo D; Lanino E; Pulanic D; Serventi-Seiwerth R; Garnier A; Ljungman P; Bonifazi F; Giammarco S; Tournilhac O; Pioltelli P; Rovo A; Risitano AM; de Latour RP; Dufour C; Passweg J
Article: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2019;143(6):2238-2253

Hematopoietic stem cell transplantation for CD40 ligand deficiency: Results from an EBMT/ESID-IEWP-SCETIDE-PIDTC study

Ferrua F; Galimberti S; Courteille V; Slatter MA; Booth C; Moshous D; Neven B; Blanche S; Cavazzana M; Laberko A; Shcherbina A; Balashov D; Soncini E; Porta F; Al-Mousa H; Al-Saud B; Al-Dhekri H; Arnaout R; Formankova R; Bertrand Y; Lange A; Smart J; Wolska-Kusnierz B; Aquino VM; Dvorak CC; Fasth A; Fouyssac F; Heilmann C; Hoenig M; Schuetz C; Kelecic J; Bredius RGM; Lankester AC; Lindemans CA; Suarez F; Sullivan KE; Albert MH; Kalwak K; Barlogis V; Bhatia M; Bordon V; Czogala W; Alonso L; Dogu F; Gozdzik J; Ikinciogullari A; Krivan G; Ljungman P; Meyts I; Mustillo P; Smith AR; Speckmann C; Sundin M; Keogh SJ; Shaw PJ; Boelens JJ; Schulz AS; Sedlacek P; Veys P; Mahlaoui N; Janda A; Davies EG; Fischer A; Cowan MJ; Gennery AR
Article: HAEMATOLOGICA. 2019;104(5):929-936

Optimized EBMT transplant-specific risk score in myelodysplastic syndromes after allogeneic stem-cell transplantation

Gagelmann N; Eikema D-J; Stelljes M; Beelen D; de Wreede L; Mufti G; Knelange NS; Niederwieser D; Friis LS; Ehninger G; Nagler A; Yakoub-Agha I; Meijer E; Ljungman P; Maertens J; Kanz L; Lopez-Corral L; Brecht A; Craddock C; Finke J; Cornelissen JJ; Bernasconi P; Chevallier P; Sierra J; Robin M; Kroeger N
Article: CLINICAL INFECTIOUS DISEASES. 2019;68(8):1420-1426

Definitions of Resistant and Refractory Cytomegalovirus Infection and Disease in Transplant Recipients for Use in Clinical Trials

Chemaly RF; Chou S; Einsele H; Griffiths P; Avery R; Razonable RR; Mullane KM; Kotton C; Lundgren J; Komatsu TE; Lischka P; Josephson F; Douglas CM; Umeh O; Miller V; Ljungman P
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2019;25(3):522-528

Family Mismatched Allogeneic Stem Cell Transplantation for Myelofibrosis: Report from the Chronic Malignancies Working Party of European Society for Blood and Marrow Transplantation

Raj K; Eikema D-J; McLornanl DP; Olavarria E; Bloke H-J; Bregante S; Ciceri F; Passweg J; Ljungman P; Schaap N; Carlson K; Zuckerman T; de Wreede LC; Volin L; Koc Y; Luis Diez-Martin J; Brossart P; Wolf D; Blaise D; Di Bartolomeo P; Vitek A; Robin M; Yakoub-Agha I; Chalandon Y; Kroger N
Article: LEUKEMIA. 2019;33(3):686-695

Late treatment-related mortality versus competing causes of death after allogeneic transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia

Schetelig J; de Wreede LC; van Gelder M; Koster L; Finke J; Niederwieser D; Beelen D; Mufti GJ; Platzbecker U; Ganser A; Heidenreich S; Maertens J; Socie G; Brecht A; Stelljes M; Kobbe G; Volin L; Nagler A; Vitek A; Luft T; Ljungman P; Yakoub-Agha I; Robin M; Kroeger N
Article: LEUKEMIA. 2019;33(2):508-517

European experience and risk factor analysis of donor cell-derived leukaemias/MDS following haematopoietic cell transplantation

Engel N; Rovo A; Badoglio M; Labopin M; Basak GW; Beguin Y; Guyotat D; Ljungman P; Nagler A; Schattenberg A; Schroeder T; Schroyens W; Tischer J; Socie G; Kolb H-J; Tichelli A; Salooja N; Duarte RF
Article: EXPERIMENTAL HEMATOLOGY & ONCOLOGY. 2019;8:7

The Karolinska experience of autologous stem-cell transplantation for lymphoma: a population-based study of all 433 patients 1994-2016

Carlsten M; Jadersten M; Hellstrom A; Littmann K; Melen CM; Junlen HR; Sonnevi K; Ljungman P; Bjorkstrand B; Wahlin BE
Article: FRONTIERS IN IMMUNOLOGY. 2019;10:189

Individualization of Hematopoietic Stem Cell Transplantation Using Alpha/Beta T-Cell Depletion

Radestad E; Sundin M; Torlen J; Thunberg S; Onfelt B; Ljungman P; Watz E; Mattsson J; Uhlin M
Article: PLOS ONE. 2019;14(2):e0211927

Infectious complications and NK cell depletion following daratumumab treatment of Multiple Myeloma

Nahi H; Chrobok M; Gran C; Lund J; Gruber A; Gahrton G; Ljungman P; Wagner AK; Alici E
Article: BONE MARROW TRANSPLANTATION. 2019;54(1):44-52

Ibrutinib for bridging to allogeneic hematopoietic cell transplantation in patients with chronic lymphocytic leukemia or mantle cell lymphoma: a study by the EBMT Chronic Malignancies and Lymphoma Working Parties

Dreger P; Michallet M; Bosman P; Dietrich S; Sobh M; Boumendil A; Nagler A; Scheid C; Cornelissen J; Niederwieser D; Mueller L; Vandenberghe E; Scortechini I; Schoemans H; Andersen NS; Finke J; Russo D; Ljungman P; Passweg J; van Gelder M; Durakovic N; Labussiere-Wallet H; Berg T; Wulf G; Bethge W; Bunjes D; Stilgenbauer S; Canepari ME; Schaap M; Fox CP; Kroeger N; Montoto S; Schetelig J
Article: EUROPEAN JOURNAL OF CANCER. 2019;106:212-219

Impact of anti-thymocyte globulin on results of allogeneic peripheral blood stem cell transplantation for patients with Philadelphia-positive acute lymphoblastic leukaemia: An analysis by the Acute Leukemia Working Party of the EBMT

Giebel S; Labopin M; Czerw T; Socie G; Blaise D; Ghavamzadeh A; Passweg J; Ljungman P; Poire X; Chevallier P; Remenyi P; Rambaldi A; Anafasyev B; Fegueux N; Rovira M; Itala-Remes M; Bornhaeuser M; Mohty M; Nagler A
Article: BONE MARROW TRANSPLANTATION. 2018;53(12):1548-1552

Recommendations from the European Society for Blood and Marrow Transplantation (EBMT) for a curriculum in hematopoietic cell transplantation

Mohty M; Duarte RF; Kuball J; Bader P; Basak GW; Bonini C; Carreras E; Chabannon C; Dufour C; Gennery A; Lankester A; Lanza F; Ljungman P; Montoto S; Nagler A; Snowden JA; Styczynski J; Sureda A; Kroeger N
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2018;24(9):1783-1787

Varicella Zoster Virus Reactivation in Adult Survivors of Hematopoietic Cell Transplantation: How Do We Best Protect Our Patients?

Lee CJ; Savani BN; Ljungman P
Article: AMERICAN JOURNAL OF HEMATOLOGY. 2018;93(9):1142-1152

Measurable residual disease, conditioning regimen intensity, and age predict outcome of allogeneic hematopoietic cell transplantation for acute myeloid leukemia in first remission: A registry analysis of 2292 patients by the Acute Leukemia Working Party European Society of Blood and Marrow Transplantation

Gilleece MH; Labopin M; Yakoub-Agha I; Volin L; Socie G; Ljungman P; Huynh A; Deconinck E; Wu D; Bourhis JH; Cahn JY; Polge E; Mohty M; Savani BN; Nagler A
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2018;182(3):418-422

Outcome of patients with Myelofibrosis relapsing after allogeneic stem cell transplant: a retrospective study by the Chronic Malignancies Working Party of EBMT

McLornan DP; Szydlo R; Robin M; van Biezen A; Koster L; Blok HJP; Van Lint MT; Finke J; Vitek A; Carlson K; Griskevicius L; Holler E; Itala-Remes M; Schaap M; Socie G; Bay J-O; Beguin Y; Bruno B; Cornelissen JJ; Gedde-Dahl T; Ljungman P; Rubio MT; Yakoub-Agha I; Klyuchnikov E; Olavarria E; Chalandon Y; Kroeger N
Article: CLINICAL INFECTIOUS DISEASES. 2018;67(4):564-572

Incidence, Risk Factors, and Long-term Outcome of Acute Leukemia Patients With Early Candidemia After Allogeneic Stem Cell Transplantation: A Study by the Acute Leukemia and Infectious Diseases Working Parties of European Society for Blood and Marrow Transplantation

Cesaro S; Tridello G; Blijlevens N; Ljungman P; Craddock C; Michallet M; Martin A; Snowden JA; Mohty M; Maertens J; Passweg J; Petersen E; Nihtinen A; Isaksson C; Milpied N; Rohlich P-S; Deconinck E; Crawley C; Ledoux M-P; Hoek J; Nagler A; Styczynski J
Article: JOURNAL OF CLINICAL APHERESIS. 2018;33(3):226-235

Short-term side effects and attitudes towards second donation: A comparison of related and unrelated haematopoietic stem cell donors

Pahnke S; Larfors G; Axdorph-Nygell U; Fischer-Nielsen A; Haastrup E; Heldal D; Itala-Remes M; Johansson J-E; Kauppila M; Lenhoff S; Ljungman P; Niittyvuopio R; Sandstedt A; Hagglund H
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2018;100(6):613-620

Low response rate to ATG-based immunosuppressive therapy in very severe aplastic anaemia A Swedish nationwide cohort study

Vaht K; Goransson M; Carlson K; Isaksson C; Lenhoff S; Sandstedt A; Uggla B; Winiarski J; Ljungman P; Brune M; Andersson P-O
Article: SCIENTIFIC REPORTS. 2018;8(1):8293

The effect of N-acetyl-l-cysteine (NAC) on liver toxicity and clinical outcome after hematopoietic stem cell transplantation

El-Serafi I; Remberger M; El-Serafi A; Benkessou F; Zheng W; Martell E; Ljungman P; Mattsson J; Hassan M
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2018;24(5):930-936

Incidence of Second Primary Malignancies after Autologous Transplantation for Multiple Myeloma in the Era of Novel Agents

Sahebi F; Iacobelli S; Sbianchi G; Koster L; Blaise D; Remenyi P; Russell NH; Ljungman P; Kobbe G; Apperley J; Trneny M; Krejci M; Wiktor-Jedrzejczak W; Sanchez JF; Schaap N; Isaksson C; Lenhoff S; Browne P; Scheid C; Wilson KMO; Yakoub-Agha I; Muniz SG; Schoenland S; Morris C; Garderet L; Kroeger N
Article: MEDICAL ONCOLOGY. 2018;35(6):79

Reduced intensity conditioning increases risk of severe cGVHD: identification of risk factors for cGVHD in a multicenter setting

Afram G; Perez-Simon JA; Remberger M; Caballero-Velazquez T; Martino R; Luis Pinana J; Ringden O; Esquirol A; Lopez-Corral L; Garcia I; Lopez-Godino O; Sierra J; Caballero D; Ljungman P; Vazquez L; Hagglund H
Article: CLINICAL CANCER RESEARCH. 2018;24(8):1834-1844

Complete Remission with Reduction of High-Risk Clones following Haploidentical NK-Cell Therapy against MDS and AML

Bjorklund AT; Carlsten M; Sohlberg E; Liu LL; Clancy T; Karimi M; Cooley S; Miller JS; Klimkowska M; Schaffer M; Watz E; Wikstrom K; Blomberg P; Wahlin BE; Palma M; Hansson L; Ljungman P; Hellstrom-Lindberg E; Ljunggren H-G; Malmberg K-J
Article: TRANSPLANT INFECTIOUS DISEASE. 2018;20(2):e12847

Norovirus causing severe gastrointestinal disease following allogeneic hematopoietic stem cell transplantation: A retrospective analysis

Swartling L; Ljungman P; Remberger M; Sundin M; Tiveljung A; Mattsson J; Sparrelid E
Article: BONE MARROW TRANSPLANTATION. 2018;53(4):422-430

Comparable survival using a CMV-matched or a mismatched donor for CMV plus patients undergoing T-replete haplo-HSCT with PT-Cy for acute leukemia: a study of behalf of the infectious diseases and acute leukemia working parties of the EBMT

Cesaro S; Crocchiolo R; Tridello G; Knelange N; Van Lint MT; Koc Y; Ciceri F; Gulbas Z; Tischer J; Afanasyev B; Bruno B; Castagna L; Blaise D; Mohty M; Irrera G; Diez-Martin JL; Pierelli L; Pioltelli P; Arat M; Delia M; Fagioli F; Ehninger G; Aljurf M; Carella AM; Ozdogu H; Mikulska M; Ljungman P; Nagler A; Styczynski J
Article: EUROPEAN JOURNAL OF CANCER CARE. 2018;27(2):e12808

Occupational status among adult survivors following allogeneic stem cell transplantation in childhood

Winterling J; Johansson E; Wettergren L; Ljungman P; Alexanderson K
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2018;24(3):507-513

Allogeneic Stem Cell Transplantation for Myelodysplastic Syndrome Patients with a 5q Deletion

Garderet L; Ziagkos D; Van Biezen A; Lacobelli S; Finke J; Maertens J; Volin L; Ljungman P; Chevallier P; Passweg J; Schaap N; Beelen D; Nagler A; Blaise D; Poire X; Yakoub-Agha I; Lenhoff S; Craddock C; Schots R; Rambaldi A; Sanz J; Jindra P; Mufti GJ; Robin M; Kroeger N
Article: AMERICAN JOURNAL OF HEMATOLOGY. 2018;93(1):31-39

Relatively favorable outcome after allogeneic stem cell transplantation for BCR-ABL1-positive AML: A survey from the acute leukemia working party of the European Society for blood and marrow transplantation (EBMT)

Lazarevic VL; Labopin M; Wu D; Yakoub-Agha I; Huynh A; Ljungman P; Schaap N; Cornelissen JJ; Maillard N; Pioltelli P; Gedde-Dahl T; Lenhoff S; Houhou M; Esteve J; Mohty M; Nagler A
Article: NEW ENGLAND JOURNAL OF MEDICINE. 2017;377(25):2433-2444

Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation

Marty FM; Ljungman P; Chemaly RF; Maertens J; Dadwal SS; Duarte RF; Haider S; Ullmann AJ; Katayama Y; Brown J; Mullane KM; Boeckh M; Blumberg EA; Einsele H; Snydman DR; Kanda Y; DiNubile MJ; Teal VL; Wan H; Murata Y; Kartsonis NA; Leavitt RY; Badshah C
Article: SUPPORTIVE CARE IN CANCER. 2017;25(12):3675-3682

Feasibility of a self-help web-based intervention targeting young cancer patients with sexual problems and fertility distress

Wiklander M; Strandquist J; Obol CM; Eriksson LE; Winterling J; Rodriguez-Wallberg KA; Fugl-Meyer KS; Ahlgren J; Ljungman P; Lampic C; Wettergren L
Article: CLINICAL INFECTIOUS DISEASES. 2017;65(11):1819-1828

Antimicrobial Resistance in Gram-Negative Rods Causing Bacteremia in Hematopoietic Stem Cell Transplant Recipients: Intercontinental Prospective Study of the Infectious Diseases Working Party of the European Bone Marrow Transplantation Group

Averbuch D; Tridello G; Hoek J; Mikulska M; Akan H; Yanez San Segundo L; Pabst T; Ozcelik T; Klyasova G; Donnini I; Wu D; Gulbas Z; Zuckerman T; de Sousa AB; Beguin Y; Xhaard A; Bachy E; Ljungman P; de la Camara R; Rascon J; Ruiz Camps I; Vitek A; Patriarca F; Cudillo L; Vrhovac R; Shaw PJ; Wolfs T; O'Brien T; Avni B; Silling G; Al Sabty F; Graphakos S; Sankelo M; Sengeloev H; Pillai S; Matthes S; Melanthiou F; Iacobelli S; Styczynski J; Engelhard D; Cesaro S
Article: BONE MARROW TRANSPLANTATION. 2017;52(11):1519-1525

Validation of the revised IPSS at transplant in patients with myelodysplastic syndrome/transformed acute myelogenous leukemia receiving allogeneic stem cell transplantation: a retrospective analysis of the EBMT chronic malignancies working party

Scheid C; de Wreede L; van Biezen A; Koenecke C; Gohring G; Volin L; Maertens J; Finke J; Passweg J; Beelen D; Cornelissen JJ; Itaelae-Remes M; Chevallier P; Russell N; Petersen E; Milpied N; Espiga CR; Peniket A; Sierra J; Mufti G; Crawley C; Veelken JH; Ljungman P; Cahn JY; Alessandrino EP; de Witte T; Robin M; Kroeger N
Article: INTERNATIONAL JOURNAL OF HEMATOLOGY. 2017;106(4):471-475

Toxicological effects of fludarabine and treosulfan conditioning before allogeneic stem-cell transplantation

Remberger M; Torlen J; El Serafi I; Garming-Legert K; Bjorklund A; Ljungman P; Sundin M; Hassan M; Mattsson J
Article: HAEMATOLOGICA. 2017;102(10):1683-1690

Incidence and outcome of acquired aplastic anemia: real-world data from patients diagnosed in Sweden from 2000-2011

Vaht K; Goransson M; Carlson K; Isaksson C; Lenhoff S; Sandstedt A; Uggla B; Winiarski J; Ljungman P; Brune M; Andersson P-O
Article: ACTA ONCOLOGICA. 2017;56(8):1103-1110

Oncologists and hematologists' perceptions of fertility-related communication - a nationwide survey

Obol CM; Armuand GM; Rodriguez-Wallberg KA; Ahlgren J; Ljungman P; Wettergren L; Lampic C
Article: AMERICAN JOURNAL OF HEMATOLOGY. 2017;92(8):789-796

ABO incompatibility in mismatched unrelated donor allogeneic hematopoietic cell transplantation for acute myeloid leukemia: A report from the acute leukemia working party of the EBMT

Canaani J; Savani BN; Labopin M; Michallet M; Craddock C; Socie G; Volin L; Maertens JA; Crawley C; Blaise D; Ljungman PT; Cornelissen J; Russell N; Baron F; Gorin N; Esteve J; Ciceri F; Schmid C; Giebel S; Mohty M; Nagler A
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2017;23(4):677-683

Impact of Pretransplantation Indices in Hematopoietic Stem Cell Transplantation: Knowledge of Center-Specific Outcome Data Is Pivotal before Making Index-Based Decisions

Torlen J; Remberger M; Le Blanc K; Ljungman P; Mattsson J
Article: BLOOD ADVANCES. 2017;1(7):477-485

Alternative donors for allogeneic hematopoietic stem cell transplantation in poor-risk AML in CR1

Versluis J; Labopin M; Ruggeri A; Socie G; Wu D; Volin L; Blaise D; Milpied N; Craddock C; Yakoub-Agha I; Maertens J; Ljungman P; Huynh A; Michallet M; Deconinck E; Chevallier P; Passweg J; Ciceri F; Mohty M; Cornelissen JJ; Nagler A
Article: CLINICAL INFECTIOUS DISEASES. 2017;64(1):87-91

Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials

Ljungman P; Boeckh M; Hirsch HH; Josephson F; Lundgren J; Nichols G; Pikis A; Razonable RR; Miller V; Griffiths PD
Article: HAEMATOLOGICA. 2016;101(11):1417-1425

A prospective randomized trial comparing cyclosporine/methotrexate and tacrolimus/sirolimus as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantation

Torlen J; Ringden O; Garming-Legert K; Ljungman P; Winiarski J; Remes K; Itala-Remes M; Remberger M; Mattsson J
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2016;22(9):1684-1689

Risk Factors for Invasive Mold Infections and Implications for Choice of Prophylaxis after Allogeneic Stem Cell Transplantation

Blennow O; Remberger M; Torlen J; Szakos A; Ljungman P; Mattsson J
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2016;22(9):1615-1620

Comparison of Intensive Chemotherapy and Hypomethylating Agents before Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndromes: A Study of the Myelodysplastic Syndrome Subcommittee of the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplant Research

Potter VT; Iacobelli S; van Biezen A; Maertens J; Bourhis J-H; Passweg JR; Yakhoub-Agha I; Tabrizi R; Bay J-O; Chevallier P; Chalandon Y; Huynh A; Cahn JY; Ljungman P; Craddock C; Lenhoff S; Russell NH; Fegueux N; Socie G; Benedetto B; Meijer E; Mufti GJ; de Witte T; Robin M; Kroeger N
Article: HAEMATOLOGICA. 2016;101(7):884-890

Unrelated alternative donor transplantation for severe acquired aplastic anemia: a study from the French Society of Bone Marrow Transplantation and Cell Therapies and the EBMT Severe Aplastic Anemia Working Party.

Devillier R; Dalle J-H; Kulasekararaj A; D'aveni M; Clément L; Chybicka A; Vigouroux S; Chevallier P; Koh M; Bertrand Y; Michallet M; Zecca M; Yakoub-Agha I; Cahn J-Y; Ljungman P; Bernard M; Loiseau P; Dubois V; Maury S; Socié G; Dufour C; Peffault de Latour R
Article: JOURNAL OF CLINICAL ONCOLOGY. 2016;34(19):2212-2220

Impact of Donor Epstein-Barr Virus Serostatus on the Incidence of Graft-Versus-Host Disease in Patients With Acute Leukemia After Hematopoietic Stem-Cell Transplantation: A Study From the Acute Leukemia and Infectious Diseases Working Parties of the European Society for Blood and Marrow Transplantation

Styczynski J; Tridello G; Gil L; Ljungman P; Hoek J; Iacobelli S; Ward KN; Cordonnier C; Einsele H; Socie G; Milpied N; Veelken H; Chevallier P; Yakoub-Agha I; Maertens J; Blaise D; Cornelissen J; Michallet M; Daguindau E; Petersen E; Passweg J; Greinix H; Duarte RF; Kroeger N; Dreger P; Mohty M; Nagler A; Cesaro S
Article: HAEMATOLOGICA. 2016;101(6):773-780

Expanding transplant options to patients over 50 years. Improved outcome after reduced intensity conditioning mismatched-unrelated donor transplantation for patients with acute myeloid leukemia: a report from the Acute Leukemia Working Party of the EBMT

Savani BN; Labopin M; Kroeger N; Finke J; Ehninger G; Niederwieser D; Schwerdtfeger R; Bunjes D; Glass B; Socie G; Ljungman P; Craddock C; Baron F; Ciceri F; Gorin NC; Esteve J; Schmid C; Giebel S; Mohty M; Nagler A
Article: BONE MARROW TRANSPLANTATION. 2016;51(4):573-580

The incidence, mortality and timing of Pneumocystis jiroveci pneumonia after hematopoietic cell transplantation: a CIBMTR analysis

Williams KM; Ahn KW; Chen M; Aljurf MD; Agwu AL; Chen AR; Walsh TJ; Szabolcs P; Boeckh MJ; Auletta JJ; Lindemans CA; Zanis-Neto J; Malvezzi M; Lister J; de Toledo Codina JS; Sackey K; Chakrabarty JLH; Ljungman P; Wingard JR; Seftel MD; Seo S; Hale GA; Wirk B; Smith MS; Savani BN; Lazarus HM; Marks DI; Ustun C; Abdel-Azim H; Dvorak CC; Szer J; Storek J; Yong A; Riches MR
Article: BONE MARROW TRANSPLANTATION. 2016;51(3):418-423

Influence of pre-existing invasive aspergillosis on allo-HSCT outcome: a retrospective EBMT analysis by the Infectious Diseases and Acute Leukemia Working Parties

Penack O; Tridello G; Hoek J; Socie G; Blaise D; Passweg J; Chevallier P; Craddock C; Milpied N; Veelken H; Maertens J; Ljungman P; Cornelissen J; Thiebaut-Bertrand A; Lioure B; Michallet M; Iacobelli S; Nagler A; Mohty M; Cesaro S
Article: HAEMATOLOGICA. 2016;101(2):115-208

The European Hematology Association Roadmap for European Hematology Research: a consensus document

Engert A; Balduini C; Brand A; Coiffier B; Cordonnier C; Doehner H; de Wit TD; Eichinger S; Fibbe W; Green T; de Haas F; Iolascon A; Jaffredo T; Rodeghiero F; Salles G; Schuringa JJ; Andre M; Andre-Schmutz I; Bacigalupo A; Bochud P-Y; den Boer M; Bonini C; Camaschella C; Cant A; Cappellini MD; Cazzola M; Lo Celso C; Dimopoulos M; Douay L; Dzierzak E; Einsele H; Ferreri A; De Franceschi L; Gaulard P; Gottgens B; Greinacher A; Gresele P; Gribben J; de Haan G; Hansen J-B; Hochhaus A; Kadir R; Kaveri S; Kouskoff V; Kuehne T; Kyrle P; Ljungman P; Maschmeyer G; Mendez-Ferrer S; Milsom M; Mummery C; Ossenkoppele G; Pecci A; Peyvandi F; Philipsen S; Reitsma P; Maria Ribera J; Risitano A; Rivella S; Ruf W; Schroeder T; Scully M; Socie G; Staal F; Stanworth S; Stauder R; Stilgenbauer S; Tamary H; Theilgaard-Monch K; Thein SL; Tilly H; Trneny M; Vainchenker W; Vannucchi AM; Viscoli C; Vrielink H; Zaaijer H; Zanella A; Zolla L; Zwaginga JJ; Martinez PA; van den Akker E; Allard S; Anagnou N; Andolfo I; Andrau J-C; Angelucci E; Anstee D; Aurer I; Avet-Loiseau H; Aydinok Y; Bakchoul T; Balduini A; Barcellini W; Baruch D; Baruchel A; Bayry J; Bento C; van den Berg A; Bernardi R; Bianchi P; Bigas A; Biondi A; Bohonek M; Bonnet D; Borchmann P; Borregaard N; Braekkan S; van den Brink M; Brodin E; Bullinger L; Buske C; Butzeck B; Cammenga J; Campo E; Carbone A; Cervantes F; Cesaro S; Charbord P; Claas F; Cohen H; Conard J; Coppo P; Vives Corrons J-L; da Costa L; Davi F; Delwel R; Dianzani I; Domanovic D; Donnelly P; Drnovsek TD; Dreyling M; Du M-Q; Dufour C; Durand C; Efremov D; Eleftheriou A; Elion J; Emonts M; Engelhardt M; Ezine S; Falkenburg F; Favier R; Federico M; Fenaux P; Fitzgibbon J; Flygare J; Foa R; Forrester L; Galacteros F; Garagiola I; Gardiner C; Garraud O; van Geet C; Geiger H; Geissler J; Germing U; Ghevaert C; Girelli D; Godeau B; Goekbuget N; Goldschmidt H; Goodeve A; Graf T; Graziadei G; Griesshammer M; Gruel Y; Guilhot F; von Gunten S; Gyssens I; Halter J; Harrison C; Harteveld C; Hellstrom-Lindberg E; Hermine O; Higgs D; Hillmen P; Hirsch H; Hoskin P; Huls G; Inati A; Johnson P; Kattamis A; Kiefel V; Kleanthous M; Klump H; Krause D; Hovinga JK; Lacaud G; Lacroix-Desmazes S; Landman-Parker J; LeGouill S; Lenz G; von Lilienfeld-Toal M; von Lindern M; Lopez-Guillermo A; Lopriore E; Lozano M; MacIntyre E; Makris M; Mannhalter C; Martens J; Mathas S; Matzdorff A; Medvinsky A; Menendez P; Migliaccio AR; Miharada K; Mikulska M; Minard V; Montalban C; de Montalembert M; Montserrat E; Morange P-E; Mountford J; Muckenthaler M; Mueller-Tidow C; Mumford A; Nadel B; Navarro J-T; el Nemer W; Noizat-Pirenne F; O'Mahony B; Oldenburg J; Olsson M; Oostendorp R; Palumbo A; Passamonti F; Patient R; de Latour RP; Pflumio F; Pierelli L; Piga A; Pollard D; Raaijmakers M; Radford J; Rambach R; Rao AK; Raslova H; Rebulla P; Rees D; Ribrag V; Rijneveld A; Rinalducci S; Robak T; Roberts I; Rodrigues C; Rosendaal F; Rosenwald A; Rule S; Russo R; Saglio G; Sanchez M; Scharf RE; Schlenke P; Semple J; Sierra J; So-Osman C; Manuel Soria J; Stamatopoulos K; Stegmayr B; Stunnenberg H; Swinkels D; Taborda Barata JP; Taghon T; Taher A; Terpos E; Thachil J; Tissot JD; Touw I; Toye A; Trappe R; Traverse-Glehen A; Unal S; Vaulont S; Viprakasit V; Vitolo U; van Wijk R; Wojtowicz A; Zeerleder S; Zieger B
Article: JOURNAL OF IMMUNOLOGY. 2016;196(3):1400-1411

Naive Donor NK Cell Repertoires Associated with Less Leukemia Relapse after Allogeneic Hematopoietic Stem Cell Transplantation

Bjorklund AT; Clancy T; Goodridge JP; Beziat V; Schaffer M; Hovig E; Ljunggren H-G; Ljungman PT; Malmberg K-J
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2016;96(2):175-180

Decreased invasive fungal disease but no impact on overall survival by posaconazole compared to fluconazole prophylaxis: a retrospective cohort study in patients receiving induction therapy for acute myeloid leukaemia/myelodysplastic syndromes

Dahlen T; Kalin M; Cederlund K; Nordlander A; Bjorkholm M; Ljungman P; Blennow O
Article: HAEMATOLOGICA. 2016;101(2):248-255

Monosomal karyotype as an adverse prognostic factor in patients with acute myeloid leukemia treated with allogeneic hematopoietic stem-cell transplantation in first complete remission: a retrospective survey on behalf of the ALWP of the EBMT

Brands-Nijenhuis AVM; Labopin M; Schouten HC; Volin L; Socie G; Cornelissen JJ; Huynh A; Ljungman P; Malard F; Esteve J; Nagler A; Mohty M
Article: EBIOMEDICINE. 2015;2(12):2101-2109

Economics and Outcome After Hematopoietic Stem Cell Transplantation: A Retrospective Cohort Study

Gratwohl A; Sureda A; Baldomero H; Gratwohl M; Dreger P; Kroeger N; Ljungman P; McGrath E; Mohty M; Nagler A; Rambaldi A; de Elvira CR; Snowden JA; Passweg J; Apperley J; Niederwieser D; Stijnen T; Brand R
Article: BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY. 2015;53(10):1007-1011

Role of intravenous dosage regimens of bisphosphonates in relation to other aetiological factors in the development of osteonecrosis of the jaws in patients with myeloma

Jarnbring F; Kashani A; Bjork A; Hoffman T; Krawiec K; Ljungman P; Lund B
Article: TRANSPLANT INFECTIOUS DISEASE. 2015;17(6):785-794

Prolonged outbreak of adenovirus A31 in allogeneic stem cell transplant recipients

Swartling L; Allard A; Torlen J; Ljungman P; Mattsson J; Sparrelid E
Article: BLOOD. 2015;126(16):1885-1892

Stem cell transplantation in severe congenital neutropenia: an analysis from the European Society for Blood and Marrow Transplantation

Fioredda F; Iacobelli S; van Biezen A; Gaspar B; Ancliff P; Donadieu J; Aljurf M; Peters C; Calvillo M; Matthes-Martin S; Morreale G; van't Veer-Tazelaar N; de Wreede L; Al Seraihy A; Yesilipek A; Fischer A; Bierings M; Ozturk G; Smith O; Veys P; Ljungman P; de latour RP; Codina JSDT; Or R; Ganser A; Afanasyev B; Wynn R; Kalwak K; Marsh J; Dufour C
Article: TRANSFUSION. 2015;55(10):2339-2350

Quality of the hematopoietic stem cell graft affects the clinical outcome of allogeneic stem cell transplantation

Watz E; Remberger M; Ringden O; Ljungman P; Sundin M; Mattsson J; Uhlin M
Article: BONE MARROW TRANSPLANTATION. 2015;50(9):1217-1223

Increased incidence of chronic GvHD and CMV disease in patients with vitamin D deficiency before allogeneic stem cell transplantation

von Bahr L; Blennow O; Alm J; Bjorklund A; Malmberg K-J; Mougiakakos D; Le Blanc A; Oefner PJ; Labopin M; Ljungman P; Le Blanc K
Article: MYCOSES. 2015;58(8):470-477

Epidemiology and outcomes of patients with invasive mould infections: a retrospective observational study from a single centre (2005-2009)

Klingspor L; Saaedi B; Ljungman P; Szakos A
Article: CLINICAL INFECTIOUS DISEASES. 2015;61(3):313-323

Immunogenicity, Safety, and Tolerability of 13-Valent Pneumococcal Conjugate Vaccine Followed by 23-Valent Pneumococcal Polysaccharide Vaccine in Recipients of Allogeneic Hematopoietic Stem Cell Transplant Aged ≥2 Years: An Open-Label Study

Cordonnier C; Ljungman P; Juergens C; Maertens J; Selleslag D; Sundaraiyer V; Giardina PC; Clarke K; Gruber WC; Scott DA; Schmoele-Thoma B
Article: BONE MARROW TRANSPLANTATION. 2015;50(7):978-983

Long-term persistence of the immune response to antipneumococcal vaccines after Allo-SCT: 10-year follow-up of the EBMT-IDWP01 trial

Cordonnier C; Labopin M; Robin C; Ribaud P; Cabanne L; Chadelat C; Cesaro S; Ljungman P
Article: TRANSPLANT INFECTIOUS DISEASE. 2015;17(3):371-379

Immunogenicity of virosomal adjuvanted trivalent influenza vaccination in allogeneic stem cell transplant recipients

Ambati A; Einarsdottir S; Magalhaes I; Poiret T; Bodenstein R; LeBlanc K; Brune M; Maeurer M; Ljungman P
Article: BONE MARROW TRANSPLANTATION. 2015;50(6):858-864

Evaluation of pretransplant influenza vaccination in hematopoietic SCT: a randomized prospective study

Ambati A; Boas LSV; Ljungman P; Testa L; de Oliveira JF; Aoun M; Colturato V; Maeurer M; Machado CM
Article: BONE MARROW TRANSPLANTATION. 2015;50(6):802-807

Comparison of upfront tandem autologous-allogeneic transplantation versus reduced intensity allogeneic transplantation for multiple myeloma

Sahebi F; Iacobelli S; Biezen AV; Volin L; Dreger P; Michallet M; Ljungman PT; de Witte T; Henseler A; Schaap NPM; Lopez-Corral L; Poire X; Passweg J; Hamljadi R-M; Thomas SH; Schonland S; Gahrton G; Morris C; Kroeger N; Garderet L
Article: AMERICAN JOURNAL OF TRANSPLANTATION. 2015;15(3):705-714

Allogeneic Hematopoietic Stem Cell Transplantation in Solid Organ Transplant Recipients: A Retrospective, Multicenter Study of the EBMT

Basak GW; Wiktor-Jedrzejczak W; Labopin M; Schoemans H; Ljungman P; Kobbe G; Beguin Y; Lang P; Koenecke C; Sykora KW; te Boome L; van Biezen A; van der Werf S; Mohty M; de Witte T; Marsh J; Dreger P; Kroeger N; Duarte R; Ruutu T
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2014;20(10):1646-1649

Varicella-zoster reactivation after allogeneic stem cell transplantation without routine prophylaxis--the incidence remains high.

Blennow O; Fjaertoft G; Winiarski J; Ljungman P; Mattsson J; Remberger M
Article: CLINICAL INFECTIOUS DISEASES. 2014;59(4):473-481

Donor Cytomegalovirus Status Influences the Outcome of Allogeneic Stem Cell Transplant: A Study by the European Group for Blood and Marrow Transplantation

Ljungman P; Brand R; Hoek J; de la Camara R; Cordonnier C; Einsele H; Styczynski J; Ward KN; Cesaro S
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2014;93(2):137-142

Long-term follow-up of bone density, general and reproductive health in female survivors after treatment for haematological malignancies

Naessen S; Bergstrom I; Ljungman P; Landgren B-M
Article: BONE MARROW TRANSPLANTATION. 2014;49(6):836-842

Occupational status among adult survivors following allo-SCT

Winterling J; Johansson E; Wennman-Larsen A; Petersson L-M; Ljungman P; Alexanderson K
Article: HAEMATOLOGICA. 2014;99(5):908-915

Use of the quality management system "JACIE" and outcome after hematopoietic stem cell transplantation

Gratwohl A; Brand R; McGrath E; van Biezen A; Sureda A; Ljungman P; Baldomero H; Chabannon C; Apperley J
Article: HAEMATOLOGICA. 2014;99(2):346-352

Risk factors for Epstein-Barr virus-related post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation

Uhlin M; Wikell H; Sundin M; Blennow O; Maeurer M; Ringden O; Winiarski J; Ljungman P; Remberger M; Mattsson J
Article: CLINICAL INFECTIOUS DISEASES. 2014;58(3):309-318

2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host

Rubin LG; Levin MJ; Ljungman P; Davies EG; Avery R; Tomblyn M; Bousvaros A; Dhanireddy S; Sung L; Keyserling H; Kang I
Article: TRANSPLANT INFECTIOUS DISEASE. 2014;16(1):106-114

Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations

Blennow O; Ljungman P; Sparrelid E; Mattsson J; Remberger M
Article: CLINICAL INFECTIOUS DISEASES. 2014;58(3):E44-E100

2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host

Rubin LG; Levin MJ; Ljungman P; Davies EG; Avery R; Tomblyn M; Bousvaros A; Dhanireddy S; Sung L; Keyserling H; Kang I
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2014;20(2):264-271

Analysis of Donor and Recipient ABO Incompatibility and Antibody-Associated Complications after Allogeneic Stem Cell Transplantation with Reduced-Intensity Conditioning

Watz E; Remberger M; Ringden E; Lundahl J; Ljungman P; Mattsson J; Wikman A; Uhlin M
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2014;20(1):128-132

Reduced IL-7 Responsiveness Defined by Signal Transducer and Activator of Transcription 5 Phosphorylation in T Cells May Be a Marker for Increased Risk of Developing Cytomegalovirus Disease in Patients after Hematopoietic Stem Cell Transplantation

Perez-Bercoff L; Vudattu NK; Byrareddy SN; Mattsson J; Maeurer M; Ljungman P
Article: PLOS ONE. 2014;9(4):e89648

Whole CMV Proteome Pattern Recognition Analysis after HSCT Identifies Unique Epitope Targets Associated with the CMV Status

Perez-Bercoff L; Valentini D; Gaseitsiwe S; Mahdavifar S; Schutkowski M; Poiret T; Perez-Bercoff A; Ljungman P; Maeurer MJ
Article: CLINICAL INFECTIOUS DISEASES. 2013;57(6):794-802

Response to Rituximab-Based Therapy and Risk Factor Analysis in Epstein Barr Virus-Related Lymphoproliferative Disorder After Hematopoietic Stem Cell Transplant in Children and Adults: A Study From the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation

Styczynski J; Gil L; Tridello G; Ljungman P; Donnelly P; van der Velden W; Omar H; Martino R; Halkes C; Faraci M; Theunissen K; Kalwak K; Hubacek P; Sica S; Nozzoli C; Fagioli F; Matthes S; Diaz MA; Migliavacca M; Balduzzi A; Tomaszewska A; de la Camara R; van Biezen A; Hoek J; Iacobelli S; Einsele H; Cesaro S
Article: BLOOD. 2013;122(7):1284-1292

Tyrosine kinase inhibitor usage, treatment outcome, and prognostic scores in CML: report from the population-based Swedish CML registry

Hoglund M; Sandin F; Hellstrom K; Bjoreman M; Bjorkholm M; Brune M; Dreimane A; Ekblom M; Lehmann S; Ljungman P; Malm C; Markevarn B; Myhr-Eriksson K; Ohm L; Olsson-Stromberg U; Sjalander A; Wadenvik H; Simonsson B; Stenke L; Richter J
Article: JOURNAL OF INTERNAL MEDICINE. 2013;274(2):153-162

A prospective randomized toxicity study to compare reduced-intensity and myeloablative conditioning in patients with myeloid leukaemia undergoing allogeneic haematopoietic stem cell transplantation

Ringden O; Erkers T; Aschan J; Garming-Legert K; Le Blanc K; Hagglund H; Omazic B; Svenberg P; Dahllof G; Mattsson J; Ljungman P; Remberger M
Article: CLINICAL TRANSPLANTATION. 2013;27(4):E368-E374

A high antithymocyte globulin dose increases the risk of relapse after reduced intensity conditioning HSCT with unrelated donors

Remberger M; Ringden O; Hagglund H; Svahn B-M; Ljungman P; Uhlin M; Mattsson J
Article: TRANSPLANT INFECTIOUS DISEASE. 2013;15(3):251-258

Environmental prevention of infection in stem cell transplant recipients: a survey of the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation

Hicheri Y; Einsele H; Martino R; Cesaro S; Ljungman P; Cordonnier C
Article: BLOOD. 2013;121(14):2678-2688

NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs

Beziat V; Liu LL; Malmberg J-A; Ivarsson MA; Sohlberg E; Bjorklund AT; Retiere C; Sverremark-Ekstrom E; Traherne J; Ljungman P; Schaffer M; Price DA; Trowsdale J; Michaelsson J; Ljunggren H-G; Malmberg K-J
Article: CLINICAL MICROBIOLOGY AND INFECTION. 2013;19(4):E218-E221

Candidaemia in Sweden: a nationwide prospective observational survey

Ericsson J; Chryssanthou E; Klingspor L; Johansson AG; Ljungman P; Svensson E; Sjolin J
Article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2013;45(4):285-291

Bacteremia in Swedish hematological patients with febrile neutropenia: Bacterial spectrum and antimicrobial resistance patterns

Aust C; Tolfvenstam T; Broliden K; Ljungman P; Kalin M; Giske CG; Ohrmalm L
Article: LUPUS. 2013;22(3):245-253

Autologous haematopoietic stem cell transplantation for systemic lupus erythematosus: data from the European Group for Blood and Marrow Transplantation registry

Alchi B; Jayne D; Labopin M; Kotova O; Sergeevicheva V; Alexander T; Gualandi F; Gruhn B; Ouyang J; Rzepecki P; Held G; Sampol A; Voswinkel J; Ljungman P; Fassas A; Badoglio M; Saccardi R; Farge D
Article: LEUKEMIA. 2013;27(2):377-388

Immunosuppressive CD14⁺HLA-DR^low/neg IDO⁺ myeloid cells in patients following allogeneic hematopoietic stem cell transplantation

Mougiakakos D; Jitschin R; von Bahr L; Poschke I; Gary R; Sundberg B; Gerbitz A; Ljungman P; Le Blanc K
Article: MEDICAL ONCOLOGY. 2012;29(4):2348-2358

Different impact of intermediate and unfavourable cytogenetics at the time of diagnosis on outcome of de novo AML after allo-SCT: a long-term retrospective analysis from a single institution

Nahi H; Remberger M; Machaczka M; Ungerstedt J; Mattson J; Ringden O; Le-Blanc K; Ljungman P; Hagglund H
Article: TRANSPLANTATION. 2012;94(10):1066-1074

Factors With an Impact on Chimerism Development and Long-Term Survival After Umbilical Cord Blood Transplantation

Berglund S; Le Blanc K; Remberger M; Gertow J; Uzunel M; Svenberg P; Winiarski J; Ljungman P; Ringden O; Uhlin M; Mattsson J
Article: CLINICAL INFECTIOUS DISEASES. 2012;55(8):1064-1073

Rapid Salvage Treatment With Virus-Specific T Cells for Therapy-Resistant Disease

Uhlin M; Gertow J; Uzunel M; Okas M; Berglund S; Watz E; Brune M; Ljungman P; Maeurer M; Mattsson J
Article: TRANSPLANT INFECTIOUS DISEASE. 2012;14(5):468-478

No increased mortality from donor or recipient hepatitis B- and/or hepatitis C-positive serostatus after related-donor allogeneic hematopoietic cell transplantation

Tomblyn M; Chen M; Kukreja M; Aljurf MD; Al Mohareb F; Bolwell BJ; Cahn J-Y; Carabasi MH; Gale RP; Gress RE; Gupta V; Hale GA; Ljungman P; Maziarz RT; Storek J; Wingard JR; Young J-AH; Horowitz MM; Ballen KK
Article: MEDICAL ONCOLOGY. 2012;29(3):2191-2199

Autologous hematopoietic stem cell transplantation in multiple myeloma and lymphoma: an analysis of factors influencing stem cell collection and hematological recovery

Ungerstedt JS; Watz E; Uttervall K; Johansson B-M; Wahlin BE; Nasman P; Ljungman P; Gruber A; Nygell UA; Nahi H
Article: BONE MARROW TRANSPLANTATION. 2012;47(9):1217-1221

Long-term follow-up of HCV-infected hematopoietic SCT patients and effects of antiviral therapy

Ljungman P; Locasciulli A; de Soria VG; Bekassy AN; Brinch L; Espigado I; Ferrant A; Franklin IM; O'Riordan J; Rovira M; Shaw P; Einsele H
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2012;18(4):557-564

Long-Term Complications, Immunologic Effects, and Role of Passage for Outcome in Mesenchymal Stromal Cell Therapy

von Bahr L; Sundberg B; Lonnies L; Sander B; Karbach H; Hagglund H; Ljungman P; Gustafsson B; Karlsson H; Le Blanc K; Ringden O
Article: BLOOD. 2012;119(6):1599-1606

Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantation.

Schmid C; Labopin M; Nagler A; Niederwieser D; Castagna L; Tabrizi R; Stadler M; Kuball J; Cornelissen J; Vorlicek J; Socié G; Falda M; Vindeløv L; Ljungman P; Jackson G; Kröger N; Rank A; Polge E; Rocha V; Mohty M; Acute Leukaemia Working Party of the European Grou
Article: PLOS ONE. 2012;7(5):e36543

Viral Findings in Adult Hematological Patients with Neutropenia

Ohrmalm L; Wong M; Aust C; Ljungman P; Norbeck O; Broliden K; Tolfvenstam T
Article: PEDIATRIC TRANSPLANTATION. 2011;15(7):691-698

The socioeconomic and psychosocial circumstances of adult long-term survivors of hematopoietic stem cell transplantation in childhood

Lof CM; Winiarski J; Ljungman P; Forinder U
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2011;17(11):1688-1697

Improved Survival after Allogeneic Hematopoietic Stem Cell Transplantation in Recent Years. A Single-Center Study

Remberger M; Ackefors M; Berglund S; Blennow O; Dahllof G; Dlugosz A; Garming-Legert K; Gertow J; Gustafsson B; Hassan M; Hassan Z; Hauzenberger D; Hagglund H; Karlsson H; Klingspor L; Kumlien G; Le Blanc K; Ljungman P; Machaczka M; Malmberg K-J; Marschall H-U; Mattsson J; Olsson R; Omazic B; Sairafi D; Schaffer M; Svahn B-M; Svenberg P; Swartling L; Szakos A; Uhlin M; Uzunel M; Watz E; Wernerson A; Wikman A; Wikstrom A-C; Winiarski J; Ringden O
Article: HAEMATOLOGICA. 2011;96(8):1231-1235

Outcome of pandemic H1N1 infections in hematopoietic stem cell transplant recipients

Ljungman P; de la Camara R; Perez-Bercoff L; Abecasis M; Nieto Campuzano JB; Jimena Cannata-Ortiz M; Cordonnier C; Einsele H; Gonzalez-Vicent M; Espigado I; Halter J; Martino R; Mohty B; Sucak G; Ullmann AJ; Vazquez L; Ward KN; Engelhard D
Article: JOURNAL OF CLINICAL ONCOLOGY. 2011;29(15):1980-1986

Introduction of a Quality Management System and Outcome After Hematopoietic Stem-Cell Transplantation

Gratwohl A; Brand R; Niederwieser D; Baldomero H; Chabannon C; Cornelissen J; de Witte T; Ljungman P; McDonald F; McGrath E; Passweg J; Peters C; Rocha V; Slaper-Cortenbach I; Sureda A; Tichelli A; Apperley J
Article: JOURNAL OF IMMUNOTHERAPY. 2011;34(4):390-396

Decreased IL-7 Signaling in T Cells From Patients With PTLD After Allogeneic HSCT

Omar H; Ahmed R; Rane L; Bjorklund A; Gustafsson-Jernberg A; Ljungman P; Maeurer MJ
Article: LANCET INFECTIOUS DISEASES. 2011;11(4):284-292

Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial

Marty FM; Ljungman P; Papanicolaou GA; Winston DJ; Chemaly RF; Strasfeld L; Young J-AH; Rodriguez T; Maertens J; Schmitt M; Einsele H; Ferrant A; Lipton JH; Villano SA; Chen H; Boeckh M
Article: PEDIATRIC BLOOD & CANCER. 2011;56(3):444-451

Hematopoietic Stem Cell Transplantation in Severe Congenital Neutropenia

Carlsson G; Winiarski J; Ljungman P; Ringden O; Mattsson J; Nordenskjold M; Touw I; Henter J-I; Palmblad J; Fadeel B; Hagglund H
Article: BONE MARROW TRANSPLANTATION. 2011;46(3):408-415

Prospective comparison of PCR-based vs late mRNA-based preemptive antiviral therapy for HCMV infection in patients after allo-SCT

Hebart H; Lengerke C; Ljungman P; Paya CV; Klingebiel T; Loeffler J; Pfaffenrath S; Lewensohn-Fuchs I; Barkholt L; Tomiuk J; Meisner C; Lunenberg J; Top B; Razonable RR; Patel R; Litzow MR; Jahn G; Einsele H
Article: HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA. 2011;25(1):151-169

Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients

Ljungman P; Hakki M; Boeckh M
Article: BONE MARROW TRANSPLANTATION. 2011;46(2):267-272

Evaluation of a surveillance strategy for early detection of adenovirus by PCR of peripheral blood in hematopoietic SCT recipients: incidence and outcome

Ohrmalm L; Lindblom A; Omar H; Norbeck O; Gustafson I; Lewensohn-Fuchs I; Johansson J-E; Brune M; Ljungman P; Broliden K
Article: HAEMATOLOGICA. 2011;96(1):156-162

The European LeukemiaNet: achievements and perspectives

Hehlmann R; Grimwade D; Simonsson B; Apperley J; Baccarani M; Barbui T; Barosi G; Bassan R; Bene MC; Berger U; Buechner T; Burnett A; Cross NCP; de Witte TJM; Doehner H; Dombret H; Einsele H; Engelich G; Foa R; Fonatsch C; Goekbuget N; Gluckman E; Gratwohl A; Guilhot F; Haferlach C; Haferlach T; Hallek M; Hasford J; Hochhaus A; Hoelzer D; Kiladjian J-J; Labar B; Ljungman P; Mansmann U; Niederwieser D; Ossenkoppele G; Ribera JM; Rieder H; Serve H; Schrotz-King P; Sanz MA; Saussele S
Article: BONE MARROW TRANSPLANTATION. 2010;45(12):1710-1718

Randomized PCR-based therapy and risk factors for invasive fungal infection following reduced-intensity conditioning and hematopoietic SCT

Blennow O; Remberger M; Klingspor L; Omazic B; Fransson K; Ljungman P; Mattsson J; Ringden O
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2010;16(12):1728-1737

Leukemia Lineage-Specific Chimerism Analysis and Molecular Monitoring Improve Outcome of Donor Lymphocyte Infusions

Sairafi D; Remberger M; Uhlin M; Ljungman P; Ringden O; Mattsson J
Article: HAEMATOLOGICA. 2010;95(10):1762-1768

Voriconazole for secondary prophylaxis of invasive fungal infections in allogeneic stem cell transplant recipients: results of the VOSIFI study

Cordonnier C; Rovira M; Maertens J; Olavarria E; Faucher C; Bilger K; Pigneux A; Cornely OA; Ullmann AJ; Bofarull RM; de la Camara R; Weisser M; Liakopoulou E; Abecasis M; Heussel CP; Pineau M; Ljungman P; Einsele H
Article: TRANSPLANT INFECTIOUS DISEASE. 2010;12(5):465-469

Poor outcome of adenovirus infections in adult hematopoietic stem cell transplant patients with sustained adenovirus viremia

Omar H; Yun Z; Lewensohn-Fuchs I; Perez-Bercoff L; Orvell C; Engstrom L; Vuong G-K; Ljungman P
Article: BONE MARROW TRANSPLANTATION. 2010;45(9):1423-1426

Relationship between IgG titers and opsonocytophagocytic activity of anti-pneumococcal antibodies after immunization with the 7-valent conjugate vaccine in allogeneic stem cell transplant

Cordonnier C; Labopin M; Jansen KU; Pride M; Chesnel V; Bonnet E; Einsele H; Ljungman P
Article: INFECTIOUS DISEASE CLINICS OF NORTH AMERICA. 2010;24(2):319-337

Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients

Ljungman P; Hakki M; Boeckh M
Article: INTERNATIONAL JOURNAL OF HEMATOLOGY. 2010;91(4):596-601

Molecular monitoring of viral infections after hematopoietic stem cell transplantation

Ljungman P
Article: BLOOD. 2010;115(13):2686-2694

NK cells expressing inhibitory KIR for non-self-ligands remain tolerant in HLA-matched sibling stem cell transplantation

Bjorklund AT; Schaffer M; Fauriat C; Ringden O; Remberger M; Hammarstedt C; Barrett AJ; Ljungman P; Ljunggren H-G; Malmberg K-J
Article: VACCINE. 2010;28(15):2730-2734

Immune response to the 23-valent polysaccharide pneumococcal vaccine after the 7-valent conjugate vaccine in allogeneic stem cell transplant recipients: Results from the EBMT IDWP01 trial

Cordonnier C; Labopin M; Chesnel V; Ribaud P; De La Camara R; Martino R; Ullmann AJ; Parkkali T; Locasciulli A; Yakouben K; Pauksens K; Bonnet E; Einsele H; Niederwieser D; Apperley J; Ljungman P
Article: BONE MARROW TRANSPLANTATION. 2010;45(3):558-564

Outcome of patients developing GVHD after DLI given to treat CML relapse: a study by the chronic leukemia working party of the EBMT

Chalandon Y; Passweg JR; Schmid C; Olavarria E; Dazzi F; Simula MP; Ljungman P; Schattenberg A; de Witte T; Lenhoff S; Jacobs P; Volin L; Iacobelli S; Finke J; Niederwieser D; Guglielmi C
Article: BONE MARROW TRANSPLANTATION. 2010;45(2):219-234

Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009

Ljungman P; Bregni M; Brune M; Cornelissen J; de Witte T; Dini G; Einsele H; Gaspar HB; Gratwohl A; Passweg J; Peters C; Rocha V; Saccardi R; Schouten H; Sureda A; Tichelli A; Velardi A; Niederwieser D
Article: BONE MARROW TRANSPLANTATION. 2010;45(1):53-61

Comparison of general vs regional anaesthesia for BM harvesting: a retrospective study of anaesthesia-related complications

Machaczka M; Kalaitzakis E; Eleborg L; Ljungman P; Hagglund H
Article: TRANSPLANTATION. 2009;88(10):1222-1226

Respiratory Syncytial Virus Infection in Recipients of Allogeneic Stem-Cell Transplantation: A Retrospective Study of the Incidence, Clinical Features, and Outcome

Avetisyan G; Mattsson J; Sparrelid E; Ljungman P
Article: BONE MARROW TRANSPLANTATION. 2009;44(9):589-594

Outcome after allogeneic transplantation for adult acute myeloid leukemia patients exhibiting isolated or associated trisomy 8 chromosomal abnormality: a survey on behalf of the ALWP of the EBMT

Chevallier P; Labopin M; Nagler A; Ljungman P; Verdonck LF; Volin L; Zander AR; Finke J; Socie G; Cordonnier C; Harousseau J-L; Mohty M; Rocha V
Article: BONE MARROW TRANSPLANTATION. 2009;44(8):521-526

Vaccination of hematopoietic cell transplant recipients

Ljungman P; Cordonnier C; Einsele H; Englund J; Machado CM; Storek J; Small T
Article: BONE MARROW TRANSPLANTATION. 2009;44(8):471-482

Viral disease prevention after hematopoietic cell transplantation

Zaia J; Baden L; Boeckh MJ; Chakrabarti S; Einsele H; Ljungman P; McDonald GB; Hirsch H
Article: TRANSPLANT INFECTIOUS DISEASE. 2009;11(5):393-399

Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction

Omar H; Hagglund H; Gustafsson-Jernberg A; LeBlanc K; Mattsson J; Remberger M; Ringden O; Sparrelid E; Sundin M; Winiarski J; Yun Z; Ljungman P
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2009;15(9):1108-1115

Lymphocyte Recovery Is a Major Determinant of Outcome after Matched Unrelated Myeloablative Transplantation for Myelogenous Malignancies

Le Blanc K; Barrett AJ; Schaffer M; Hagglund H; Ljungman P; Ringden O; Remberger M
Article: HAEMATOLOGICA. 2009;94(4):542-549

Risk factors for therapy-related myelodysplastic syndrome and acute myeloid leukemia treated with allogeneic stem cell transplantation.

Kröger N; Brand R; van Biezen A; Zander A; Dierlamm J; Niederwieser D; Devergie A; Ruutu T; Cornish J; Ljungman P; Gratwohl A; Cordonnier C; Beelen D; Deconinck E; Symeonidis A; de Witte T; Myelodysplastic Syndromes Subcommittee of The Chro
Article: BONE MARROW TRANSPLANTATION. 2009;43(7):553-561

A prospective randomized controlled trial comparing PCR-based and empirical treatment with liposomal amphotericin Bin patients after allo-SCT

Hebart H; Klingspor L; Klingebiel T; Loeffler J; Tollemar J; Ljungman P; Wandt H; Schaefer-Eckart K; Dornbusch HJ; Meisner C; Engel C; Stenger N; Mayer T; Ringden O; Einsele H
Article: BONE MARROW TRANSPLANTATION. 2009;43(6):461-468

Health-related quality of life in adult survivors after paediatric allo-SCT

Lof CM; Winiarski J; Giesecke A; Ljungman P; Forinder U
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2009;144(6):933-945

Serial chimerism analyses indicate that mixed haemopoietic chimerism influences the probability of graft rejection and disease recurrence following allogeneic stem cell transplantation (SCT) for severe aplastic anaemia (SAA): indication for routine assessment of chimerism post SCT for SAA

Lawler M; McCann SR; Marsh JCW; Ljungman P; Hows J; Vandenberghe E; O'Riordan J; Locasciulli A; Socie G; Kelly A; Schrezenmeier H; Marin P; Tichelli A; Passweg JR; Dickenson A; Ryan J; Bacigalupo A
Article: JOURNAL OF CLINICAL VIROLOGY. 2008;43(1):79-85

Quantification of adenovirus DNA in unrelated donor hematopoietic stem cell transplant recipients

Gustafson I; Lindblom A; Yun Z; Omar H; Engstrom L; Lewensohn-Fuchs I; Ljungman P; Broliden K
Article: TRANSPLANTATION. 2008;86(2):257-263

Evaluation of immune responses to seasonal influenza vaccination in healthy volunteers and in patients after stem cell transplantation

Avetisyan G; Aschan J; Hassan M; Ljungman P
Article: APMIS. 2008;116(5):345-351

A prospective study of diagnosis of Toxoplasma gondii infection after bone marrow transplantation

Edvinsson B; Lundquist J; Ljungman P; Ringden O; Evengard B
Article: BONE MARROW TRANSPLANTATION. 2008;41(8):737-742

BK-viruria and haemorrhagic cystitis are more frequent in allogeneic haematopoietic stem cell transplant patients receiving full conditioning and unrelated-HLA-mismatched grafts

Giraud G; Priftakis P; Bogdanovic G; Remberger M; Dubrulle M; Hau A; Gutmark R; Mattson J; Svahn B-M; Ringden O; Winiarski J; Ljungman P; Dalianis T
Article: JOURNAL OF INFECTION. 2008;56(3):204-210

Identification of species of viridans group streptococci in clinical blood culture isolates by sequence analysis of the RNase P RNA gene, rnpB

Westling K; Julander I; Ljungman P; Vondracek M; Wretlind B; Jalal S
Article: BONE MARROW TRANSPLANTATION. 2008;41(3):267-273

Allogeneic stem cell transplantation:: low immunoglobulin levels associated with decreased survival

Norlin A-C; Sairafi D; Mattsson J; Ljungman P; Ringden O; Remberger M
Article: BONE MARROW TRANSPLANTATION. 2008;41(1):45-50

Recent improvement in outcome of unrelated donor transplantation for aplastic anemia

Viollier R; Socie G; Tichelli A; Bacigalupo A; Korthof ET; Marsh J; Cornish J; Ljungman P; Oneto R; Bekassy AN; Fuehrer M; Maury S; Schrezenmeier H; van Lint MT; Wojcik D; Locasciulli A; Passweg JR
Article: BONE MARROW TRANSPLANTATION. 2007;40(11):1055-1062

Risk factors for fatal infectious complications developing late after allogeneic stem cell transplantation

Bjorklund A; Aschan J; Labopin M; Remberger M; Ringden O; Winiarski J; Ljungman P
Article: BONE MARROW TRANSPLANTATION. 2007;40(9):865-869

Evaluation of intervention strategy based on CMV-specific immune responses after allogeneic SCT

Avetisyan G; Aschan J; Haegglund H; Ringden O; Ljungman P
Article: HAEMATOLOGICA. 2007;92(8):1139-1142

Factors influencing CMV seropositivity in stem cell transplant patients and donors

Ljungman P; Brandan R
Article: LEUKEMIA. 2007;21(8):1733-1738

Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells

Le Blanc K; Samuelsson H; Gustafsson B; Remberger M; Sundberg B; Arvidson J; Ljungman P; Lonnies H; Nava S; Ringden O
Article: SUPPORTIVE CARE IN CANCER. 2007;15(7):849-857

Factors associated with poor general health after stem-cell transplantation

Larsen J; Nordstrom G; Ljungman P; Gardulf A
Article: BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY. 2007;20(2):209-217

Risk assessment in haematopoietic stem cell transplantation: Viral status

Ljungman P
Article: BONE MARROW TRANSPLANTATION. 2007;39(8):497-499

Effectiveness of ganciclovir against human herpesvirus-6 excreted in saliva in stem cell transplant recipients

Ljungman P; Dahl H; Xu Y-H; Larsson K; Brytting M; Linde A
Article: BONE MARROW TRANSPLANTATION. 2007;39(7):383-388

Fludarabine-based disease-specific conditioning or conventional myeloablative conditioning in hematopoietic stem cell transplantation for treatment of non-malignant diseases

Ringden O; Remberger M; Svenberg P; Svahn B-M; Dahllof G; Gustafsson B; Hassan Z; Omazic B; Uzunel M; Aschan J; Barkholt L; Winiarski J; Ljungman P; Mattsson J
Article: ANNALS OF ONCOLOGY. 2007;18(4):694-700

Long-term follow-up of the SBG 9401 study comparing tailored FEC-based therapy versus marrow-supported high-dose therapy

Wilking N; Lidbrink E; Wiklund T; Erikstein B; Lindman H; Malmstroem P; Kellokumpu-Lehtinen P; Bengtsson N-O; Soederlund G; Anker G; Wist E; Ottosson S; Salminen E; Ljungman P; Holte H; Nilsson J; Blomqvist C; Bergh J
Article: BONE MARROW TRANSPLANTATION. 2006;38(12):799-805

Comparison of long-term outcomes after allogeneic hematopoietic stem cell transplantation from matched sibling and unrelated donors

Hows JM; Passweg JR; Tichelli A; Locasciulli A; Szydlo R; Bacigalupo A; Jacobson N; Ljungman P; Cornish J; Nunn A; Bradley B; Socie G
Article: BLOOD. 2006;108(9):2928-2936

Impact of the intensity of the pretransplantation conditioning regimen in patients with prior invasive aspergillosis undergoing allogeneic hematopoietic stem cell transplantation:: a retrospective survey of the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation

Martino R; Parody R; Fukuda T; Maertens J; Theunissen K; Ho A; Mufti GJ; Kroger N; Zander AR; Heim D; Paluszewska M; Selleslag D; Steinerova K; Ljungman P; Cesaro S; Nihtinen A; Cordonnier C; Vazquez L; Lopez-Duarte M; Lopez J; Cabrera R; Rovira M; Neuburger S; Cornely O; Hunter AE; Marr KA; Dombusch HJ; Einsele H
Article: BONE MARROW TRANSPLANTATION. 2006;38(10):687-692

Impact on the cytomegalovirus (CMV) viral load by CMV-specific T-cell immunity in recipients of allogeneic stem cell transplantation

Avetisyan G; Larsson K; Aschan J; Nilsson C; Hassan M; Ljungman P
Article: LEUKEMIA & LYMPHOMA. 2006;47(9):1768-1773

Successful mobilization of Ph-negative blood stem cells with intensive chemotherapy plus G-CSF in patients with chronic myelogenous leukemia in first chronic phase

Olsson-Stromberg U; Hoglund M; Bjorkholm M; Braide I; Carlson K; Gahrton G; Grimfors G; Hast R; Lerner R; Linder O; Ljungman P; Lofvenberg E; Malm C; Nilsson P-G; Paul C; Rodjer S; Stenke L; Tidefeldt U; Turesson I; Uden A-M; Wahlin A; Vilen L; Winqvist I; Zettervall O; Oberg G; Simonsson B
Article: LAKARTIDNINGEN. 2006;103(21-22):1741-1743

[Diphosphonates can cause necrosis of the jaw. Patients with malignant skeletal diseases are at risk].

Jarnbring F; Ulmner M; Blomlöf J; Ljungman P
Article: JOURNAL OF CLINICAL MICROBIOLOGY. 2006;44(5):1847-1850

Polymorphisms in the genes encoding chemokine receptor 5, interleukin-10, and monocyte chemoattractant protein 1 contribute to cytomegalovirus reactivation and disease after allogeneic stem cell transplantation

Loeffler J; Michael S; Arlt EM; Toliat MR; Mezger M; Suk A; Wienker TF; Hebart H; Nürnberg P; Boeckh M; Ljungman P; Trenschel R; Einsele H
Article: JOURNAL OF CLINICAL VIROLOGY. 2006;35(4):493-495

Would monitoring CMV immune responses allow improved control of CMV in stem cell transplant patients

Ljungman P
Article: TRANSPLANTATION. 2006;81(5):718-725

Allogeneic hematopoietic stem cell transplantation for inherited disorders:: Experience in a single center

Ringdén O; Remberger M; Svahn BM; Barkholt L; Mattsson J; Aschan J; Le Blanc K; Gustafsson B; Hassan Z; Omazic B; Svenberg P; Solders G; von Döbeln U; Winiarski J; Ljungman P; Malm G
Article: HAEMATOLOGICA. 2006;91(3):401-404

The incidence of hemorrhagic cystitis and BK-viruria in allogeneic hematopoietic stem cell recipients according to intensity of the conditioning regimen

Giraud G; Bogdanovic G; Priftakis P; Remberger M; Svahn B-M; Barkholt L; Ringden O; Winiarski J; Ljungman P; Dalianis T
Article: BONE MARROW TRANSPLANTATION. 2006;37(5):439-449

Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe

Ljungman P; Urbano-Ispizua A; Cavazzana-Calvo M; Demirer T; Dini G; Einsele H; Gratwohl A; Madrigal A; Niederwieser D; Passweg J; Rocha V; Saccardi R; Schouten H; Schmitz N; Socie G; Sureda A; Apperley J
Article: HAEMATOLOGICA. 2006;91(1):78-83

Risk factors for the development of cytomegalovirus disease after allogeneic stem cell transplantation

Ljungman P; Perez-Bercoff L; Jonsson J; Avetisyan G; Sparrelid E; Aschan J; Barkholt L; Larsson K; Winiarski J; Yun Z; Ringden O
Article: BONE MARROW TRANSPLANTATION. 2005;36(5):411-415

Cell-mediated immune responses to influenza vaccination in healthy volunteers and allogeneic stem cell transplant recipients

Avetisyan G; Ragnavölgyi E; Toth GT; Hassan M; Ljungman P
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2005;130(1):96-98

Vaccination of patients with haematological malignancies with one or two doses of influenza vaccine: a randomised study

Ljungman P; Nahi H; Linde A
Article: BONE MARROW TRANSPLANTATION. 2005;35(8):737-746

Vaccination of stem cell transplant recipients:: recommendations of the Infectious Diseases Working Party of the EBMT

Ljungman P; Engelhard D; de la Cámara R; Einsele H; Locasciulli A; Martino R; Ribaud P; Ward K; Cordonnier C
Article: BONE MARROW TRANSPLANTATION. 2005;35(6):609-617

The impact of donor gender on outcome of allogeneic hematopoietic stem cell transplantation for multiple myeloma:: reduced relapse risk in female to male transplants

Gahrton G; Iacobelli S; Apperley J; Bandini G; Björkstrand B; Bladé J; Boiron JM; Cavo M; Cornelissen J; Corradini P; Kröger N; Ljungman P; Michallet M; Russell NH; Samson D; Schattenberg A; Sirohi B; Verdonck LF; Volin L; Zander A; Niederwieser D
Article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2005;37(2):121-126

The value of CMV and fungal PCR for monitoring of acute leukaemia and autologous stem cell transplant patients

Ljungman P; Von Döbeln L; Ringholm L; Lewensohn-Fuchs I; Klingspor L; Sparrelid E
Article: ACTA HAEMATOLOGICA. 2005;113(3):155-162

Intensive treatment and stem cell transplantation in chronic myelogenous leukemia:: Long-term follow-up

Simonsson B; Öberg G; Björeman M; Björkholm M; Carneskog J; Karlsson K; Gahrton G; Grimfors G; Hast R; Karle H; Linder O; Ljungman P; Nielsen JL; Nilsson J; Löfvenberg E; Malm C; Olsson K; Olsson-Strömberg U; Paul C; Stenke L; Stentoft J; Turesson I; Udén AM; Wahlin A; Vilén L; Weis-Bjerrum O
Article: BONE MARROW TRANSPLANTATION. 2004;34(11):955-962

Lenograstim after autologous peripheral blood progenitor cell transplantation: results of a double-blind, randomized trial.

Schmitz N; Ljungman P; Cordonnier C; Kempf C; Linkesch W; Alegre A; Solano C; Simonsson B; Sonnen R; Diehl V; Fischer T; Caballero D; Littlewood T; Noppeney R; Schafhausen P; Jost L; Delabarre F; Marcus R
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2004;10(12):877-882

Allogenic stem cell transplantation for nonmalignant disorders using matched unrelated donors

Svenberg P; Remberger M; Svennilson J; Mattsson J; Leblanc K; Gustafsson B; Aschan J; Barkholt L; Winiarski J; Ljungman P; Ringdén O
Article: BONE MARROW TRANSPLANTATION. 2004;34(12):1067-1069

Long-term immunity to poliovirus after vaccination of allogeneic stem cell transplant recipients

Ljungman P; Aschan J; Gustafsson B; Lewensohn-Fuchs I; Winiarski J; Ringdén O
Article: JOURNAL OF CLINICAL MICROBIOLOGY. 2004;42(11):5394-5396

Association between a high BK virus load in urine samples of patients with graft-versus-host disease and development of hemorrhagic cystitis after hematopoietic stem cell transplantation

Bogdanovic G; Priftakis P; Giraud G; Kuzniar M; Ferraldeschi R; Kokhaei P; Mellstedt H; Remberger M; Ljungman P; Winiarski J; Dalianis T
Article: CLINICAL MICROBIOLOGY AND INFECTION. 2004;10(10):899-903

Reduced susceptibility to penicillin of viridans group streptococci in the oral cavity of patients with haematological disease

Westling K; Julander I; Ljungman P; Heimdahl A; Thalme A; Nord CE
Article: BONE MARROW TRANSPLANTATION. 2004;34(7):589-593

Measles immunity after allogeneic stem cell transplantation;: influence of donor type, graft type, intensity of conditioning, and graft-versus host disease

Ljungman P; Aschan J; Barkholt L; Broliden PA; Gustafsson B; Lewensohn-Fuchs I; Löfgren C; Winiarski J; Ringdén O
Article: BONE MARROW TRANSPLANTATION. 2004;33(11):1075-1081

Management of CMV infections: recommendations from the infectious diseases working party of the EBMT.

Ljungman P; Reusser P; de la Camara R; Einsele H; Engelhard D; Ribaud P; Ward K; European Group for Blood and Marrow Transplantatio
Article: CLINICAL INFECTIOUS DISEASES. 2004;38(9):1229-1236

Mycobacterial infection: a difficult and late diagnosis in stem cell transplant recipients.

Cordonnier C; Martino R; Trabasso P; Held TK; Akan H; Ward MS; Fabian K; Ullmann AJ; Wulffraat N; Ljungman P; Alessandrino EP; Pretnar J; Gmür J; Varela R; Vitek A; Sica S; Rovira M; European Blood and Marrow Transplant Group Infecti
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2004;10(3):195-203

Graft-versus-Host disease is associated with a lower relapse incidence after hematopoietic stem cell transplantation in patients with acute lymphoblastic leukemia

Nordlander A; Mattsson J; Ringdén O; Leblanc K; Gustafsson B; Ljungman P; Svenberg P; Svennilson J; Remberger M
Article: TRANSPLANTATION. 2004;77(4):526-531

Reduced risk for extensive chronic graft-versus-host disease in patients receiving transplants with human leukocyte antigen-identical sibling donors given polymerase chain reaction-based preemptive therapy against cytomegalovirus

Larsson K; Aschan J; Remberger M; Ringdén O; Winiarski J; Ljungman P
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2004;10(2):128-134

Which donor should be chosen for hematopoietic stem cell transplantation among unrelated HLA-A, -B, and-DRB1 genomically identical volunteers?

Ringdén O; Schaffer M; Le Blanc AA; Persson U; Hauzenberger D; Abedi MR; Olerup O; Ljungman P; Remberger M
Article: HEMATOLOGY JOURNAL. 2004;5(6):462-466

Comparison of busulphan, hydroxyurea and allogeneic bone marrow transplantation (BMT) in chronic myeloid leukaemia:: BMT prolongs survival

Olsson-Strömberg U; Simonsson B; Ahlgren T; Björkholm M; Carlsson K; Gahrton G; Hast R; Löfvenberg E; Linder O; Ljungman P; Malm C; Paul C; Rödjer S; Turesson I; Udén AM; Wahlin A; Killander A; Wadman B; Westin J; Vikrot O; Zettervall O; Öberg G
Article: CANCER NURSING. 2004;27(1):55-64

Symptom occurrence, symptom intensity, and symptom distress in patients undergoing high-dose chemotherapy with stem-cell transplantation

Larsen J; Nordström G; Ljungman P; Gardulf A
Article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2004;36(8):593-600

A prospective, randomized study comparing cefepime and imipenem-cilastatin in the empirical treatment of febrile neutropenia in patients treated for haematological malignancies

Cherif H; Björkholm M; Engervall P; Johansson P; Ljungman P; Hast R; Kalin M
Article: BONE MARROW TRANSPLANTATION. 2004;33(1):79-85

Viridans streptococcal septicaemia in neutropenic patients:: role of proinflammatory cytokines

Ihendyane N; Sparrelid E; Wretlind B; Remberger M; Andersson J; Ljungman P; Ringdén O; Normark BH; Allen U; Low DE; Norrby-Teglund A
Article: BLOOD. 2003;102(13):4255-4260

Donor CMV serologic status and outcome of CMV-seropositive recipients after unrelated donor stem cell transplantation: an EBMT megafile analysis.

Ljungman P; Brand R; Einsele H; Frassoni F; Niederwieser D; Cordonnier C
Article: SUPPORTIVE CARE IN CANCER. 2003;11(11):739-741

Vaccination of autologous stem cell transplant recipients with live varicella vaccine: a pilot study.

Ljungman P; Wang FZ; Nilsson C; Solheim V; Linde A
Article: JOURNAL OF VIROLOGICAL METHODS. 2003;110(1):73-79

A real-time TaqMan PCR for routine quantitation of cytomegalovirus DNA in crude leukocyte lysates from stem cell transplant patients

Yun ZB; Lewensohn-Fuchs I; Ljungman P; Ringholm L; Jonsson J; Alberta J
Article: BLOOD. 2003;101(6):2426-2433

Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trial.

van Rhenen D; Gulliksson H; Cazenave J-P; Pamphilon D; Ljungman P; Klüter H; Vermeij H; Kappers-Klunne M; de Greef G; Laforet M; Lioure B; Davis K; Marblie S; Mayaudon V; Flament J; Conlan M; Lin L; Metzel P; Buchholz D; Corash L; euroSPRITE trial
Article: BONE MARROW TRANSPLANTATION. 2003;31(6):481-486

Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: a survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation

Ljungman P; Ribaud P; Eyrich M; Matthes-Martin S; Einsele H; Bleakley M; Machaczka M; Bierings M; Bosi A; Gratecos N; Cordonnier C
Article: BONE MARROW TRANSPLANTATION. 2003;31(6):429-435

The effect of metronidazole on busulfan pharmacokinetics in patients undergoing hematopoietic stem cell transplantation

Nilsson C; Aschan J; Hentschke P; Ringdén O; Ljungman P; Hassan M
Article: EUROPEAN JOURNAL OF CANCER CARE. 2003;12(1):71-80

Symptom distress, functional status and health-related quality of life before high-dose chemotherapy with stem-cell transplantation

Larsen J; Nordström G; Björkstrand B; Ljungman P; Gardulf A
Article: BONE MARROW TRANSPLANTATION. 2002;30(12):833-841

A phase II trial of liposomal busulphan as an intravenous myeloablative agent prior to stem cell transplantation:: 500 mg/m² as a optimal total dose for conditioning

Hassan M; Nilsson C; Hassan Z; Gungor T; Aschan J; Winiarski J; Hentschke P; Ringdén O; Eber S; Seger R; Ljungman P
Article: BONE MARROW TRANSPLANTATION. 2002;30(11):761-768

The graft-versus-leukaemia effect in haematopoietic stem cell transplantation using unrelated donors

Remberger M; Mattsson J; Hentschke P; Aschan J; Barkholt L; Svennilson J; Ljungman P; Ringdén O
Article: BONE MARROW TRANSPLANTATION. 2002;30(8):521-526

Human herpesvirus 6 infection and cytomegalovirus-specific lymphoproliferative responses in allogeneic stem cell transplant recipients

Wang FZ; Larsson K; Linde A; Ljungman P
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2002;118(4):1112-1119

Thrombotic thrombocytopenic purpura after allogeneic stem cell transplantation: a survey of the European Group for Blood and Marrow Transplantation (EBMT).

Ruutu T; Hermans J; Niederwieser D; Gratwohl A; Kiehl M; Volin L; Bertz H; Ljungman P; Spence D; Verdonck LF; Prentice HG; Bosi A; Du Toit CE; Brinch L; Apperley JF; EBMT Chronic Leukaemia Working Party
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2002;118(4):1048-1054

Intensive chemotherapy in patients with chronic myelogenous leukaemia (CML) in accelerated or blastic phase -: a report from the Swedish CML Group

Axdorph U; Stenke L; Grimfors G; Carneskog J; Hansen J; Linder O; Ljungman P; Löfvenberg E; Malm C; Simonsson B; Turesson I; Vilén L; Udén AM; Björkholm M
Article: BLOOD. 2002;100(2):397-405

Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: prognostic relevance of the initial cell dose.

Guglielmi C; Arcese W; Dazzi F; Brand R; Bunjes D; Verdonck LF; Schattenberg A; Kolb H-J; Ljungman P; Devergie A; Bacigalupo A; Gomez M; Michallet M; Elmaagacli A; Gratwohl A; Apperley J; Niederwieser D
Article: TRANSPLANT INFECTIOUS DISEASE. 2002;4(2):75-79

CMV retinitis after allogeneic bone marrow transplantation: a report of five cases.

Larsson K; Lönnqvist B; Ringdén O; Hedquist B; Ljungman P
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2002;117(2):444-450

Early and late invasive pneumococcal infection following stem cell transplantation: a European Bone Marrow Transplantation survey.

Engelhard D; Cordonnier C; Shaw PJ; Parkalli T; Guenther C; Martino R; Dekker AW; Prentice HG; Gustavsson A; Nurnberger W; Ljungman P; Infectious Disease Working Party of the European B
Article: BLOOD. 2002;99(8):3050-3056

Randomized study of valacyclovir as prophylaxis against cytomegalovirus reactivation in recipients of allogeneic bone marrow transplants.

Ljungman P; de La Camara R; Milpied N; Volin L; Russell CA; Crisp A; Webster A; Valacyclovir International Bone Marrow Transplant
Article: CLINICAL INFECTIOUS DISEASES. 2002;34(8):1094-1097

Definitions of cytomegalovirus infection and disease in transplant recipients

Ljungman P; Griffiths P; Paya C
Article: BONE MARROW TRANSPLANTATION. 2002;29(8):639-646

Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe.

Urbano-Ispizua A; Schmitz N; de Witte T; Frassoni F; Rosti G; Schrezenmeier H; Gluckman E; Friedrich W; Cordonnier C; Socie G; Tyndall A; Niethammer D; Ljungman P; Gratwohl A; Apperley J; Niederwieser D; Bacigalupo A; European Group for Blood and Marrow Transplantatio
Article: TRANSPLANTATION. 2002;73(6):930-936

Clinical tolerance after allogeneic hematopoietic stem cell transplantation -: A study of influencing factors

Hentschke P; Remberger M; Mattsson J; Barkholt L; Aschan J; Ljungman P; Ringdén O
Article: BLOOD. 2002;99(4):1159-1164

Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation.

Reusser P; Einsele H; Lee J; Volin L; Rovira M; Engelhard D; Finke J; Cordonnier C; Link H; Ljungman P; Infectious Diseases Working Party of the European
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2002;8(12):674-682

Risk factors for moderate-to-severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

Remberger M; Kumlien G; Aschan J; Barkholt L; Hentschke P; Ljungman P; Mattsson J; Svennilson J; Ringdén O
Article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2002;34(5):347-350

Leukocyte depleted, unscreened blood products give a low risk for CMV infection and disease in CMV seronegative allogeneic stem cell transplant recipients with seronegative stem cell donors

Ljungman P; Larsson K; Kumlien G; Aschan J; Barkholt L; Gustaffson-Jernberg Å; Lewensohn-Fuchs I; Ringdén O
Article: STEM CELLS AND DEVELOPMENT. 2001;10(6):895-903

Practices of infectious disease prevention and management during hematopoietic stem cell transplantation: a survey from the European group for blood and marrow transplantation.

Krüger WH; Hornung RJ; Hertenstein B; Kern WV; Kröger N; Ljungman P; Zander AR; European group for blood and marrow transplantatio
Article: BONE MARROW TRANSPLANTATION. 2001;28(7):657-664

Population pharmacokinetic analysis resulting in a tool for dose individualization of busulphan in bone marrow transplantation recipients

Sandström M; Karlsson MO; Ljungman P; Hassan Z; Jonsson EN; Nilsson C; Ringden O; Öberg G; Bekassy A; Hassan M
Article: BONE MARROW TRANSPLANTATION. 2001;28(5):479-484

Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation

Ljungman P; Ward KN; Crooks BNA; Parker A; Martino R; Shaw PJ; Brinch L; Brune M; De La Camara R; Dekker A; Pauksen K; Russell N; Schwarer AP; Cordonnier C
Article: LANCET. 2001;358(9278):271-276

Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective survey.

Salooja N; Szydlo RM; Socie G; Rio B; Chatterjee R; Ljungman P; Van Lint MT; Powles R; Jackson G; Hinterberger-Fischer M; Kolb HJ; Apperley JF; Late Effects Working Party of the European Group f
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2001;47(6):855-861

Comparable aciclovir exposures produced by oral valaciclovir and intravenous aciclovir in immunocompromised cancer patients

Höglund M; Ljungman P; Weller S
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2001;113(1):209-216

Progress in allogenic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983--93 and 1994--8 at European Group for Blood and Marrow Transplantation centres.

Gahrton G; Svensson H; Cavo M; Apperly J; Bacigalupo A; Björkstrand B; Bladé J; Cornelissen J; de Laurenzi A; Facon T; Ljungman P; Michallet M; Niederwieser D; Powles R; Reiffers J; Russell NH; Samson D; Schaefer UW; Schattenberg A; Tura S; Verdonck LF; Vernant JP; Willemze R; Volin L; European Group for Blood and Marrow Transplantatio
Article: BONE MARROW TRANSPLANTATION. 2001;27(5):511-515

Alpha-interferon maintenance treatment is associated with improved survival after high-dose treatment and autologous stem cell transplantation in patients with multiple myeloma:: a retrospective registry study from the European Group for Blood and Marrow Transplantation (EBMT)

Björkstrand B; Svensson H; Goldschmidt H; Ljungman P; Apperley J; Mandelli F; Marcus R; Boogaerts M; Alegre A; Remes K; Cornelissen JJ; Bladé J; Lenhoff S; Iriondo A; Carlson K; Volin L; Littlewood T; Goldstone AH; San Miguel J; Schattenberg A; Gahrton G
Article: BONE MARROW TRANSPLANTATION. 2001;27(5):479-485

Pharmacokinetics of liposomal busulphan in man

Hassan Z; Ljungman P; Ringdén O; Winiarski J; Nilsson C; Aschan J; Whitley HR; Hassan M
Article: BLOOD. 2001;97(2):388-392

Cidofovir for cytomegalovirus infection and disease in allogeneic stem cell transplant recipients. The Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.

Ljungman P; Deliliers GL; Platzbecker U; Matthes-Martin S; Bacigalupo A; Einsele H; Ullmann J; Musso M; Trenschel R; Ribaud P; Bornhäuser M; Cesaro S; Crooks B; Dekker A; Gratecos N; Klingebiel T; Tagliaferri E; Ullmann AJ; Wacker P; Cordonnier C
Article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2001;33(5):323-328

Management of infections caused by respiratory syncytial virus

Rastad AA; Andersson J; Beermann B; Bohlin AB; Brandt C; Eriksson M; Ewald U; Göthberg S; Lind A; Lindroth M; Ljungman P; Navér L; Norrby SR; Pauksen K; Ransjö U; Rebbel H; Östlund MR; Sigurs N; Ståhle L; Säwe J; Sönnerborg A; Uhnoo I; Stopner B
Article: CANCER INVESTIGATION. 2001;19(1):13-22

A randomized, double-blind trial of famciclovir versus acyclovir for the treatment of localized dermatomal herpes zoster in immunocompromised patients

Tyring S; Belanger R; Bezwoda W; Ljungman P; Boon R; Saltzman RL
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2001;66(1):50-56

An ethnic role for chronic, but not acute, graft-versus-host disease after HLA-identical sibling stem cell transplantation

Remberger M; Aschan J; Lönnqvist B; Carlens S; Gustafsson B; Hentschke P; Klaesson S; Mattsson J; Ljungman P; Ringdén O
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2000;111(3):774-781

High levels of human herpesvirus 6 DNA in peripheral blood leucocytes are correlated to platelet engraftment and disease in allogeneic stem cell transplant patients

Ljungman P; Wang FZ; Clark DA; Emery VC; Remberger M; Ringdén O; Linde A
Article: JOURNAL OF MEDICAL VIROLOGY. 2000;62(4):498-504

Antibodies to human herpesvirus 8 latent and lytic antigens in blood donors and potential high-risk groups in Sweden:: Variable frequencies found in a multicenter serological study

Enbom M; Sheldon J; Lennette E; Schulz T; Ablashi DV; Neipel F; Biberfeld P; Carlberg H; Ljungman P; Nilsson A; Söderström T; Wadström J; Linde A
Article: LAKARTIDNINGEN. 2000;97(45):5086-5087

[Defend vaccination against measles! A life-threatening disease for immunocompromised patients].

Ljungman P
Article: LANCET. 2000;356(9239):1384-1391

Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer:: a randomised trial

Bergh J; Wiklund T; Erikstein B; Lidbrink E; Lindman H; Malmström P; Kellokumpu-Lehtinen P; Bengtsson NO; Söderlund G; Anker G; Wist E; Ottosson S; Salminen E; Ljungman P; Holte H; Nilsson J; Blomqvist C; Wilking N
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2000;110(3):620-630

Haematopoietic stem cell transplantation for patients with myelodysplastic syndromes and secondary acute myeloid leukaemias: a report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)

de Witte T; Hermans J; Vossen J; Bacigalupo A; Meloni G; Jacobsen N; Ruutu T; Ljungman P; Gratwohl A; Runde V; Niederwieser D; van Biezen A; Devergie A; Cornelissen J; Jouet JP; Arnold R; Apperley J
Article: THERAPEUTIC DRUG MONITORING. 2000;22(4):383-385

Ketobemidone may alter busulfan pharmacokinetics during high-dose therapy

Hassan M; Svensson JO; Nilsson C; Hentschke P; AL-Shurbaji A; Aschan J; Ljungman P; Ringdén O
Article: BONE MARROW TRANSPLANTATION. 2000;26(2):187-192

Cardiac systolic function before and after hematopoietic stem cell transplantation

Lehmann S; Isberg B; Ljungman P; Paul C
Article: BONE MARROW TRANSPLANTATION. 2000;25(9):915-924

The effect of busulphan on the pharmacokinetics of cyclophosphamide and its 4-hydroxy metabolite:: time interval influence on therapeutic efficacy and therapy-related toxicity

Hassan M; Ljungman P; Ringdén O; Hassan Z; Öberg G; Nilsson C; Békassy A; Bielenstein M; Abdel-Rehim M; Georén S; Astner L
Article: TRANSPLANTATION. 2000;69(8):1733-1736

Real-time monitoring of cytomegalovirus infections after stem cell transplantation using the TaqMan polymerase chain reaction assays

Yun ZB; Lewensohn-Fuchs I; Ljungman P; Vahlne A
Article: TRANSPLANTATION. 2000;69(8):1582-1586

Serum immunoglobulin levels in relation to levels of specific antibodies in allogeneic and autologous bone marrow transplant recipients

Hammarström V; Pauksen K; Svensson H; Lönnqvist B; Simonsson B; Ringdén O; Ljungman P
Article: LEUKEMIA. 2000;14(2):247-254

Minimal residual disease is common after allogeneic stem cell transplantation in patients with B cell chronic lymphocytic leukemia and may be controlled by graft-versus-host disease

Mattsson J; Uzunel M; Remberger M; Ljungman P; Kimby E; Ringdén O; Zetterquist H
Article: CLINICAL INFECTIOUS DISEASES. 2000;30(2):342-348

Granulocyte-macrophage colony-stimulating factor as immunomodulating factor together with influenza vaccination in stem cell transplant patients

Pauksen K; Linde A; Hammarström V; Sjölin J; Carneskog J; Jonsson G; Öberga G; Engelmann H; Ljungman P
Article: BLOOD. 2000;95(3):807-814

Epstein-Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease:: prophylactic infusion of EBV-specific cytotoxic T cells

Gustafsson Å; Levitsky V; Zou JZ; Frisan T; Dalianis T; Ljungman P; Ringden O; Winiarski J; Ernberg I; Masucci MG
Article: BLOOD. 2000;95(2):422-429

Outcome of 69 allogeneic stem cell transplantations for Fanconi anemia using HLA-matched unrelated donors: a study on behalf of the European Group for Blood and Marrow Transplantation.

Guardiola P; Pasquini R; Dokal I; Ortega JJ; van Weel-Sipman M; Marsh JC; Ball SE; Locatelli F; Vermylen C; Skinner R; Ljungman P; Miniero R; Shaw PJ; Souillet G; Michallet M; Bekassy AN; Krivan G; Di Bartolomeo P; Heilmann C; Zanesco L; Cahn JY; Arcese W; Bacigalupo A; Gluckman E
Article: BONE MARROW TRANSPLANTATION. 1999;24(11):1201-1206

Human herpesvirus 6 infection inhibits specific lymphocyte proliferation responses and is related to lymphocytopenia after allogeneic stem cell transplantation

Wang FZ; Linde A; Dahl H; Ljungman P
Article: TRANSPLANTATION. 1999;68(10):1486-1491

The role of hepatitis C and B virus infections as risk factors for severe liver complications following allogeneic BMT: A prospective study by the Infectious Disease Working Party of the European Blood and Marrow Transplantation Group

Locasciulli A; Testa M; Valsecchi MG; Bacigalupo A; Solinas S; Tomas JF; Ljungman P; Alberti A
Article: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 1999;48(5):669-677

A mechanism-based pharmacokinetic-enzyme model for cyclophosphamide autoinduction in breast cancer patients

Hassan M; Svensson USH; Ljungman P; Björkstrand B; Olsson H; Bielenstein M; Abdel-Rehim M; Nilsson C; Johansson M; Karlsson MO
Article: BONE MARROW TRANSPLANTATION. 1999;24(9):1033-1035

Bilateral subdural haematomas following lumbar puncture in three haematopoietic stem cell transplant recipients

Hentschke P; Hägglund H; Mattsson J; Carlens S; Lönnqvist B; Ljungman P; Aschan J; Fredrikson S; Ringdén O
Article: BONE MARROW TRANSPLANTATION. 1999;24(7):741-745

Syngeneic transplantation in multiple myeloma - a case-matched comparison with autologous and allogeneic transplantation. European Group for Blood and Marrow Transplantation.

Gahrton G; Svensson H; Björkstrand B; Apperley J; Carlson K; Cavo M; Ferrant A; Fouillard L; Gratecos N; Gratwohl A; Guilhot F; Lambertenghi Deliliers G; Ljungman P; Masszi T; Milligan DW; Powles RL; Reiffers J; Samson JD; Stoppa AM; Vernant JP; Volin L; Wallvik J
Article: BONE MARROW TRANSPLANTATION. 1999;23(10):1043-1047

Nutritional status and growth after bone marrow transplantation (BMT) during childhood:: EBMT Late-Effects Working Party retrospective data

Cohen A; Duell T; Socié G; van Lint MT; Weiss M; Tichelli A; Rovelli A; Apperley JF; Ljungman P; Kolb HJ
Article: BONE MARROW TRANSPLANTATION. 1999;23(8):835-837

Acute quadriplegic myopathy following autologous peripheral blood stem cell transplantation for breast cancer

Samuelsson J; Zackrisson H; Tokics L; Ljungman P; Lidbrink E; Pircher P; Larsson L
Article: BLOOD. 1999;93(7):2196-2201

Increased risk of chronic graft-versus-host disease, obstructive bronchiolitis, and alopecia with busulfan versus total body irradiation:: Long-term results of a randomized trial in allogeneic marrow recipients with leukemia

Ringdén O; Remberger M; Ruutu T; Nikoskelainen J; Volin L; Vindelov L; Parkkali T; Lenhoff S; Sallerfors B; Mellander L; Ljungman P; Jacobsen N
Article: CLINICAL INFECTIOUS DISEASES. 1999;28(3):562-568

Human herpesvirus 6 DNA in cerebrospinal fluid specimens from allogeneic bone marrow transplant patients:: Does it wave clinical significance?

Wang FZ; Linde A; Hägglund A; Testa M; Locasciulli A; Ljungman P
Article: ANNALS OF INTERNAL MEDICINE. 1999;130(3):193-201

Effectiveness of immunosuppressive therapy in older patients with aplastic anemia. European Group for Blood and Marrow Transplantation Severe Aplastic Anaemia Working Party.

Tichelli A; Socié G; Henry-Amar M; Marsh J; Passweg J; Schrezenmeier H; McCann S; Hows J; Ljungman P; Marin P; Raghavachar A; Locasciulli A; Gratwohl A; Bacigalupo A
Article: JOURNAL OF MEDICAL VIROLOGY. 1999;57(2):134-139

Lymphoproliferative responses to human herpesvirus-6 variant A and variant B in healthy adults

Wang FZ; Dahl H; Ljungman P; Linde A
Article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 1999;31(1):43-49

Subsets of T-cells and in vitro cytokine production after measles and varicellae-zoster virus antigen stimulation in allogeneic BMT patients

Pauksen K; Sjölin J; Linde A; Andersson B; Lenkei R; Öberg G; Ljungman P
Article: ACTA ONCOLOGICA. 1999;38(2):239-245

FEC mobilized stem cells for high-dose therapy in breast cancer patients

Lindman H; Wiklund T; Holte H; Ljungman P; Blomqvist C; Kvalheim G; Bengtsson M; Höglund M; Wilking N; Bergh J
Article: BLOOD. 1998;92(12):4568-4572

Norethisterone treatment, a major risk-factor for veno-occlusive disease in the liver after allogeneic bone marrow transplantation

Hägglund H; Remberger M; Klaesson S; Lönnqvist B; Ljungman P; Ringdén O
Article: BONE MARROW TRANSPLANTATION. 1998;22(11):1119-1122

Improved peripheral nerve conduction, EEG and verbal IQ after bone marrow transplantation for adult metachromatic leukodystrophy

Solders G; Celsing G; Hagenfeldt L; Ljungman P; Isberg B; Ringdén O
Article: TRANSPLANTATION. 1998;66(10):1330-1334

Results of different strategies for reducing:: Cytomegalovirus-associated mortality in allogeneic stem cell transplant recipients

Ljungman P; Aschan J; Lewensohn-Fuchs I; Carlens S; Larsson K; Lönnqvist B; Mattsson J; Sparrelid E; Winiarski J; Ringdén O
Article: BONE MARROW TRANSPLANTATION. 1998;22(8):795-800

Bacteraemia during the aplastic phase after allogeneic bone marrow transplantation is associated with early death from invasive fungal infection

Sparrelid E; Hägglund H; Remberger M; Ringdén O; Lönnqvist B; Ljungman P; Andersson J
Article: BONE MARROW TRANSPLANTATION. 1998;22(8):755-761

Risk factors for chronic graft-versus-host disease after bone marrow transplantation:: a retrospective single centre analysis

Carlens S; Ringdén O; Remberger M; Lönnqvist B; Hägglund H; Klaesson S; Mattsson J; Svahn BM; Winiarski J; Ljungman P; Aschan J
Article: TRANSPLANTATION. 1998;66(5):620-625

Low incidence of acute graft-versus-host disease, using unrelated HLA-A-, HLA-B-, and HLA-DR-compatible donors and conditioning, including, anti-T-cell antibodies

Ringdén O; Remberger M; Carlens S; Hagglund H; Mattsson J; Aschan J; Lönnqvist B; Klaesson S; Winiarski J; Dalianis T; Olerup O; Sparrelid E; Elmhorn-Rosenborg A; Svahn BM; Ljungman P
Article: BONE MARROW TRANSPLANTATION. 1998;22(5):499-501

Detection of hepatitis G virus GB virus C after allogeneic bone marrow transplantation

Ljungman P; Halasz R; Hägglund H; Sönnerborg A; Ringdén O
Article: BONE MARROW TRANSPLANTATION. 1998;22(5):445-448

High-dose chemotherapy with autologous stem cell support in patients with responding stage IV breast cancer

Ljungman P; Björkstrand B; Fornander T; Höglund M; Juliusson G; Lindman H; Malmström A; Rotstein S; Söderberg M; Wilking N; Villman K; Bergh J
Article: SUPPORTIVE CARE IN CANCER. 1998;6(5):469-472

Tetanus immunity in patients with hematological malignancies

Hamarstrom V; Pauksen K; Svensson H; Oberg G; Paul C; Ljungman P
Article: BONE MARROW TRANSPLANTATION. 1998;22(1):67-71

Tetanus immunity in autologous bone marrow and blood stem cell transplant recipients.

Hammarström V; Pauksen K; Björkstrand B; Simonsson B; Oberg G; Ljungman P
Article: SUPPORTIVE CARE IN CANCER. 1998;6(4):378-383

Faster engraftment but no reduction in infectious complications after peripheral blood stem cell transplantation compared to autologous bone marrow transplantation

Larsson K; Bjorkstrand B; Ljungman P
Article: BONE MARROW TRANSPLANTATION. 1998;22(1):73-78

Booster marrow or blood cells for graft failure after allogeneic bone marrow transplantation

Remberger M; Ringdén O; Ljungman P; Hägglund H; Winiarski J; Lönnqvist B; Aschan J
Article: BONE MARROW TRANSPLANTATION. 1998;21(12):1231-1238

Influence of protective isolation on outcome of allogeneic bone marrow transplantation for leukemia.

Passweg JR; Rowlings PA; Atkinson KA; Barrett AJ; Gale RP; Gratwohl A; Jacobsen N; Klein JP; Ljungman P; Russell JA; Schaefer UW; Sobocinski KA; Vossen JM; Zhang MJ; Horowitz MM
Article: PEDIATRIC TRANSPLANTATION. 1998;2(2):150-156

Engraftment and chimerism, particularly of T- and B-cells, in children undergoing allogeneic bone marrow transplantation.

Winiarski J; Mattsson J; Gustafsson A; Wester D; Borgström B; Ringdén O; Ljungman P; Dalianis T
Article: CLINICAL INFECTIOUS DISEASES. 1998;26(5):1098-1103

Impact of previous aspergillosis on the outcome of bone marrow transplantation

Offner F; Cordonnier C; Ljungman P; Prentice HG; Engelhard D; De Bacquer D; Meunier F; De Pauw B
Article: CLINICAL TRANSPLANTATION. 1998;12(2):84-92

Risk factors in bone marrow transplant recipients with leukaemia. Increased relapse risk in patients treated with ciprofloxacin for gut decontamination

Carlens S; Ringden O; Aschan J; Hagglund H; Ljungman P; Mattsson J; Remberger M
Article: BONE MARROW TRANSPLANTATION. 1998;21(5):473-476

Use of intravenous immune globulin in addition to antiviral therapy in the treatment of CMV gastrointestinal disease in allogeneic bone marrow transplant patients:: a report from the European Group for Blood and Marrow Transplantation (EBMT)

Ljungman P; Cordonnier C; Einsele H; Bender-Götze C; Bosi A; Dekker A; De la Camara R; Gmür J; Newland AC; Prentice HG; Robinson AJ; Rovira M; Rösler W; Veil D
Article: BONE MARROW TRANSPLANTATION. 1998;21(3):255-261

Bone marrow transplantation from HLA identical siblings as first-line treatment in patients with myelodysplastic syndromes: early transplantation is associated with improved outcome

Runde V; de Witte T; Arnold R; Gratwohl A; Hermans J; Van Biezen A; Niederwieser D; Labopin M; Walter-Noel MP; Bacigalupo A; Jacobsen N; Ljungman P; Carreras E; Kolb HJ; Aul C; Apperley J
Article: BONE MARROW TRANSPLANTATION. 1998;21(1):43-49

Transplantation with unrelated bone marrow in leukaemic patients above 40 years of age

Ringdén O; Remberger M; Mattsson J; Aschan J; Carlens S; Hägglund H; Lönnqvist B; Sparrelid E; Ljungman P
Article: BONE MARROW TRANSPLANTATION. 1997;20(11):909-913

High busulfan concentrations are associated with increased transplant-related mortality in allogeneic bone marrow transplant patients

Ljungman P; Hassan M; Bekassy AN; Ringden O; Oberg G
Article: SUPPORTIVE CARE IN CANCER. 1997;5(6):485-488

Peroperative teicoplanin for prevention of gram-positive infections in neutropenic patients with indwelling central venous catheters: a randomized, controlled study

Ljungman P; Hagglund H; Bjorkstrand B; Lonnqvist B; Ringden O
Article: BONE MARROW TRANSPLANTATION. 1997;20(4):317-323

Th1 and Th2 cytokine responses after measles antigen stimulation in vitro in bone marrow transplant patients: response to measles vaccination

Pauksen K; Sjolin J; Linde A; Alm G; Andersson B; Lonnerholm G; Ljungman P
Article: BONE MARROW TRANSPLANTATION. 1997;20(1):11-19

European results of matched unrelated donor bone marrow transplantation for chronic myeloid leukemia. Impact of HLA class II matching. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

Devergie A; Apperley JF; Labopin M; Madrigal A; Jacobsen N; Carreras E; Prentice HG; Jouet JP; Kolb HJ; Herstenstein B; Bacigalupo A; Evensen SA; Ljungman P; de Witte T; Reiffers J; Nagler A; Clark RE; Goldman JM; Gratwohl A
Article: BONE MARROW TRANSPLANTATION. 1997;19(9):905-908

Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infections

Sparrelid E; Ljungman P; EkelofAndstrom E; Aschan J; Ringden O; Winiarski J; Wahlin B; Andersson J
Article: AMERICAN JOURNAL OF MEDICINE. 1997;102(3A):44-47

Respiratory virus infections in bone marrow transplant recipients: the European perspective.

Ljungman P
Article: BONE MARROW TRANSPLANTATION. 1997;19(3):237-240

Hepatitis C virus genotypes and liver disease in patients undergoing allogeneic bone marrow transplantation

Locasciulli A; Testa M; Pontisso P; Bacigalupo A; Ljungman P; Frickhofen N; Alberti A
Article: BONE MARROW TRANSPLANTATION. 1997;19(3):233-236

No prevention of cytomegalovirus infection by anti-cytomegalovirus hyperimmune globulin in seronegative bone marrow transplant recipients

Ruutu T; Ljungman P; Brinch L; Lenhoff S; Lonnqvist B; Ringden O; Ruutu P; Volin L; Albrechtsen D; Sallerfors B; Ebeling F; Myllyla G
Article: ANNALS OF INTERNAL MEDICINE. 1997;126(3):184

Health and functional status of long-term survivors of bone marrow transplantation. EBMT Working Party on Late Effects and EULEP Study Group on Late Effects. European Group for Blood and Marrow Transplantation.

Duell T; van Lint MT; Ljungman P; Tichelli A; Socié G; Apperley JF; Weiss M; Cohen A; Nekolla E; Kolb HJ
Article: BONE MARROW TRANSPLANTATION. 1997;19(2):129-133

Long-term survival in allogeneic bone marrow transplant recipients following acyclovir prophylaxis for CMV infection. The European Acyclovir for CMV Prophylaxis Study Group.

Prentice HG; Gluckman E; Powles RL; Ljungman P; Milpied NJ; Camara R; Mandelli F; Kho P; Kennedy L; Bell AR
Article: BLOOD. 1996;88(12):4711-4718

Allogeneic bone marrow transplantation versus autologous stem cell transplantation in multiple myeloma: A retrospective case-matched study from the European group for blood and marrow transplantation

Bjorkstrand B; Ljungman P; Svensson H; Hermans J; Alegre A; Apperley J; Blade J; Carlson K; Cavo M; Ferrant A; Goldstone AH; deLaurenzi A; Majolino I; Marcus R; Prentice HG; Remes K; Samson D; Sureda A; Verdonck LF; Volin L; Gahrton G
Article: BONE MARROW TRANSPLANTATION. 1996;18(6):1179-1181

Rejection of the second allogeneic graft in a patient with severe aplastic anemia reversed by antilymphocyte globulin and donor lymphocyte infusions

Ljungman P; Lawler M; Lonnqvist B; Ringden O; Shanwell A
Article: BONE MARROW TRANSPLANTATION. 1996;18(5):969-973

Influence of the specific T cell response on seroconversion after measles vaccination in autologous bone marrow transplant patients

Pauksen K; Linde A; Lonnerholm G; Ljungman P; Sjolin J
Article: BLOOD. 1996;88(9):3615-3620

Lymphotropic herpesviruses in allogeneic bone marrow transplantation

Wang FZ; Dahl H; Linde A; Brytting M; Ehrnst A; Ljungman P
Article: TRANSPLANTATION. 1996;62(8):1076-1080

Treatment of hepatic venoocclusive disease with recombinant human tissue plasminogen activator or orthotopic liver transplantation after allogeneic bone marrow transplantation

Hagglund H; Ringden O; Ericzon BG; Duraj F; Ljungman P; Lonnqvist B; Winiarski J; Tyden G
Article: BONE MARROW TRANSPLANTATION. 1996;18(4):677-691

The European Group for Blood and Marrow Transplantation (EBMT): a report from the president and the chairmen of the working parties.

Gratwohl A; Gorin C; Apperley J; Goldstone A; Rosti G; Bacigalupo A; Gluckman E; Fischer A; Ljungman P; Kolb HJ; Niethammer D
Article: CANCER NURSING. 1996;19(5):368-375

Health-related quality of life in women with breast cancer undergoing autologous stem cell transplantation

Larsen J; Gardulf A; Nordstrom G; Bjorkstrand B; Ljungman P
Article: JOURNAL OF CHEMOTHERAPY. 1996;8(5):382-386

Imipenem/cilastatin monotherapy as salvage treatment in febrile neutropenic patients

Engervall P; Gunther G; Ljungman P; Lonnqvist B; Hast R; Stiernstedt G; Kalin M; Ringertz S; Bjorkholm M
Article: BONE MARROW TRANSPLANTATION. 1996;18(3):565-568

Foscarnet for pre-emptive therapy of CMV infection detected by a leukocyte-based nested PCR in allogeneic bone marrow transplant patients

Ljungman P; Oberg G; Aschan J; Ehrnst A; Lonnqvist B; Pauksen K; Sulila P
Article: BONE MARROW TRANSPLANTATION. 1996;18(2):333-337

Loss of seroreactivity against human papillomavirus (HPV) in bone marrow transplant recipients

LewensohnFuchs I; Ljungman P; Kjerrstrom A; Ringden O; Dalianis T
Article: BONE MARROW TRANSPLANTATION. 1996;18(1):241-242

Lymphoblastoid human interferon and low dose IL-2 combined with donor lymphocyte infusion as therapy of a third relapse of CML--a case report.

Lönnqvist B; Brune M; Ljungman P
Article: CLINICAL INFECTIOUS DISEASES. 1996;23(1):167-169

Oral ribavirin for prevention of severe liver disease caused by hepatitis C virus during allogeneic bone marrow transplantation

Ljungman P; Andersson J; Aschan J; Bjorkstrand B; Hagglund H; Lonnqvist B; Ringden O; Winiarski J
Article: BONE MARROW TRANSPLANTATION. 1996;17(6):1105-1111

Late-onset keratoconjunctivitis sicca syndrome after bone marrow transplantation: Incidence and risk factors

Tichelli A; Duell T; Weiss M; Socie G; Ljungman P; Cohen A; vanLint M; Gratwohl A; Kolb HJ
Article: BONE MARROW TRANSPLANTATION. 1996;17(5):813-817

European survey of herpesvirus resistance to antiviral drugs in bone marrow transplant recipients. Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT).

Reusser P; Cordonnier C; Einsele H; Engelhard D; Link D; Locasciulli A; Ljungman P
Article: JOURNAL OF CLINICAL MICROBIOLOGY. 1996;34(5):1166-1170

A three-center European external quality control study of PCR for detection of cytomegalovirus DNA in blood.

Grundy JE; Ehrnst A; Einsele H; Emery VC; Hebart H; Prentice HG; Ljungman P
Article: BONE MARROW TRANSPLANTATION. 1996;17(4):583-587

Use of a semi-quantitative PCR for cytomegalovirus DNA as a basis for pre-emptive antiviral therapy in allogeneic bone marrow transplant patients

Ljungman P; Lore K; Aschan J; Klaesson S; LewensohnFuchs I; Lonnqvist B; Ringden O; Winiarski J; Ehrnst A
Article: BONE MARROW TRANSPLANTATION. 1996;17(4):573-576

Presence of human polyomavirus DNA in the peripheral circulation of bone marrow transplant patients with and without hemorrhagic cystitis

Bogdanovic G; Ljungman P; Wang F; Dalianis T
Article: ACTA PAEDIATRICA. 1996;85(3):327-335

Bone marrow transplantation in children using unrelated donors at Huddinge Hospital

Winiarski J; Ringden O; Remberger M; Dalianis T; Ljungman P; Borgstrom B
Article: TRANSPLANTATION. 1996;61(4):600-609

Cytomegalovirus-induced CD13-specific autoimmunity - A possible cause of chronic graft-versus-host disease

Soderberg C; Larsson S; Rozell BL; SumitranKaruppan S; Ljungman P; Moller E
Article: TRANSPLANTATION. 1996;61(4):594-600

CD13-specific autoimmunity in cytomegalovirus infected immunocompromised patients

Soderberg C; SumitranKaruppan S; Ljungman P; Moller E
Article: ACTA PAEDIATRICA. 1996;85(2):168-172

Fungal pneumonia: The predominant lung infection causing death in children undergoing bone marrow transplantation

Heurlin N; Bergstrom SE; Winiarski J; Ringden O; Ljungman P; Lonnqvist B; Andersson J
Article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 1996;28(3):297-303

Trimethoprim-sulfamethoxazole plus amikacin versus ceftazidime monotherapy as empirical treatment in patients with neutropenia and fever

Engervall P; Gunther G; Ljungman P; Lonnqvist B; Hast R; Stiernstedt G; Kalin M; Ringertz S; Bjokholm M
Article: TRANSPLANTATION. 1995;60(11):1225-1230

Does high-dose intravenous immune globulin treatment after bone marrow transplantation increase mortality in veno-occlusive disease of the liver?

Klaesson S; Ringden O; Ljungman P; Aschan J; Hagglund H; Winiarski J
Article: BONE MARROW TRANSPLANTATION. 1995;16(6):807-813

Specific T and B cell immunity to measles after allogeneic and autologous bone marrow transplantation

Pauksen K; Linde A; Ljungman P; Bolme P; Lonnerholm G; Oberg G; Sjolin J
Article: BONE MARROW TRANSPLANTATION. 1995;16(6):747-753

Risk factors for acute graft-versus-host disease in 291 consecutive HLA-identical bone marrow transplant recipients

Hagglund H; Bostrom L; Remberger M; Ljungman P; Nilsson B; Ringden O
Article: TRANSPLANTATION. 1995;60(9):961-965

CYTOMEGALOVIRUS DNA IN PERIPHERAL-BLOOD LEUKOCYTES AND PLASMA FROM BONE-MARROW TRANSPLANT RECIPIENTS

BRYTTING M; MOUSAVIJAZI M; BOSTROM L; LARSSON M; LUNDEBERG J; LJUNGMAN P; RINGDEN O; SUNDQVIST VA
Article: BLOOD. 1995;86(5):2041-2050

GRAFT-VERSUS-LEUKEMIA EFFECT OF DONOR LYMPHOCYTE TRANSFUSIONS IN MARROW GRAFTED PATIENTS

KOLB HJ; SCHATTENBERG A; GOLDMAN JM; HERTENSTEIN B; JACOBSEN N; ARCESE W; LJUNGMAN P; FERRANT A; VERDONCK L; NIEDERWIESER D; VANRHEE F; MITTERMUELLER J; DEWITTE T; HOLLER E; ANSARI H
Article: BLOOD. 1995;86(4):1614-1618

LONG-TERM EFFECTS OF HEPATITIS-C VIRUS-INFECTION IN ALLOGENEIC BONE-MARROW TRANSPLANT RECIPIENTS

LJUNGMAN P; JOHANSSON N; ASCHAN J; GLAUMANN H; LONNQVIST B; RINGDEN O; SPARRELID E; SONNERBORG A; WINIARSKI J; GAHRTON G
Article: STEM CELLS. 1995;13 Suppl 2:122-125

An update of prognostic factors for allogeneic bone marrow transplantation in multiple myeloma using matched sibling donors. European Group for Blood and Marrow Transplantation.

Gahrton G; Tura S; Ljungman P; Bladé J; Cavo M; De Laurenzi A; Façon T; Gratwohl A; Michallet M; Nikoskelainen J
Article: CURRENT OPINION IN INFECTIOUS DISEASES. 1995;8(4):254-257

IMMUNIZATION IN THE IMMUNOCOMPROMISED HOST

LJUNGMAN P
Article: STEM CELLS. 1995;13:140-146

AUTOLOGOUS STEM-CELL TRANSPLANTATION IN MULTIPLE-MYELOMA - RESULTS OF THE EUROPEAN GROUP FOR BONE-MARROW TRANSPLANTATION

BJORKSTRAND B; LJUNGMAN P; BIRD JM; SAMSON D; BRANDT L; ALEGRE A; AUZANNEAU G; BLADE J; BRUNET S; CARLSON K; CAVO M; FERRANT A; GRAVETT P; DELAURENZI A; PRENTICE HG; PROCTOR S; REMES K; TROUSSARD X; VERDONCK LF; WILLIAMS C; GAHRTON G
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 1995;55(1):19-23

MITOXANTRONE, ETOPOSIDE AND ARA-C VS DOXORUBICIN-DNA, ARA-C, THIOGUANINE, VINCRISTINE AND PREDNISOLONE IN THE TREATMENT OF PATIENTS WITH ACUTE MYELOCYTIC-LEUKEMIA - A RANDOMIZED COMPARISON

BJORKHOLM M; LILIEMARK J; GAHRTON G; GRIMFORS G; GRUBER A; HAST R; JULIUSSON G; JARNMARK M; KILLANDER A; KIMBY E; LERNER R; LJUNGMAN P; LONNQVIST B; PALMBLAD J; PAUL C; PETTERSON C; SIMONSSON B; STALFELT AM; STENKE L; SUNDSTROM C; TIDEFELT U; UDEN AM; OBERG G; OST A
Article: JOURNAL OF CLINICAL ONCOLOGY. 1995;13(6):1312-1322

Prognostic factors in allogeneic bone marrow transplantation for multiple myeloma.

Gahrton G; Tura S; Ljungman P; Bladé J; Brandt L; Cavo M; Façon T; Gratwohl A; Hagenbeek A; Jacobs P
Article: BONE MARROW TRANSPLANTATION. 1995;15(6):869-871

BUSULFAN CONCENTRATION IN RELATION TO PERMANENT ALOPECIA IN RECIPIENTS OF BONE-MARROW TRANSPLANTS

LJUNGMAN P; HASSAN M; BEKASSY AN; RINGDEN O; OBERG G
Article: BIODRUGS. 1995;3(5):330-337

IMMUNIZATION OF TRANSPLANT RECIPIENTS

LJUNGMAN P; HAMMARSTROM V
Article: CLINICAL AND DIAGNOSTIC VIROLOGY. 1995;3(4):371-375

CONTINUOUS DETECTION OF CMV DNA IN PLASMA OF PATIENTS WITH ADVANCED HIV-INFECTION IMPLIES THE POOREST PROGNOSIS

WANG FH; BRYTTING M; BRATT G; LJUNGMAN P; WAHREN B
Article: BONE MARROW TRANSPLANTATION. 1995;15(4):619-625

SIMILAR INCIDENCE OF GRAFT-VERSUS-HOST DISEASE USING HLA-A, HLA-B AND HLA-DR IDENTICAL UNRELATED BONE-MARROW DONORS AS WITH HLA-IDENTICAL SIBLINGS

RINGDEN O; REMBERGER M; PERSSON U; LJUNGMAN P; ALDENER A; ANDSTROM E; ASCHAN J; BOLME P; DAHLLOF G; DALIANIS T; GAHRTON G; HAGGLUND H; LONNQVIST B; OLERUP O; SHANWELL A; SPARRELID E; WINIARSKI J; MOLLER E; OBERG M
Article: BONE MARROW TRANSPLANTATION. 1995;15(3):455-460

Immunisations after bone marrow transplantation: results of a European survey and recommendations from the infectious diseases working party of the European Group for Blood and Marrow Transplantation.

Ljungman P; Cordonnier C; de Bock R; Einsele H; Engelhard D; Grundy J; Link H; Locasciulli A; Prentice G; Reusser P
Article: LAKARTIDNINGEN. 1995;92(9):849-853

[High-dose chemotherapy in breast cancer. Promising results in combination with stem cell support].

Ljungman P; Björkstrand B; Gahrton G; Nordenström J; Shanwell A; Glas U; Rotstein S; Rutqvist LE; Wilking N
Article: BONE MARROW TRANSPLANTATION. 1995;15(3):367-371

DOUBLE HIGH-DOSE CHEMORADIOTHERAPY WITH AUTOLOGOUS STEM-CELL TRANSPLANTATION CAN INDUCE MOLECULAR REMISSIONS IN MULTIPLE-MYELOMA

BJORKSTRAND B; LJUNGMAN P; BIRD JM; SAMSON D; GAHRTON G
Article: BONE MARROW TRANSPLANTATION. 1995;15(3):331-335

ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN SWEDEN

BOLME P; HENTER JI; WINIARSKI J; ELINDER G; LJUNGMAN P; LONNERHOLM G; RINGDEN O
Article: CLINICAL AND DIAGNOSTIC VIROLOGY. 1995;3(2):139-153

CMV PCR MONITORING IN LEUKOCYTES OF TRANSPLANT PATIENTS

EHRNST A; BARKHOLT L; LEWENSOHNFUCHS I; LJUNGMAN P; TEODOSIU O; STALAND A; RINGDEN O; TYDEN G; JOHANSSON B
Article: NORDISK MEDICIN. 1995;110(12):320-321

[Infections following bone marrow transplantation].

Ljungman P; Andersson J; Sparrelid E
Show more

All other publications

Letter: LEUKEMIA. 2023;37(9):1933-1938

Update of recommendations for the management of COVID-19 in patients with haematological malignancies, haematopoietic cell transplantation and CAR T therapy, from the 2022 European Conference on Infections in Leukaemia (ECIL 9)

Cesaro S; Mikulska M; Hirsch HH; Styczynski J; Meylan S; Cordonnier C; Navarro D; von Lilienfeld-Toal M; Mehra V; Marchesi F; Besson C; Masculano RC; Beutel G; Einsele H; Maertens J; de la Camara R; Ljungman P; Pagano L
Review: LANCET HAEMATOLOGY. 2023;10(4):e295-e305

Endemic or regionally limited parasitic and fungal infections in haematopoietic stem-cell transplantation recipients: a Worldwide Network for Blood and Marrow Transplantation (WBMT) Review

Muhsen IN; Galeano S; Niederwieser D; Koh MBC; Ljungman P; Machado CM; Kharfan-Dabaja MA; de la Camara R; Kodera Y; Szer J; Rasheed W; Cesaro S; Hashmi SK; Seber A; Atsuta Y; Saleh MFM; Srivastava A; Styczynski J; Alrajhi A; Almaghrabi R; Abid MB; Chemaly RF; Gergis U; Brissot E; El Fakih R; Riches M; Mikulska M; Worel N; Weisdorf D; Greinix H; Cordonnier C; Aljurf M
Review: LANCET HAEMATOLOGY. 2023;10(4):e284-e294

Endemic or regionally limited bacterial and viral infections in haematopoietic stem-cell transplantation recipients: a Worldwide Network for Blood and Marrow Transplantation (WBMT) Review

Muhsen IN; Galeano S; Niederwieser D; Koh MBC; Ljungman P; Machado CM; Kharfan-Dabaja MA; de la Camara R; Kodera Y; Szer J; Rasheed W; Cesaro S; Hashmi SK; Seber A; Atsuta Y; Saleh MFM; Srivastava A; Styczynski J; Alrajhi A; Almaghrabi R; Abid MB; Chemaly RF; Gergis U; Brissot E; El Fakih R; Riches M; Mikulska M; Worel N; Weisdorf D; Greinix H; Cordonnier C; Aljurf M
Corrigendum: FRONTIERS IN IMMUNOLOGY. 2023;14:1195142

Different recovery patterns of CMV-specific and WT1-specific T cells in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: impact of CMV infection and leukemia relapse (vol 13, 1027593, 2023)

Luo X-H; Poiret T; Liu Z; Meng Q; Nagchowdhury A; Ljungman P
Review: TRANSPLANT INFECTIOUS DISEASE. 2022;24(6):e13977

Cytomegalovirus in the transplant setting: Where are we now and what happens next? A report from the International CMV Symposium 2021.

Kotton CN; Torre-Cisneros J; International CMV Symposium Faculty; Aguado JM; Alain S; Baldanti F; Baumann G; Boeken U; de la Calle M; Carbone J; Ciceri F; Comoli P; Couzi L; Danziger-Isakov L; Fernández-Ruiz M; Girmenia C; Grossi PA; Hirsch HH; Humar A; Kamar N; Kotton C; Ljungman P; Malagola M; Mira E; Mueller N; Sester M; Teng C-LJ; Torre-Cisneros J; Ussetti P; Westall G; Wolf D; Zamora M
Letter: HAEMATOLOGICA. 2022;107(6):1479-1482

Reduced immunogenicity of a third COVID-19 vaccination among recipients of allogeneic hematopoietic stem cell transplantation

Einarsdottir S; Martner A; Nicklasson M; Wiktorin HG; Arabpour M; Tornell A; Vaht K; Waldenstrom J; Ringlander J; Bergstrom T; Brune M; Hellstrand K; Ljungman P; Lagging M
Review: LEUKEMIA. 2022;36(6):1467-1480

Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European Conference on Infections in Leukaemia (ECIL 9)

Cesaro S; Ljungman P; Mikulska M; Hirsch HH; Von Lilienfeld-Toal M; Cordonnier C; Meylan S; Mehra V; Styczynski J; Marchesi F; Besson C; Baldanti F; Cordoba Masculano R; Beutel G; Einsele H; Azoulay E; Maertens J; de la Camara R; Pagano L
Corrigendum: BONE MARROW TRANSPLANTATION. 2022;57(2):331

Correction to: Special issues related to the diagnosis and management of acquired aplastic anemia in countries with restricted resources, a report on behalf of the Eastern Mediterranean Blood and Marrow Transplantation (EMBMT) Group and Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation (SAAWP of EBMT).

Iftikhar R; Ahmad P; de Latour R; Dufour C; Risitano A; Chaudhri N; Bazarbachi A; De La Fuente J; Höchsmann B; Osman Ahmed S; Gergis U; Elhaddad A; Halkes C; Albeirouti B; Alotaibi S; Kulasekararaj A; Alzahrani H; Ben Othman T; Cesaro S; Alahmari A; Rihani R; Alshemmari S; Hamidieh AA; Bekadja M-A; Passweg J; Al-Khabori M; Rasheed W; Bacigalupo A; Chaudhry Q-U; Ljungman P; Marsh J; El Fakih R; Aljurf M; Eastern Mediterranean Blood and Marrow Transplanta; Severe Aplastic Anemia Working Party of the Europe
Letter: BONE MARROW TRANSPLANTATION. 2022;57(2):299-301

Defining the impact of SARS-COV-2 on delivery of CAR T-cell therapy in Europe: a retrospective survey from the CTIWP of the EBMT

Ghorashian S; Malard F; Yuksel MK; Mauff K; Hoogenboom JD; Urbano-Ispizua A; Kuball J; de la Camara R; Ljungman P; Ruggeri A; Chabannon C
Editorial comment: HEMASPHERE. 2021;5(12):e662

The EHA Research Roadmap: Infections in Hematology

Cordonnier C; Ljungman P; Cesaro S; Hirsch HH; Maschmeyer G; von Lilienfeld-Toal M; Vehreschild M; Mikulska M; Emonts M; Gennery AR; Neofytos D; Bochud P-Y; Einsele H; Maertens J
Letter: LEUKEMIA. 2021;35(12):3585-3588

Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group

Spanjaart AM; Ljungman P; de La Camara R; Tridello G; Ortiz-Maldonado V; Urbano-Ispizua A; Barba P; Kwon M; Caballero D; Sesques P; Bachy E; Di Blasi R; Thieblemont C; Calkoen F; Mutsaers P; Maertens J; Giannoni L; Nicholson E; Collin M; Vaz CP; Metafuni E; Martinez-Lopez J; Dignan FL; Ribera J-M; Nagler A; Folber F; Sanderson R; Bloor A; Ciceri F; Knelange N; Ayuk F; Kroger N; Kersten MJ; Mielke S
Editorial comment: BLOOD. 2021;138(14):1208-1209

One step at a time

Schoemans H; Ljungman P
Editorial comment: HAEMATOLOGICA. 2021;106(10):2783-2787

Successful pregnancies after transplantation of ovarian tissue retrieved and cryopreserved at time of childhood acute lymphoblastic leukemia - a case report

Rodriguez-Wallberg KA; Milenkovic M; Papaikonomou K; Keros V; Gustafsson B; Sergouniotis F; Wikander I; Perot R; Borgstrom B; Ljungman P; Barbany G
Review: JOURNAL FOR IMMUNOTHERAPY OF CANCER. 2021;9(6):e002630

COVID-19 in immunocompromised populations: implications for prognosis and repurposing of immunotherapies

Goldman JD; Robinson PC; Uldrick TS; Ljungman P
Corrigendum: BONE MARROW TRANSPLANTATION. 2021;56(3):755

Correction: The challenge of COVID-19 and hematopoietic cell transplantation: EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy.

Ljungman P; Mikulska M; de la Camara R; Basak GW; Chabannon C; Corbacioglu S; Duarte R; Dolstra H; Lankester AC; Mohty M; Montoto S; Murray J; de Latour RP; Snowden JA; Yakoub-Agha I; Verhoeven B; Kröger N; Styczynski J; European Society for Blood and Marrow Transplantat
Corrigendum: FRONTIERS IN IMMUNOLOGY. 2021;12:813838

Haplotype Motif-Based Models for KIR-Genotype Informed Selection of Hematopoietic Cell Donors Fail to Predict Outcome of Patients With Myelodysplastic Syndromes or Secondary Acute Myeloid Leukemia (vol 11, 584520, 2021)

Schetelig J; Baldauf H; Koster L; Kuxhausen M; Heidenreich F; de Wreede LC; Spellman S; van Gelder M; Bruno B; Onida F; Lange V; Massalski C; Potter V; Ljungman P; Schaap N; Hayden P; Lee SJ; Kroeger N; Hsu K; Schmidt AH; Yakoub-Agha I; Robin M
Corrigendum: BONE MARROW TRANSPLANTATION. 2020;55(9):1884

Correction: Long-term outcome after allogeneic hematopoietic stem cell transplantation for Shwachman-Diamond syndrome: a retrospective analysis and a review of the literature by the Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation (SAAWP-EBMT).

Cesaro S; Pillon M; Sauer M; Smiers F; Faraci M; de Heredia CD; Wynn R; Greil J; Locatelli F; Veys P; Uyttebroeck A; Ljungman P; Chevalier P; Ansari M; Badell I; Güngör T; Salim R; Tischer J; Tecchio C; Russell N; Chybicka A; Styczynski J; Krivan G; Smith O; Stein J; Afanasyev B; Pochon C; Menconi MC; Bosman P; Mauro M; Tridello G; de Latour RP; Dufour C
Letter: BRITISH JOURNAL OF HAEMATOLOGY. 2020;189(5):e213-e217

Treosulfan conditioning for allogeneic transplantation in multiple myeloma - improved overall survival in first line haematopoietic stem cell transplantation - a large retrospective study by the Chronic Malignancies Working Party of the EBMT

Gran C; Wang J; Nahi H; Koster L; Gahrton G; Einsele H; Niittyvoupio R; Edinger M; Beelen D; Ciceri F; Bornhaeuser M; Finke J; de Wreede LC; Ljungman P; Mielke S; Tischer J; Garderet L; Schoenland S; Yakoub-Agha I; Kroeger N
Review: BLOOD. 2020;135(19):1619-1629

How I treat CMV reactivation after allogeneic hematopoietic stem cell transplantation

Einsele H; Ljungman P; Boeckh M
Editorial comment: BLOOD. 2020;135(17):1413-1414

Is antiviral therapy against HHV-6B beneficial?

Ljungman P
Corrigendum: BONE MARROW TRANSPLANTATION. 2020;55(4):838-839

Benchmarking of survival outcomes following haematopoietic stem cell transplantation: A review of existing processes and the introduction of an international system from the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) (vol 55, pg 681, 2019)

Snowden JA; Saccardi R; Orchard K; Ljungman P; Duarte RF; Labopin M; McGrath E; Brook N; de Elvira CR; Gordon D; Poirel HA; Ayuk F; Beguin Y; Bonifazi F; Gratwohl A; Milpied N; Moore J; Passweg J; Rizzo JD; Spellman SR; Sierra J; Solano C; Sanchez-Guijo F; Worel N; Gusi A; Adams G; Balan T; Baldomero H; Macq G; Marry E; Mesnil F; Oldani E; Pearce R; Perry J; Raus N; Schanz U; Tran S; Wilcox L; Basak GW; Chabannon C; Corbacioglu S; Dolstra H; Kuball J; Mohty M; Lankester A; Montoto S; Nagler A; Styczynski J; Yakoub-Agha I; de Latour RP; Kroeger N; Brand R; de Wreede LC; van Zwet E; Putter H
Review: BONE MARROW TRANSPLANTATION. 2020;55(4):681-694

Benchmarking of survival outcomes following haematopoietic stem cell transplantation: A review of existing processes and the introduction of an international system from the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)

Snowden JA; Saccardi R; Orchard K; Ljungman P; Duarte RF; Labopin M; McGrath E; Brook N; de Elvira CR; Gordon D; Poirel HA; Ayuk F; Beguin Y; Bonifazi F; Gratwohl A; Milpied N; Moore J; Passweg J; Rizzo JD; Spellman SR; Sierra J; Solano C; Sanchez-Guijo F; Worel N; Gusi A; Adams G; Balan T; Baldomero H; Macq G; Marry E; Mesnil F; Oldani E; Pearce R; Perry J; Raus N; Schanz U; Tran S; Wilcox L; Basak GW; Chabannon C; Corbacioglu S; Dolstra H; Kuball J; Mohty M; Lankester A; Montoto S; Nagler A; Styczynski J; Yakoub-Agha I; de Latour RP; Kroeger N; Brand R; de Wreede LC; van Zwet E; Putter H
Review: BONE MARROW TRANSPLANTATION. 2020;55(1):110-116

Incidence and outcome of Kaposi sarcoma after hematopoietic stem cell transplantation: a retrospective analysis and a review of the literature, on behalf of infectious diseases working party of EBMT

Cesaro S; Tridello G; van der Werf S; Bader P; Socie G; Ljungman P; McQuaker G; Giardino S; Uckan-Cetinkaya D; Anagnostopoulos A; Ozdogu H; Schots R; Jindra P; Ladetto M; Schroyens W; Mikulska M; Styczynski J
Editorial comment: CLINICAL MICROBIOLOGY AND INFECTION. 2019;25(12):1451-1453

Reporting infectious complications in haematology clinical trials should be improved

Cordonnier C; Maschmeyer G; Cesaro S; Ljungman P
Editorial comment: LANCET INFECTIOUS DISEASES. 2019;19(9):921-922

Varicella zoster virus vaccine in patients with haematological malignancies

Ljungman P
Review: LANCET INFECTIOUS DISEASES. 2019;19(8):e260-e272

Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the 2017 European Conference on Infections in Leukaemia (ECIL 7)

Ljungman P; de la Camara R; Robin C; Crocchiolo R; Einsele H; Hill JA; Hubacek P; Navarro D; Cordonnier C; Ward KN; Greinix H; Slavin M; De Greef J; Maertens J; Hubacek P; Racil Z; Lundgren J; Bergeron A; Cordonnier C; Di Blasi R; Herbrecht R; Lortholary O; Robin C; Thiebaut A; Einsele H; Lehrnbecher T; Maschmeyer G; Mellinghoff S; Penack O; Roilides E; Kassa C; Averbuch D; Busca A; Cesaro S; Crocchiolo R; Gallo G; Mikulska M; Nosari AM; Pagano L; Viscoli C; Blijlevens N; Donnelly P; Koltan PS; Styczynski J; de Sousa AB; Klyasova G; Aljurf M; Drgona L; de la Camara R; Duarte R; Martino R; Navarro D; Rovira M; Einarsdottir S; Ljungman P; Paukssen K; Wenneras C; Calandra T; Akova M; de lavallade H; Ward KN; Hill JA; Dubel L; Mills L; Rupp M; Sanchez S; Zeitler S
Review: INFECTIOUS DISEASES. 2019;51(7):479-484

Management of BK-virus infection - Swedish recommendations

Dalianis T; Eriksson B-M; Felldin M; Friman V; Hammarin A-L; Herthelius M; Ljungmang P; Molne J; Wennberg L; Swartling L
Letter: LANCET INFECTIOUS DISEASES. 2019;19(7):694-695

2017 ECIL 7 vaccine guidelines

Cordonnier C; Mikulska M; Einarsdottir S; Cesaro S; Ljungman P
Published conference paper: LANCET INFECTIOUS DISEASES. 2019;19(6):e188-e199

Vaccination of patients with haematological malignancies who did not have transplantations: guidelines from the 2017 European Conference on Infections in Leukaemia (ECIL 7)

Mikulska M; Cesaro S; de Lavallade H; Di Blasi R; Einarsdottir S; Gallo G; Rieger C; Engelhard D; Lehrnbecher T; Ljungman P; Cordonnier C; Akova M; Aljurf M; Averbuch D; Bergeron A; Blijlevens N; de Sousa AB; Busca A; Calandra T; Crocchiolo R; De Greef J; de la Camara R; Donnelly P; Drgona L; Duarte R; Einsele H; Greinix H; Herbrecht R; Hill J; Hubacek P; Kassa C; Klyasova G; Koltan S; Lortholary O; Lundgren J; Maertens J; Martino R; Maschmeyer G; Mellinghoff S; Navarro D; Nosari AM; Pagano L; Paukssen K; Penack O; Racil Z; Robin C; Roilides E; Rovira M; Slavin M; Styczynski J; Thiebaut A; Viscoli C; Ward K; Wenneras C
Published conference paper: LANCET INFECTIOUS DISEASES. 2019;19(6):e200-e212

Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7)

Cordonnier C; Einarsdottir S; Cesaro S; Di Blasi R; Mikulska M; Rieger C; de Lavallade H; Gallo G; Lehrnbecher T; Engelhard D; Ljungman P; Akova M; Aljurf M; Averbuch D; Bergeron A; Blijlevens N; de Sousa AB; Busca A; Calandra T; Cesaro S; Crocchiolo R; De Greef J; de la Camara R; Donnelly P; Drgona L; Duarte R; Einarsdottir S; Einsele H; Greinix H; Herbrecht R; Hill J; Hubacek P; Kassa C; Klyasova G; Koltan S; Lortholary O; Lundgren J; Maertens J; Martino R; Maschmeyer G; Mellinghoff S; Navarro D; Nosari AM; Pagano L; Paukssen K; Penack O; Racil Z; Robin C; Roilides E; Rovira M; Slavin M; Styczynski J; Thiebaut A; Viscoli C; Ward K; Wenneras C
Review: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2018;73(12):3221-3230

European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia

Maertens JA; Girmenia C; Bruggemann RJ; Duarte RF; Kibbler CC; Ljungman P; Racil Z; Ribaud P; Slavin MA; Cornely OA; Donnelly JP; Cordonnier C
Review: TRANSPLANTATION AND CELLULAR THERAPY. 2018;24(11):2324-2336

Human Herpesvirus-6B Reactivation Is a Risk Factor for Grades II to IV Acute Graft-versus-Host Disease after Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis

Phan TL; Carlin K; Ljungman P; Politikos I; Boussiotis V; Boeckh M; Shaffer ML; Zerr DM
Review: TRANSPLANTATION AND CELLULAR THERAPY. 2018;24(10):2101-2109

Comparative Efficacy and Safety of Different Antiviral Agents for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation: A Systematic Review and Meta-Analysis

Gagelmann N; Ljungman P; Styczynski J; Kroeger N
Editorial comment: ANNALS OF ONCOLOGY. 2018;29(6):1348-1349

Stringent vaccination of cancer patients: is it that important

Weber T; Ljungman P
Review: CLINICAL INFECTIOUS DISEASES. 2018;66(4):617-631

Use of Viral Load as a Surrogate Marker in Clinical Studies of Cytomegalovirus in Solid Organ Transplantation: A Systematic Review and Meta-analysis

Natori Y; Alghamdi A; Tazari M; Miller V; Husain S; Komatsu T; Griffiths P; Ljungman P; Orchanian-Cheff A; Kumar D; Humar A
Review: TRANSPLANTATION AND CELLULAR THERAPY. 2017;23(10):1614-1621

Measuring Immune Response to Commonly Used Vaccinations in Adult Recipients of Allogeneic Hematopoietic Cell Transplantation

Kennedy LB; Li Z; Savani BN; Ljungman P
Editorial comment: BLOOD. 2017;130(8):961-962

Chromosomally integrated HHV-6: a new piece of the puzzle

Ljungman P
Letter: ANNALS OF ONCOLOGY. 2017;28(7):1672-1673

Lethal aplastic anemia caused by dual immune checkpoint blockade in metastatic melanoma

Helgadottir H; Kis L; Ljungman P; Larkin J; Kefford R; Ascierto PA; Hansson J; Masucci G
Review: BLOOD. 2017;129(13):1753-1762

Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel

de Witte T; Bowen D; Robin M; Malcovati L; Niederwieser D; Yakoub-Agha I; Mufti GJ; Fenaux P; Sanz G; Martino R; Alessandrino EP; Onida F; Symeonidis A; Passweg J; Kobbe G; Ganser A; Platzbecker U; Finke J; van Gelder M; van de Loosdrecht AA; Ljungman P; Stauder R; Volin L; Deeg HJ; Cutler C; Saber W; Champlin R; Giralt S; Anasetti C; Kroeger N
Letter: BONE MARROW TRANSPLANTATION. 2016;51(11):1518-1521

High incidence of severe chronic GvHD after HSCT with sibling donors. A single center analysis

Remberger M; Afram G; Sundin M; Uhlin M; LeBlanc K; Bjorklund A; Mattsson J; Ljungman P
Review: HAEMATOLOGICA. 2016;101(7):803-811

Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelines

Styczynski J; van der Velden W; Fox CP; Engelhard D; de la Camara R; Cordonnier C; Ljungman P
Review: LANCET INFECTIOUS DISEASES. 2016;16(5):606-617

Management of viral hepatitis in patients with haematological malignancy and in patients undergoing haemopoietic stem cell transplantation: recommendations of the 5th European Conference on Infections in Leukaemia (ECIL-5)

Mallet V; van Boemmel F; Doerig C; Pischke S; Hermine O; Locasciulli A; Cordonnier C; Berg T; Moradpour D; Wedemeyer H; Ljungman P
Editorial comment: LANCET HAEMATOLOGY. 2016;3(3):e102

Does cytomegalovirus viral load in stem-cell transplant recipients matter?

Ljungman P
Review: BLOOD REVIEWS. 2016;30(2):139-147

Vaccinations in patients with hematological malignancies

Tsigrelis C; Ljungman P
Review: BRITISH JOURNAL OF HAEMATOLOGY. 2016;172(4):497-511

The challenge of antibiotic resistance in haematology patients

Blennow O; Ljungman P
Review: BONE MARROW TRANSPLANTATION. 2015;50(7):899-903

Pretransplant vaccinations in allogeneic stem cell transplantation donors and recipients: an often-missed opportunity for immunoprotection?

Harris AE; Styczynski J; Bodge M; Mohty M; Savani BN; Ljungman P
Editorial comment: BLOOD. 2015;125(11):1683-1684

Enterovirus D68: a new threat to hematology patients?

Ljungman P
Letter: TRANSPLANTATION. 2014;98(12):e95-e96

Allogeneic Hematopoietic Cell Transplantation for GATA2 Deficiency in a Patient With Disseminated Human Papillomavirus Disease

Maeurer M; Magalhaes I; Andersson J; Ljungman P; Sandholm E; Uhlin M; Mattsson J; Ringden O
Review: CURRENT OPINION IN HEMATOLOGY. 2014;21(6):466-469

The role of cytomegalovirus serostatus on outcome of hematopoietic stem cell transplantation

Ljungman P
Editorial comment: JOURNAL OF INFECTIOUS DISEASES. 2014;209(8):1151-1152

Respiratory Syncytial Virus in Hematopoietic Cell Transplant Recipients: Factors Determining Progression to Lower Respiratory Tract Disease

Ljungman P
Review: VACCINE. 2013;32(1):4-10

Priorities for CMV vaccine development

Krause PR; Bialek SR; Boppana SB; Griffiths PD; Laughlin CA; Ljungman P; Mocarski ES; Pass RF; Read JS; Schleiss MR; Plotkin SA
Letter: BONE MARROW TRANSPLANTATION. 2013;48(10):1366-1367

Human parvovirus B19 in pediatric and adult recipients of allogeneic hematopoietic stem cell transplantation

Ohrmalm L; Gustafson I; Lindblom A; Norbeck O; Johansson J-E; Brune M; Ljungman P; Broliden K
Editorial comment: BLOOD. 2013;122(7):1101-1102

CMV: a warrior against leukemia?

Ljungman P
Review: TRANSPLANT INFECTIOUS DISEASE. 2013;15(3):219-232

European guidelines for prevention and management of influenza in hematopoietic stem cell transplantation and leukemia patients: summary of ECIL-4 (2011), on behalf of ECIL, a joint venture of EBMT, EORTC, ICHS, and ELN

Engelhard D; Mohty B; de la Camara R; Cordonnier C; Ljungman P
Corrigendum: LUPUS. 2013;22(6):653

Autologous haematopoietic stem cell transplantation for systemic lupus erythematosus: data from the European Group for Blood and Marrow Transplantation registry (vol 22, pg 245, 2013)

Alchi B; Jayne D; Labopin M; Demin A; Sergeevicheva V; Alexander T; Gualandi F; Gruhn B; Ouyang J; Rzepecki P; Held G; Sampol A; Voswinkel J; Ljungman P; Fassas A; Badoglio M; Saccardi R; Farge D
Review: BONE MARROW TRANSPLANTATION. 2013;48(4):574-580

HHV-6 encephalitis in umbilical cord blood transplantation: a systematic review and meta-analysis

Scheurer ME; Pritchett JC; Amirian ES; Zemke NR; Lusso P; Ljungman P
Review: BONE MARROW TRANSPLANTATION. 2013;48(2):168-173

Supportive care in severe and very severe aplastic anemia

Hoechsmann B; Moicean A; Risitano A; Ljungman P; Schrezenmeier H
Review: CLINICAL INFECTIOUS DISEASES. 2013;56(2):258-266

Fourth European Conference on Infections in Leukaemia (ECIL-4): Guidelines for Diagnosis and Treatment of Human Respiratory Syncytial Virus, Parainfluenza Virus, Metapneumovirus, Rhinovirus, and Coronavirus

Hirsch HH; Martino R; Ward KN; Boeckh M; Einsele H; Ljungman P
Review: TRANSPLANT INFECTIOUS DISEASE. 2012;14(6):555-563

European guidelines for diagnosis and treatment of adenovirus infection in leukemia and stem cell transplantation: summary of ECIL-4 (2011)

Matthes-Martin S; Feuchtinger T; Shaw PJ; Engelhard D; Hirsch HH; Cordonnier C; Ljungman P
Review: CLINICAL MICROBIOLOGY AND INFECTION. 2012;18:93-99

Vaccination of immunocompromised patients

Ljungman P
Review: EUROPEAN RESPIRATORY JOURNAL. 2012;40(4):990-1013

The risk of tuberculosis in transplant candidates and recipients: a TBNET consensus statement

Bumbacea D; Arend SM; Eyuboglu F; Fishman JA; Goletti D; Ison MG; Jones CE; Kampmann B; Kotton CN; Lange C; Ljungman P; Milburn H; Morris MI; Muller E; Munoz P; Nellore A; Rieder HL; Sester U; Theodoropoulos N; Wagner D; Sester M
Letter: BONE MARROW TRANSPLANTATION. 2011;46(4):621

Vaccination of SCT recipients

Ljungman P; Small TN
Review: ANTICANCER RESEARCH. 2011;31(3):939-944

Full Myeloablative Conditioning and an Unrelated HLA Mismatched Donor Increase the Risk for BK Virus-positive Hemorrhagic Cystitis in Allogeneic Hematopoetic Stem Cell Transplanted Patients

Dalianis T; Ljungman P
Editorial comment: TRANSPLANTATION AND CELLULAR THERAPY. 2011;17(1):S2-S5

Viral Infections in Immunocompromised Patients

Englund J; Feuchtinger T; Ljungman P
Letter: LANCET INFECTIOUS DISEASES. 2010;10(8):506-507

Solid-organ transplants and the risks of pandemic influenza

Ljungman P
Letter: BRITISH JOURNAL OF HAEMATOLOGY. 2010;150(3):377-379

Should irradiated blood products be given routinely to all patients with aplastic anaemia undergoing immunosuppressive therapy with antithymocyte globulin (ATG)? A survey from the European Group for Blood and Marrow Transplantation Severe Aplastic Anaemia Working Party

Marsh J; Socie G; Tichelli A; Schrezenmeier H; Hochsmann B; Risitano AM; Fuehrer M; Bekassy AN; Korthof ET; Locasciulli A; Ljungman P; Bacigalupo A; Camitta B; Young NS; Passweg J
Meeting abstract: HUMAN IMMUNOLOGY. 2009;70:S100

MAINTAINED TOLERANCE OF NK CELLS EXPRESSING INHIBITORY KIR FOR NON-SELF LIGANDS IN HLA-MATCHED SIBLING STEM CELL TRANSPLANTATION

Schaffer M; Bjorklund A; Fauriat C; Ringden O; Remberger M; Ljungman P; Ljunggren H-G; Malmberg K-J
Review: TRANSPLANT INFECTIOUS DISEASE. 2009;11(5):383-392

Outcome of treatment of Epstein-Barr virus-related post-transplant lymphoproliferative disorder in hematopoietic stem cell recipients: a comprehensive review of reported cases

Styczynski J; Einsele H; Gil L; Ljungman P
Review: BLOOD. 2009;113(23):5711-5719

How I treat cytomegalovirus in hematopoietic cell transplant recipients

Boeckh M; Ljungman P
Published conference paper: CLINICAL INFECTIOUS DISEASES. 2009;48(10):1392-1401

Randomized Study of Early versus Late Immunization with Pneumococcal Conjugate Vaccine after Allogeneic Stem Cell Transplantation

Cordonnier C; Labopin M; Chesnel V; Ribaud P; De la Camara R; Martino R; Ullmann AJ; Parkkali T; Locasciulli A; Yakouben K; Pauksens K; Einsele H; Niederwieser D; Apperley J; Ljungman P
Review: BONE MARROW TRANSPLANTATION. 2009;43(10):757-770

Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia

Styczynski J; Reusser P; Einsele H; de la Camara R; Cordonnier C; Ward KN; Ljungman P; Engelhard D
Letter: BRITISH JOURNAL OF HAEMATOLOGY. 2008;143(5):751-753

Transmission of chronic lymphocytic leukaemia from a blood stem cell sibling donor to the recipient

Nahi H; Jansson M; Sander B; Ljungman P; Hagglund H
Review: BONE MARROW TRANSPLANTATION. 2008;42(10):637-641

Influenza vaccination in hematopoietic SCT recipients

Ljungman P; Avetisyan G
Review: BONE MARROW TRANSPLANTATION. 2008;42:S70-S72

CMV infections after hematopoietic stem cell transplantation

Ljungman P
Review: BONE MARROW TRANSPLANTATION. 2008;42(4):227-240

Management of CMV, HHV-6, HHV-7 and Kaposi-sarcoma herpesvirus (HHV-8) infections in patients with hematological malignancies and after SCT

Ljungman P; de la Camara R; Cordonnier C; Einsele H; Engelhard D; Reusser P; Styczynski J; Ward K
Review: TRANSPLANTATION. 2008;86(2):183-191

Antifungal therapy strategies in hematopoietic stem-cell transplant recipients: Early treatment options for improving outcomes

Chandrasekar P; Ljungman PT
Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2008;14(2):118-119

ROLE OF RITUXIMAB FOR PROPHYLACTIC OR PREEMPTIVE THERAPY OF EBV-DNA-emia AND THERAPY OF EBV-PTLD IN HSCT RECIPIENTS: A SYSTEMATIC REVIEW

Styczynski J; Einsele H; de la Camara R; Engelhard D; Reusser P; Ward KN; Ljungman P
Review: BLOOD. 2008;111(2):534-536

Polymorphisms, in the chemokine (C-X-C motif) ligand 10 are associated with invasive aspergillosis after allogeneic stem-cell transplantation and influence CXCL10 epression in monocyte-derived dendritic cells

Mezger M; Steffens M; Beyer M; Manger C; Eberle J; Toliat M-R; Wienker TF; Ljungman P; Hebart H; Dornbusch HJ; Einsele H; Loeffler J
Editorial comment: MEDICAL ONCOLOGY. 2007;24(3):354-356

Relapse of preB-ALL after rituximab treatment for chronic graft versus host disease.: Implications for its use?

Deneberg S; Lerner R; Ljungman P; Ringden O; Hagglund H
Published conference paper: JOURNAL OF CLINICAL VIROLOGY. 2006;37:S87-S91

Human herpesvirus-6 infection in solid organ and stem cell transplant recipients

Ljungman P; Singh N
Editorial comment: CLINICAL INFECTIOUS DISEASES. 2006;43(8):1031-1039

Clinical research in the lay press: Irresponsible journalism raises a huge dose of doubt

Anaissie EJ; Segal BH; Graybill JR; Arndt C; Perfect JR; Kleinberg M; Pappas P; Benjamin D; Rubin R; Aberg JA; Adderson EE; Adler-Shohet FC; Akan H; Akova M; Almyroudis NG; Alexander BD; Andes D; Arrieta A; Baddley JW; Barron MA; Belzberg H; Boucher HW; Boyce TG; Casadevall A; Chandrasekar PH; Cleary JD; Cordonnier C; Cornely OA; Cuenca-Estrella M; Daly JS; Daoura N; Denning DW; dePauw B; de Repentigny L; Dignani MC; Dismukes WE; Donnelly JP; Donowitz GR; Dupont B; Drusano G; Ellis M; Espinel-Ingroff A; Fishman JA; Fleming R; Forrest G; Ghannoum M; Goldman M; Grazziutti M; Greene JN; Greenberg RN; Gubbins PO; Hadley S; Herbrecht R; Hiemenz JW; Hope W; Hospenthal DR; Husain S; Ito JI; Jacobson RM; Johnson M; Keating MR; Kett DH; Knapp K; Kontoyiannis DP; Krcmery VC; Larsen R; Laverdiere M; Ljungman P; Lortholary O; Maertens J; Marriott D; Mattiuzzi G; McGinnis MR; Morris M; Nucci M; Odds FC; Pankey GA; Patterson T; Pfaller M; Razonable RR; Reboli AC; Rinaldi MG; Roberts GD; Rodriguez Tudela JL; Rotstein C; Ruhnke M; Schuster M; Shoham S; Sia IG; Siebel N; Silviera F; Singh N; Sobel J; Solomkin JS; Sorrell TC; Steinbach WJ; Temesgen Z; Tortorano A; Vartivarian S; VerWeij P; Viscoli C; Viviani MA; Walker RC; Wheat JL; Wiley J; Williamson P; Wingard JR; Yu VL; Zaoutis T
Published conference paper: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2006;28(4):292-296

Viridans group streptococci in blood culture isolates in a Swedish university hospital: antibiotic susceptibility and identification of erythromycin resistance genes

Westling K; Julander I; Ljungman P; Jalal S; Nord CE; Wretlind B
Review: TRANSFUSION MEDICINE REVIEWS. 2006;20(1):45-56

The role of photochemical treatment with amotosalen and UV-A light in the prevention of transfusion-transmitted cytomegalovirus infections

Roback JD; Conlan M; Drew WL; Ljungman P; Nichols WG; Preiksaitis JK
Review: BONE MARROW TRANSPLANTATION. 2004;34(8):657-665

Transmission of donor illness by stem cell transplantation:: should screening be different in older donors?

Niederwieser D; Gentilini C; Hegenbart U; Lange T; Moosmann P; Pönisch W; Al-Ali H; Raida M; Ljungman P; Tyndall A; Urbano-Ispizua A; Lazarus HM; Gratwohl A
Review: EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES. 2004;23(8):583-588

Treatment of adenovirus infections in the immunocompromised host

Ljungman P
Review: BRITISH JOURNAL OF HAEMATOLOGY. 2004;125(2):107-116

Risk of cytomegalovirus transmission by blood products to immunocompromised patients and means for reduction

Ljungman P
Published conference paper: HEMATOLOGY JOURNAL. 2004;5 Suppl 3:s63-s68

Viral infections: current diagnosis and treatment.

Ljungman P
Published conference paper: JOURNAL OF INFECTIOUS DISEASES. 2002;186:S99-S109

β-herpesvirus challenges in the transplant recipient

Ljungman P
Review: BRITISH JOURNAL OF HAEMATOLOGY. 2002;118(1):44-57

Prevention and treatment of viral infections in stem cell transplant recipients

Ljungman P
Published conference paper: INTERNATIONAL JOURNAL OF HEMATOLOGY. 2002;76:300

New strategies in the management of herpesvirus infections

Ljungman P
Editorial comment: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2002;34(4):316-319

Streptococcus viridans septicaemia: A comparison study in patients admitted to the departments of infectious diseases and haematology in a university hospital

Westling K; Ljungman P; Thalme A; Julander I
Published conference paper: CLINICAL INFECTIOUS DISEASES. 2001;33 Suppl 1:s15-s21

Prophylactic measures in the solid-organ recipient before transplantation.

Avery RK; Ljungman P
Published conference paper: TRANSPLANTATION PROCEEDINGS. 2001;33(1-2):1769-1770

An ethnic role for chronic, but not acute, graft-versus-host disease after HLA-identical sibling stem cell transplantation

Remberger M; Aschan J; Lönnqvist B; Carlens S; Gustafsson B; Hentschke P; Klaesson S; Mattsson J; Ljungman P; Ringdén O
Letter: BLOOD. 2001;98(5):1628

Response: Cidofovir against cytomegalovirus after allogeneic stem cell transplantation

Ljungman P; Cordonnier C
Published conference paper: TRANSPLANTATION AND CELLULAR THERAPY. 2001;7:5S-7S

Respiratory virus infections in stem cell transplant patients: The European experience

Ljungman P
Review: DRUGS. 2001;61(2):187-196

Prophylaxis against herpesvirus infections in transplant recipients

Ljungman P
Meeting abstract: EUROPEAN JOURNAL OF CANCER. 1999;35:S298

Lenograstim (glycosylated rHuG-CSF) post high-dose chemotherapy and PBPC transplant in breast cancer and NHL patients

Björkstrand B; Ljungman P; Juliusson G; Villman K; Cohen-Scali S
Meeting abstract: EUROPEAN JOURNAL OF CANCER. 1999;35:S297

Lenograstim (glycosylated rHuG-CSF) enables mobilization of enough PBPC in breast cancer and NHL patients from dose of 2.5 μg/kg/day

Björkstrand B; Ljungman P; Villman K; Juliusson G; Cohen-Scali S
Editorial comment: BONE MARROW TRANSPLANTATION. 1999;23(7):635-636

Immunization of transplant recipients

Ljungman P
Published conference paper: BONE MARROW TRANSPLANTATION. 1998;21 Suppl 2:S72-S74

Immune reconstitution and viral infections after stem cell transplantation.

Ljungman P
Published conference paper: BONE MARROW TRANSPLANTATION. 1998;21:S24-S27

Allogeneic stem cell transplantation for Fanconi anaemia

Guardiola P; Socié G; Pasquini R; Dokal I; Ortega JJ; van Weel-Sipman M; Marsh J; Locatelli F; Souillet G; Cahn JY; Ljungman P; Miniero R; Shaw J; Vermylen C; Archimbaud E; Bekassy AN; Krivan G; Di Bartolomeo P; Bacigalupo A; Gluckman E
Published conference paper: CELL BIOLOGY AND TRANSLATIONAL MEDICINE, VOL 14: STEM CELLS IN LINEAGE SPECIFIC DIFFERENTIATION AND DISEASE. 1998;451:493-497

Gene marking and gene therapy in multiple myeloma

Gahrton G; Björkstrand B; Dilber MS; Sundman-Engberg B; Ljungman P; Smith CIE
Published conference paper: TRANSPLANTATION PROCEEDINGS. 1997;29(7):3147-3149

Factors affecting risk of relapse and leukemia-free survival in HLA-identical sibling marrow transplant recipients with leukemia

Carlens S; Ringden O; Remberger M; Mattsson J; Aschan J; Hagglund H; Ljungman P
Published conference paper: TRANSPLANTATION PROCEEDINGS. 1997;29(7):3145-3146

Transplantation with unrelated bone marrow in leukemic patients above 40 years of age

Ringden O; Remberger M; Mattsson J; Aschan J; Hagglund H; Carlens S; Lonnqvist B; Sparrelid E; Ljungman P
Published conference paper: TRANSPLANTATION PROCEEDINGS. 1997;29(1-2):735-736

A low incidence of grade II to IV acute GVHD, but high mortality from, infection using HLA-A, -B, and -DR-identical unrelated donors and immunosuppression with ATG, cyclosporine, and methotrexate

Mattsson J; Ringden O; Aschan J; Barkholt L; Dalianis T; Hagglund H; Ljungman P; Lonnqvist B; Tollemar J; Winiarski J; Remberger M
Published conference paper: BONE MARROW TRANSPLANTATION. 1996;18 Suppl 2:80-85

Unrelated-donor bone marrow transplantation for Philadelphia chromosome-positive chronic myelogenous leukemia in children: experience of eight European Countries. The EBMT Paediatric Diseases Working Party.

Dini G; Rondelli R; Miano M; Vossen J; Gluckman E; Peters C; Bordigoni P; Locatelli F; Miniero R; Ljungman P; Saarinen U; Klingebiel T; Ortega J; Lanino E
Review: LEUKEMIA & LYMPHOMA. 1996;22(5-6):395-407

Aspects concerning busulfan pharmacokinetics and bioavailability

Hassan M; Ehrsson H; Ljungman P
Published conference paper: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, SUPPLEMENT. 1996;100:59-63

Cytomegalovirus infections in transplant patients

Ljungman P
Review: SEMINARS IN RESPIRATORY INFECTIONS. 1995;10(4):209-215

Cytomegalovirus pneumonia: presentation, diagnosis, and treatment.

Ljungman P
Letter: BONE MARROW TRANSPLANTATION. 1995;16(6):856-857

Transplantation with peripheral blood stem cells from unrelated donors without serious graft-versus-host disease

Ringden O; Lonnqvist B; Hagglund H; Ljungman P; Shanwell A; Lawlor E; Schmitz N
Published conference paper: TRANSPLANTATION PROCEEDINGS. 1995;27(6):3535

No beneficial effects, but severe side effects caused by recombinant human tissue plasminogen activator for treatment of hepatic veno-occlusive disease after allogeneic bone marrow transplantation

Hagglund H; Ringden O; Ljungman P; Winiarski J; Ericzon B; Tyden G
Published conference paper: TRANSPLANTATION PROCEEDINGS. 1995;27(6):3531-3532

Bone marrow transplantation for chronic myelogenous leukemia using unrelated donors: The experience at Huddinge Hospital

Aschan J; Ringden O; Ljungman P; Hagglund H; Klaesson S; Dalianis T; Remberger M
Published conference paper: TRANSPLANTATION PROCEEDINGS. 1995;27(6):3530

Risk factors for septicemia during aplastic period after allogeneic bone marrow transplantation

Sparrelid E; Hagglund H; Remberger M; Ljungman P; Malmborg AS; Winiarski J; Andersson J; Ringden O
Published conference paper: TRANSPLANTATION PROCEEDINGS. 1995;27(6):3528-3529

Less acute GVHD in patients receiving totally matched transplants from unrelated donors

Lonnqvist B; Ljungman P; Norrby M; Olerup O; Ringden O; Winiarski J
Letter: BLOOD. 1995;85(9):2640

THE GENOTYPE OF HEPATITIS-C VIRUS DOES NOT AFFECT SEVERITY OF LIVER-DISEASE AFTER BONE-MARROW TRANSPLANTATION

LOCASCIULLI A; PONTISSO P; ALBERTI A; BACIGALUPO A; LJUNGMAN P; FRICKHOFEN N
Other: BONE MARROW TRANSPLANTATION. 1995;15(5):799-801

BONE-MARROW TRANSPLANTATION IN 2 CHILDREN WITH CONGENITAL AMEGAKARYOCYTIC THROMBOCYTOPENIA

HENTER JJ; WINIARSKI J; LJUNGMAN P; RINGDEN O; OST A
Letter: BRITISH JOURNAL OF HAEMATOLOGY. 1995;89(3):691

Transmission of human T-lymphotrophic virus type 1 by bone marrow transplantation.

Miyoshi I; Murata N; Machida H; Taguchi H
Editorial comment: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 1995;:87-89

Workshop on CMV disease; Definitions, clinical severity scores, and new syndromes

Ljungman P; Plotkin SA
Show more

About me

Research

Articles

All other publications

News from KI

Events from KI